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Abstract 
The intention of the work described in this thesis was to identify whether the 
Notch signalling pathway is utilized by antigen presenting cells in order to influence 
CD4
+
 adaptive immune responses. The notion that Notch proteins may be involved 
in polarising CD4
+
 T cells is relatively recent and most of the work that had been 
done in this area so far has concentrated on the consequences of Notch signalling 
within T cells. In contrast, the work that I have done has focussed on Notch ligand 
expression by antigen presenting cells and addresses the question whether Notch 
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1.1 Bridging Innate and Adaptive Immunity 
 To successfully combat disease an organism must employ a measured and 
effective defensive mechanism. In mammals, it is critical that our immune response 
is capable of controlling infection and yet maintain the well-being of the host. This is 
accomplished by the cooperation of the innate immune system and the pathogen-
specific response elicited by the adaptive immune system. During immune challenge, 
antigen presenting cells (APCs) such as dendritic cells (DCs) and macrophages 
(MØs), can direct CD4
+
 T cells into a wide range of fates, including Th1, Th2, Th17 
and regulatory T cells and thus influence the outcome of the entire adaptive immune 
response (Zhu and Paul, 2008). Understanding the molecular mediators involved in 
this crucial juncture between innate and adaptive immunity has been a focus of 
immunological research for decades (Germain, 2004; Medzhitov and Janeway, 
1997). 
 The innate immune system comprises a wide variety of mechanisms 
immediately available for combating infectious diseases. It represents the front line 
of host defence, involving physical barriers presented by epithelial layers, chemical 
defences including antibacterial peptides, complement and lytic enzymes, as well as 
biological responses from innate immune cells patrolling the periphery (Fleer and 
Krediet, 2007). Importantly, however, innate responses are not thought to lead to any 
lasting immunity, nor are they specific for any particular pathogen. The defensive 
arsenal employed by the innate immune system is effective in combating many 
pathogens, however this system is constrained by relying on a limited and invariable 
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repertoire of pattern recognition receptors (PRRs) (Akira et al., 2006). The active 
innate cell types tasked with seeking, recognising and destroying pathogens are 
phagocytic cells, predominantly composed of MØs and neutrophils. By using a 
combination of antimicrobial peptides, Nitric oxide (NO) and lysosomes containing 
lowered pH and lytic enzymes, MØs and neutrophils can eliminate pathogens 
without the aid of the adaptive immune system (Aderem and Underhill, 1999; Dale et 
al., 2008). 
 It is only when innate host defences are impeded, avoided, or overwhelmed 
that the adaptive immune system is needed. In contrast to innate immunity, an 
adaptive immune response is specific for particular antigens (Ags) and is also 
capable of instilling immunological memory, so that prior infections trigger stronger 
and more immediate responses to subsequent infections (Ahmed and Gray, 1996; 
Dutton et al., 1998; Swain et al., 1996). The key aspect of the adaptive immune 
system is the inherent flexibility in its capacity to directly target foreign agents. This 
is made possible by the specialised antigen receptors on the surface of lymphocytes, 
which are generated by highly mutagenic and variable recombination events, 
ensuring that individual lymphocytes produce numerous copies of a single antigen 
receptor with a unique binding site (Bassing et al., 2002). Once primed, these 
lymphocytes undergo differentiation into pathogen-specific effector cells, in addition 
to memory cells, which allow the immune system to “remember” previous infectious 
encounters (Kallies, 2008).  
 It is at the interface of these two defence systems that APCs play their part in 
the fight against infection. By first assisting in the recognition of invading organisms, 
and then directing the lymphocyte response to that pathogen, APCs play a critical 
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role in the determination of the overall tone of the entire immune response 
(Banchereau and Steinman, 1998; Kapsenberg, 2003). Depending upon the 
pathogen-associated molecular patterns (PAMP) stimulus, APCs are primed for 
microbicidal activity or antigen presentation (Janeway and Medzhitov, 2002). A 
main premise of my work is ascertaining how these cells communicate the 
information necessary between innate recognition and the initiation and coordination 
of the adaptive immune response. 
 
1.2 Antigen Presenting Cells 
 A central theme of immunology in the early 1970s was understanding 
the mechanism of ‘immunogenicity’, the process by which Ag provokes an immune 
response (Steinman, 2007). A key component of this process was shown to be 
“immune response genes”, primarily major histocompatability complex (MHC) 
(Vyas et al., 2008). In humans, the genes encoding the antigen presenting proteins of 
the MHC, known as human leukocyte antigen (HLA) are found on chromosome 6 
and are recognised as the most variable region in the genome (Blackwell et al., 
2009). For MHC class I these genes include HLA-A, -B, -C, -E, -F and –G, while 
class II genes are comprised by HLA-DR, -DQ, -DM and –DP. The primary function 
of MHC I is to present antigens derived from intracellular processes, such as viral 
infections or intracellular bacteria, while MHC II exhibits antigens sampled from the 
extra-cellular milieu (Figure 1.1). In the case of MHC I, intracellular peptides are 
generated during catabolism of endogenous proteins within the cytoplasm. The 
generation of these peptides enlists specific proteases which degrade and process 
proteins into eight to ten amino acid fragments (Rock et al., 2004; York et al., 1999). 
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The proteases involved are typical of the normal turnover and degradation of proteins 
including the ubitquitin-proteasome system and aminopeptidases in both the 
cytoplasm and endoplasmic reticulum such as leucine aminopeptidase (Beninga et 
al., 1998), puromycin-senstive aminopeptidase (Stoltze et al., 2000), bleomycin 
hydrolase (Stoltze et al., 2000), tripeptidyl peptidase II (TPPII) (Seifert et al., 2003; 
Tanioka et al., 2003) and L-RAP (Tanioka et al., 2003). These aminopeptidases are 
required for trimming the precursor peptides released from the proteasome as these 
peptides typically contain an (N) terminal extension of several amino acids (Kloetzel, 
2004).  
 Following degradation, processing and trimming, intracellularly derived 
peptides are then transported to the endoplasmic reticulum by the transporter 
associated with antigen processing (TAP) (Kloetzel, 2004). Further trimming takes 
place by ER-resident aminopeptidases to produce peptides of the appropriate size to 
bind and stabilise MHC I molecules (Strehl et al., 2005). In this event, the MHC I 
heavy chain first assembles with !2-microglobulin and then with the peptide-loading 
complex (Jensen, 2007). Several of the proteins involved in peptide loading and 
stable MHC complexes including tapasin, TAP1, TAP2, !2-microglobulin and 
proteasome components are upregulated upon exposure to IFN-" (Peaper and 
Cresswell, 2008). Once MHC I has been properly folded and peptide-bound it is 
transported to outer the cell membrane.via the Golgi complex where antigen can be 
presented to CD8+ T cells (Jensen, 2007). 
In contrast to the MHC I pathway, MHC II antigen presentation focuses on 
potential extracellular pathogens by sampling antigens via the endocytic pathway 
(Jensen, 2007). Extracellular antigens are placed within the phagosome which then 
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fuses with lysosomes to form a phagolysosome. It is within this compartment that 
extracellular antigens first interact with nascent MHC II molecules (Bryant and 
Ploegh, 2004). MHC II is formed by # and ! chains as well as an invariant chain 
within the endoplasmic reticulum (ER) (Lamb and Cresswell, 1992; Marks et al., 
1990). The invariant chain occupies the peptide-binding site preventing premature 
peptide loading. After fusion with the endosomal vesicles, lysosomal proteases 
gradually degrade the invariant chain leaving behind an internal segment (CLIP) 
(van Niel et al., 2008). Importantly, the generation of CLIP by cathepsin S-mediated 
proteolysis removes the previous targeting information embedded in the cytoplasmic 
domain of the invariant chain, as well as liberating the MHC II-#! dimers (van Niel 
et al., 2008). Once CLIP has been replaced by exogenous antigen with the aid of the 
MHC-like molecule HLA-DM, the MHC-peptide complex is thought to be 
transported to cell surface by transforming the MHC II-containing vesicles into 
tubular structures directed towards the site of T cell interaction (Boes et al., 2003; 
Vyas et al., 2007). Once on the cell surface, peptide loaded MHC II is ready to 
present antigen to CD4+ T cells. 
Most cells have the capacity to present peptides on MHC I molecules, which 
is essential for identification of virus-infected cells by cytotoxic T lymphocytes, 
whereas the cells which express MHC II are far more exclusive. Select cell types, 
particularly DCs, are less stringent in their differentiation between endogenous and 
exogenous Ags and both sources of Ags can be presented by MHC I (Heath et al., 
2004). The ability to process and present exogenous Ag on MHC I is referred to as 
‘cross presentation’ (Heath et al., 2004).  
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Cells which are capable of expressing Ag upon MHC II receptors can be 
broadly defined as APCs, prime examples of which include DCs, MØs and B cells 
(Jensen, 2007). Other cell types can be induced to express MHC II during infection 
including eosinophils (Shi, 2004), mast cells (Mekori and Metcalfe, 1999; Stelekati 
et al., 2007) and even "$ T cells (Scotet et al., 2008). Although under certain 
conditions all of these cell types may carry out the process of antigen presentation, 
the primary APCs are considered to be DCs, MØs and B cells (Jensen, 2007; Vyas et 
al., 2008). The designation of DCs as ‘professional’ APCs is due to their constitutive 
expression of MHC II, Ag acquisition via phagocytosis, expression of pathogen 
recognition receptors (PRRs) and the capacity to influence CD4+ T cell 
differentiation through both co-stimulatory expression as well as cytokines (Janeway 
and Medzhitov, 2002).  
 
1.2.1 B cells 
 B lymphocytes are understood best for their role in humoral immunity. By 
differentiating into memory cells or plasma cells and secreting antigen-specific 
antibodies, B cells act as the first line of defence for adaptive immunity and provide 
the mechanism by which most vaccines work (Chen and Jensen, 2008; Gray et al., 
2007; Parker, 1993). However, the capacity for B cells to function as APCs, 
providing both co-stimulatory molecules and cytokines, while influencing T cell 
differentiation in vivo should not be neglected. Historically, B cells have been 
considered poorer APCs due to in vitro studies demonstrating inefficient presentation 
of Ag that was not specific for their B cell receptor (BCR) (Sallusto and 
Lanzavecchia, 1994). Although B cells provided with Ag that is recognisable by their 
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BCR present Ag as efficiently as DCs (Sallusto and Lanzavecchia, 1994), the fact 
that there are very few antigen-specific B cells during the beginning of infection 
appears to rule out a substantial role for B cells as the initiators of T cell priming. 
Furthermore, other work has shown that B cell-deficient mice can be fully capable of 
inducing T cell responsiveness (Chen and Jensen, 2008; Epstein et al., 1995; Vella et 
al., 1996). These results have led to the perception that B cells are not as proficient at 
inducing naïve T cell differentiation as DCs and that, instead, they are much better at 
displaying Ag to previously expanded T cell populations (Gray et al., 2007). 
   
1.2.2 Macrophages 
DCs and MØs are ubiquitously distributed cells that fulfil significant roles in 
the immune system. Both are bone marrow-derived with potent phagocytic 
properties and the capacity to induce T cell polarization (Banchereau and Steinman, 
1998). During inflammation MØs have three major functions; phagocytosis, antigen 
presentation and immunomodulation via cytokine production (Fujiwara and 
Kobayashi, 2005). Although MØs participate in the induction of an immune response 
through antigen presentation and the consequent polarisation of naïve T cells, 
evidence suggests that their primary function is in combating infectious organisms 
through the induction of antimicrobial molecules (Martinez-Pomares and Gordon, 
2007; Seljelid and Eskeland, 1993).  
Recently MØ activation has been shown to be plastic, rapid and fully 
reversible depending on the stimulus, indicating that in addition to combating 
inflammation, MØs also participate in its resolution (Benoit et al., 2008; Fujiwara 
and Kobayashi, 2005). MØs have also been found in most tissues and rapidly 
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redeploy to sites of infection or inflammation (Pozzi et al., 2005). Early studies 
implied that MØs were responsible for the stimulation of primary immune responses. 
However, at the time it was not known that DCs could acquire and cross-present Ag 
from other cells (Askonas et al., 1968; Pozzi et al., 2005). More recently, it has been 
shown by adoptive transfer that MØs can prime naïve CD8+ T cells to proliferate and 
mature into both effector and memory cells (Pozzi et al., 2005).  
Although less well understood than their proinflammatory role during acute 
microbial infection, it is becoming increasingly clear that macrophages can also 
display an ‘alternative’ activation state triggered by Th2 cytokines such as IL-4 and 
IL-13 (Gordon, 2003). These alternatively activated macrophages (AAM%s) have 
been suggested to be involved in both wound healing and tissue remodelling during 
Th2 infections and allergy (Loke et al., 2002; Nair et al., 2005; Sandler et al., 2003). 
Importantly, reliable molecular indicators for AAM%s have been identified 
including Ym1, RELM# and arginase 1 (Hesse et al., 2001; Nair et al., 2005; Raes et 
al., 2002a). However, the origins of these cells, as well as the mediators other than 
Th2 cytokines necessary for their induction, remain largely unknown (Loke et al., 
2007). 
 
1.2.3 Dendritic Cells 
Steinman and Cohn identified distinct morphological features, including 
‘dendrites’, within spleen cells prepared from mouse peripheral lymphoid organs in 
1973 and named these cells DCs (Steinman and Cohn, 1973). Concurrent work by 
Knight and others illustrated the trafficking of veiled cells (later described as DCs) 
and their interaction with lymphocytes as activators and as the carriers of contact 
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sensitizers (Balfour et al., 1985; Knight et al., 1982). Unfortunately, purifying this 
new cell type from the body to enable further characterisation proved to be difficult, 
both due to their low frequency (1-2% of the total leukocytes) and a lack of available 
identification markers (Steinman and Cohn, 1973). With the advent of reliable in 
vitro culture techniques, a wide array of functional and developmental studies were 
then able to be carried out, and it became clear that multiple and heterogenous 
subsets of DCs exist (Gluckman et al., 1997; Liu, 2001; Lutz et al., 1999; O'Garra 
and Trinchieri, 2004; Sato and Fujita, 2007; Shortman and Liu, 2002; Wilson and 
O'Neill, 2003).  
DC progenitors in the bone marrow give rise to circulating precursors that 
migrate towards tissues, where they reside in an immature state in search of 
pathogens or danger signals (Banchereau et al., 2000; Matzinger, 1998). In an 
immature state DCs retain a heightened capacity for endocytosis and phagocytosis 
but have low expression of both MHC and co-stimulatory molecules (Sato and 
Fujita, 2007). Following capture of Ag, DCs migrate towards lymphoid tissue and 
proceed to initiate naïve T cell immune responses from Ag-specific T cells 
(Banchereau et al., 2000). During the migration process, DCs also acquire a mature 
phenotype, including changes in morphology, increased MHC and costimulatory 
marker expression, loss of endocytic capacity and phagocytic receptors and the 
activation of Ag-processing machinery (Reis, 2006). Functionally mature DCs then 
migrate to the lymph nodes, facilitated by the expression of chemokine receptor 
CCR7, whose ligands are produced by the cells of the lymphatic vessels or in the T 
cell areas of secondary lymphoid tissue (Gunn et al., 1999; Kellermann et al., 1999; 
Sallusto et al., 1999). 
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The tissue in which DCs reside appears to influence the subset into which 
they develop, which may play a role in their comparative capacity to be either 
phagocytic and migratory or present Ag and polarise T cells. Within lymphoid 
tissues, follicular DCs and germinal center DCs participate in activation and 
selection of B cells, or as strong APCs for resident T cells, respectively (Sato and 
Fujita, 2007). Thymic DCs, meanwhile, are suggested to be involved in the negative 
selection of T cells (Gallegos and Bevan, 2006). DCs present within the epidermis 
are unusually slow in their migration towards lymphatic tissue (Valladeau et al., 
1999) and, as a result, are thought to play a largely immunoregulatory role, as they 
arrive after immune responses are underway (Kissenpfennig et al., 2005; Randolph 
et al., 2008).  
The basic definition of murine DCs is typically confined to cells expressing 
CD11c, MHC II, and a combination of CD4, CD8#, CD11b and CD205 (Sato and 
Fujita, 2007). Murine DCs display a great deal of heterogeneity in this regard, with 
subsets including CD4+CD8#-, CD4-CD8#+, CD4-CD8#- (DN) and CD11c+B220+ 
plasmacytoid DC (pDC) (Shortman and Liu, 2002). The T cell marker CD8 is 
expressed as an ##-homodimer by DCs rather than #!-heterodimer as is the case on 
T cells (Sato and Fujita, 2007). Although both CD8#+ and CD8#- DC subsets appear 
equally competent at driving T cell proliferation, in the past, CD8#+ DCs were 
considered the ‘lymphoid’ population which could be induced to secrete greater 
quantities of IL-12, whereas CD8#- DCs were thought to be the ‘myeloid’ 
population, which skew T cell responses towards Th2 (Maldonado-Lopez et al., 
1999; Pulendran et al., 1997; Pulendran et al., 1999). However, this perception is 
now thought to have been misconceived, given that expression of CD8# does not 
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necessarily delineate the haematopoietic origin of the DC precursor and that the 
nature of the DC precursor may bias, but does not determine, the phenotype of the 
resulting DC (Manz et al., 2001; Wu et al., 2001b). Ultimately, DCs and their 
precursors have demonstrated remarkable functional plasticity and are able to 
differentiate into different types of DC after encounters with various stimuli 
(Banchereau and Palucka, 2005). 
DCs have traditionally been considered to be the most proficient APC, as 
evidenced by mixed leukocyte reactions (MLR), which were used at the time as a 
model for graft rejection (Inaba and Steinman, 1984; Nussenzweig et al., 1980; 
Steinman and Witmer, 1978). The MLR utilizes the genetic incompatibility between 
T cells and MHC-expressing cells, which is quite frequent given the extent of 
polymorphism within MHC, leading to a T cell response (Steinman, 2007). These 
studies demonstrated that DCs were approximately 100 times more proficient at 
driving T cell proliferation than total spleen cells, despite accounting for only 1% of 
the splenic population (Steinman and Witmer, 1978). Subsequent work showed that, 
by upregulating co-stimulatory molecules and migrating to T cell areas of lymphoid 
organs, DCs are able to activate and expand antigen-specific naïve T cells 
(Banchereau and Steinman, 1998).  
 
1.3 Recognising Pathogens 
One of the conundrums of immunology in the 1970s and 1980s was how the 
adaptive immune system could discriminate between self and non-self (Matzinger, 
1998). It was recognised by Charles Janeway that one of the keys tasks of the innate 
immune system during the initial encounter with a pathogen is to discriminate 
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between non-infectious self and infectious non-self (Janeway, 1989; Janeway and 
Medzhitov, 2002). This hypothesis posited that, in addition to their role in bacterial 
killing and phagocytosis, APCs can discern the nature of the stimulus by expressing 
PRRs able to recognise evolutionarily conserved PAMPs (Janeway, 1989). In the 
intervening years, it has become clear that these various PRRs are crucial for linking 
the innate immune system to the appropriate activation of the adaptive immune 
system and provide a bridge between innate recognition and the engagement of 
acquired immunity (Fleer and Krediet, 2007). 
 
1.3.1 Toll-like Receptors 
Following Janeway’s remarkably prescient postulation, a major breakthrough 
in innate recognition occurred when human homologues of the evolutionarily 
conserved set of Drosophila receptors, known as ‘Toll’ receptors, were discovered 
(Medzhitov et al., 1997). These Toll receptors were crucial both for dorsal-ventral 
development in fly embryos (Belvin and Anderson, 1996) as well as, importantly, 
antifungal defence (Lemaitre et al., 1996). The human homologue to the Drosophila 
Toll receptor was called the Toll-like receptor (TLR), and was later found to be the 
receptor recognising lipopolysaccharide (LPS), which is now designated TLR4 
(Poltorak et al., 1998).  
TLRs are type1 membrane proteins characterized by an ectodomain capable 
of PAMP recognition as well as a cytoplasmic Toll/IL-1 receptor (TIR) region 
required for downstream signalling (Fleer and Krediet, 2007). To date there are 11 
different human TLRs and 13 TLRs in mice, each recognizing a unique set of 
microbial agents (Janeway and Medzhitov, 2002; Kawai and Akira, 2007; Pasare and 
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Medzhitov, 2004b). TLRs can be categorised into several groups depending on the 
types of PAMPs they recognise. TLRs 1, 2, 4 and 6 all recognise lipids components. 
For example, as mentioned above, TLR4 recognises the LPS component of Gram-
negative bacteria such as Salmonella typhimurium (Pasare and Medzhitov, 2004a). 
Many TLRs form heterodimers with either other TLRs, or non-TLR proteins such as 
CD36 for increased PAMP recognition capacity. TLR2, for example, is able to form 
heterodimers with TLR1 or TLR6 in order to discern lipoproteins or Gram-positive 
bacteria, petidoglycans and zymosan (Akira et al., 2006). TLR5 and TLR11 
recognise protein ligands including bacterial flagellin (Kawai and Akira, 2007). 
TLRs 3, 7, 8 and 9, meanwhile, detect foreign nucleic acids and are localized 
intracellularly, typically in endosomes (Kawai and Akira, 2007). TLR3 has been 
shown to recognise double-stranded RNA, TLR7 and TLR8 detect single-stranded 
RNA as well as imidazoquinoline-like molecules, while TLR9 is activated by CpG 
DNA (Akira et al., 2006). Thus, merely through the expression of TLRs alone, there 
is a great deal of diversity in the range of organisms that are recognisable by innate 
immune cells. 
 
1.3.2 Other PRRs 
In addition to TLRs, currently the most extensively studied of PRRs, a range 
of other molecules exist that may fulfil a similar pattern-recognition function. The 
retinoic acid-inducible gene 1 (RIG-1) like receptors (RLRs) bind viral double-
stranded RNA (Thompson and Locarnini, 2007). Similar to TLRs, signalling through 
RLRs can induce the production of proinflammatory cytokines and type I interferons 
by innate immune cells, through the transcription factor NF-&B (Kaisho and Tanaka, 
 14 
2008; Saito and Gale, 2008). Furthermore, the nucleotide-binding oligomerization 
domain (NOD) -like family of receptors function as PRRs within the cytoplasm, 
detecting bacterial-associated products such as peptidoglycans (Creagh and O'Neill, 
2006; van Vliet et al., 2007). Finally, C-type lectin receptors (CLRs), which 
normally function as cell-cell adhesion molecules, have also been shown to recognise 
pathogens and facilitate antigen presentation (van Vliet et al., 2007). CLRs such as 
dendritic cell-specific intercellular adhesion molecule-3-grabbing non- integrin (DC-
SIGN) and dendritic cell-associated C-type lectin 1 (DECTIN-1) are specific for 
glycans, including mannose structures and Lewis antigens, which are expressed by a 
variety of pathogens including viruses, bacteria and even the parasitic helminth 
Schistosoma mansoni (Meyer et al., 2005; Saunders et al., 2008; van Liempt et al., 
2007). 
 
1.3.3 TLR Signalling 
 After recognising their respective PAMPs, TLRs recruit adaptor proteins 
capable of perpetuating the pathogen recognition signal (Figure 1.2). Adaptor 
proteins utilised in this fashion include myeloid differentiation factor 88 (MyD88), 
TIR domain-containing adaptor protein (TIRAP), TIR-domain-containing adaptor-
inducing interferon-! (TRIF) and translocating chain-associating membrane 
(TRAM). MyD88 is a universal adaptor shared by all TLRs except TLR3, signalling 
through which ultimately leads to translocation of NF-&b to the nucleus, as well as 
the activation of MAP kinases (MAPK) (Underhill and Ozinsky, 2002). Importantly, 
TLR engagement induces the production and release of inflammatory signals by 
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innate immune cells including IL-1!, TNF#, IL-6, IL-10 and IL-12, chemokines and 
antimicrobial peptides (Kumagai et al., 2008).  
The association of TLRs with MyD88 stimulates the recruitment of members 
of the IL-1 receptor-associated kinases (IRAK), which then disassociate from 
MyD88 and interact with TNF receptor associated factor 6 (TRAF6). This interaction 
activates TGF-! activated kinase 1 (TAK1), a kinase in the MAPK family which, in 
turn, activates the I&B kinase (IKK) complex responsible for targeting the 
degradation of I&B and the subsequent translocation of NF-&B to the nucleus (Kawai 
and Akira, 2007). MyD88-deficient mice show a failure to activate NF-&B and 
induce inflammatory cytokines in response to TLR2, 5, 7 and 9 specific PAMPs. 
However, evidence suggests that a MyD88 independent pathway exists in TLR3 and 
TLR4 signalling. In these cases, TRIF was identified as an essential adaptor of the 
MyD88 independent pathway (Oshiumi et al., 2003; Yamamoto et al., 2002). TRIF-
deficient mice display defective IFN-" induction after LPS and poly IC stimulation 
(Hoebe et al., 2003; Yamamoto et al., 2003). NF-&B as well as MAPK activation is 
completely abolished in TRIF and MyD88 double deficient mice following LPS 
stimulation (Yamamoto et al., 2003). 
 However, the specificity of these responses is incompletely understood. It is 
thought that the association of these different intracellular signalling pathways, along 
with heterodimerisation and synergy between PRRs, cooperate to determine the 
appropriate host response (Kumagai et al., 2008). The extent to which a pathogen 
activates a variety of separate PRRs ultimately determines APC maturation state, 
achieving a specifically tailored activation status, capable of orchestrating the overall 
adaptive immune response (Napolitani et al., 2005).  
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Specific pairing or sets of different PRRs have been proposed to mediate host 
immunity. Dectin-1 and TLR-2 have been proposed to collaborate in the host 
response to fungal pathogens, and the activation of both pathways works 
synergistically in order to drive optimal cytokine, chemokine and co-stimulatory 
marker production by DCs primarily, but also by other APCs (Dennehy et al., 2008). 
It seems evident that pathogens activate a cascade of different PRRs and it is the 
synergy and collaboration of these pathways that ultimately leads to a specific 
maturation profile. 
 
1.4 APC Maturation  
The ultimate aim of APC activation is to translate environmental signals into 
a definitive pathogen-specific response and to dictate the fate of T cells capable of 
responding to that pathogen. Following stimulation in response to pathogens or 
danger signals, APCs generally lose their responsiveness to subsequent pathogen 
stimuli, while upregulating production of certain cytokines, co-stimulatory molecules 
and chemokine receptors (such as CCR7), in order to migrate towards the lymphoid 
tissue (Banchereau and Steinman, 1998; Kapsenberg, 2003). Following such 
migration, the activation and polarisation of naive CD4
+
 T cells is thought to be 
determined by three signals provided by the APC. The first signal is provided by 
peptide presented in the context of MHC II, which is bound by the appropriate T cell 
receptor- (TCR) bearing CD4
+
 cell. The second signal is co-stimulation provided by 
the APC, primarily mediated via CD28 on the T cell and CD80/CD86 on the APC, in 
whose absence T cells become anergic (Kapsenberg, 2003). Finally,  ‘signal 3’ 
represents the polarising signal provided by the APC, typically thought of as a 
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combination of cytokines and other molecules that could influence Th1, Th2, Th17 
(or other) development (Kalinski et al., 1999; Kapsenberg, 2003). 
It is quite important to separate two concepts with regards to DC maturation. 
As detailed by Reis e Sousa (2006), there is phenotypic maturation, as defined by the 
upregulation of MHC II and to co-stimulatory markers, as well as a functional 
maturation, wherein APCs acquire the ability to induce immunogenic T cell 
responses (as opposed to tolerance) (Reis, 2006). A functionally-mature APC utilises 
its arsenal of T cell polarising signals, as dictated by the nature of the stimulus 
encountered, in order to drive a pathogen-specific response. Characterising the scope 
of this arsenal in relation to different pathogens has become an underlying goal for 
understanding the interface between innate and adaptive immunity. 
 
1.4.1 Signal 2 
The second signal provided to CD4
+
 T cells during antigen presentation 
provides a crucial stimulus-driving effector function versus T cell anergy. Broadly, 
co-stimulatory molecules are defined as signals induced by ligation of membrane-
bound molecules that either synergize with or modify the signal provided through 
TCR-MHC engagement (Croft, 2003). Different profiles of activation marker 
expression can result in distinct APC phenotypes capable of directing different 
outcomes of T cell differentiation (as well as T cell tolerance) (Kapsenberg, 2003). 
Augmented expression of cell surface co-stimulatory molecules on APCs is one of 
the most significant early developments of early immune system activation (Carreno 
and Collins, 2002; Collins et al., 2005; Greenwald et al., 2005). The best 
characterised co-stimulatory molecules consist of two B7 family members CD80 
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(B7-1) and CD86 (B7-2), which bind to the same two receptors, CD28 and CTLA-4 
(CD152). CD28 is constitutively expressed on naïve T cells while the expression of 
CTLA-4, considered an inhibitory signalling mechanism, is upregulated on the T cell 
surface following activation (Carreno and Collins, 2002; Wang and Chen, 2004). 
Signalling through CD28 provides a potent signal in conjunction with an activated 
TCR, resulting in the induction of IL-2 and expression of CD25, and entry into the 
cell cycle (Alegre et al., 2001; Carreno and Collins, 2002; Greenwald et al., 2005). 
CD86 or CD80 binding to CD28 provides an important additional biochemical signal 
that enhances and prolongs those transduced by the TCR and its CD3 complex 
(Crow, 2006). There is some evidence that CD80 and CD86 may also play a role in 
retrograde signalling to APC, which can result in the induction of innate-effector 
function in M%s (Khan et al., 2007). Recently, five new members of the B7 family 
have also been discovered, including inducible costimulator (ICOS) ligand, PD-L1, 
PD-L2, B7-H3 and B7-H4 (Greenwald et al., 2005). All of these have been shown to 
be expressed on APCs and provide a potential new mechanism for regulating T cell 
activation and tolerance.  
 
1.4.2 Signal 3 
 Which subset a naïve CD4+ T cell will differentiate into is thought to be 
largely determined by the various molecular signals expressed by APCs during 
antigen presentation, sometimes termed ‘signal 3’ (Kapsenberg, 2003). The 
cytokines produced in the microenvironment in which naïve T helper cells are 
stimulated, are key to the development and regulation of the immune response. APC-
derived IL-12 has a direct and critical role in the Th1 process, stimulating production 
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of IFN-" by T cells (Kobayashi et al., 1989), although its provision by APC may not 
be absolutely necessary for Th1 induction in all cases (MacDonald and Pearce, 2002; 
Soares et al., 2007). IL-6 produced by DCs, M%s and B cells has been thought to 
play a crucial role in T cell activation by inhibiting T regulatory cell-mediated 
suppression (Pasare and Medzhitov, 2003). More recently IL-6 is has been shown to 
play a role moderating between the generation of Th17 T cells and T regulatory cells 
(Bettelli et al., 2006; Stockinger et al., 2007; Veldhoen et al., 2006), although APCs 
have yet to be shown to be the definitive source for this cytokine. However, in 
conjunction with IL-10, IL-6 is involved in a wide range of actions including the 
inhibition of Th1 cell responses (Fickenscher et al., 2002; Groux and Powrie, 1999; 
Langer et al., 2004; Moore et al., 2001; Wolk et al., 2002). In DCs, IL-10 can inhibit 
MHC II, CD86 and CD54 expression and suppress IL-1, IL-12 and tumour necrosis 
factor-# (TNF#) transcription, which is thought to be crucial for its anti-
inflammatory abilities (Liu et al., 2004; Steinbrink et al., 1997). TNF# is a highly 
pluripotent cytokine, but can be broadly considered a pro-inflammatory mediator and 
is considered a key player in processes such as septic shock (Wajant et al., 2003).  
In addition to cytokines, a range of surface molecules may provide signal 3 
for T cells. CD40 is a cell surface receptor whose association with T cell CD154 is 
thought to be essential for immune regulation as well as activation and function of 
APCs (Grewal and Flavell, 1998; van Kooten and Banchereau, 2000). DCs exposed 
to Th1 polarising Ag generally display increased CD40 expression, and ligation of 
CD40 with CD40L-expressing cells enhances their Th1-promoting capacity (de Jong 
et al., 2002). During cross-talk with T cells, CD40-CD40L results in the sustained 
activation of NF-&B and other transcription factors. This interaction in turn drives 
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increased expression of other T cell-polarizing factors, such as IL-12 (Hilkens et al., 
1997; O'Sullivan and Thomas, 2002; Snijders et al., 1998). 
OX40 (CD134) is another co-stimulatory molecule from the TNFR super 
family which is not expressed on resting T cells, but can be induced between 12-24 
hours after TCR/CD3 signalling (Gramaglia et al., 1998). Expression of OX40L by 
DCs, as well as other APCs, has been shown to be induced following activation; and 
its expression can be enhanced following CD40 signalling (Croft, 2003; Gramaglia et 
al., 1998; Murata et al., 2000; Stuber et al., 1995). Recently, OX40L has been shown 
to be particularly important for Th2, but not necessarily crucial for the generation of 
Th1 responses (Chen et al., 1999; Jenkins et al., 2007). 
 
1.5 Effector T helper Cells 
The purpose of antigen presentation is to activate T cells specific to the 
ongoing immune challenge, inducing proliferation and polarisation. The polarisation 
into specialised subsets of CD4+ effector T cells (Figure 1.3) is critical for mounting 
an effective response to diverse types of infectious micro-organisms. Originally, two 
distinct T helper subsets, named T helper 1 (Th1) and T helper 2 (Th2), were 
identified by their distinct expression of cytokines and functions (Coffman and 
Mosmann, 1991; Mosmann et al., 1986).  Later work established the CD4+ T cell 
lineages of T regulatory cells (Chen et al., 1994) and, most recently, Th17 cells 
(Weaver et al., 2006). Th cells play critical roles in orchestrating adaptive immune 
responses through the secretion of cytokines and chemokines that function to both 




Th1 CD4+ effector cells are integral to the proinflammatory responses against 
intracellular pathogens such as bacterial or viral infections, as well as some 
protozoan and fungal infections. This is mainly carried out through the production of 
IFN-" and other inflammatory cytokines, which in turn enhance the microbicidal 
activity of innate immune cells (Zhu and Paul, 2008). Th1 cells produce high levels 
of IFN-", lymphotoxin # and IL-2, along with expressing the transcription factors T-
bet (Szabo et al., 2000) and Stat1 (Lighvani et al., 2001). IFN-" production is 
important for activation of M%s (Suzuki et al., 1988), as well as the recruitment of 
lymphocytes and NK cells (Agnello et al., 2003; Zhu and Paul, 2008). IL-2, as well 
as being a T cell growth factor, is crucial for stimulation of CD8+ cells and the 
generation of Th1 memory (Darrah et al., 2007).  
 
1.5.2 Th2 
Th2 cells mediate host defence against extracellular parasites, including 
helminths, and are also important for the induction of allergic responses (Mosmann 
et al., 1986). T helper 2 (Th2) cells upregulate the transcription factor GATA3 and 
produce cytokines such as IL-4, IL-5, IL-9, IL-10, IL-13, IL-25 and IL-33 (Anthony 
et al., 2007; Perrigoue et al., 2008; Romagnani, 2000). The overall process mediating 
Th2 effector immunity is less well-understood than Th1, but involves the recruitment 
of eosinophils and mast cells, as well as class-switching to the release of IgE 
antibodies. IgE binds to the Fc'RI on basophils and mast cells leading to the 
secretion of active mediators such as histamine and serotonin (Le Gros et al., 1990; 
Swain et al., 1990; Zhu and Paul, 2008). Th2 cytokines are also responsible for the 
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induction of goblet cell hyperplasia and mucin production, recruitment of 
alternatively activated macrophages (AAMacs), and increase epithelial cell turnover 
and muscle hyper-contractility, but inhibit the functions of phagocytic cells (Anthony 
et al., 2007; Perrigoue et al., 2008; Romagnani, 2000). IL-4 is one of the key Th2 
mediators and is required for the maintenance of Th2 differentiation, as T cells from 
IL-4-/- mutant mice failed to produce Th2-derived cytokines (Kopf et al., 1993). IL-
13 is produced by activated T cells and is the main effector cytokine for the 
expulsion of helminths, the induction of airway hypersensitivity and fibrosis (Wynn, 
2003). IL-5 also plays an important role in the recruitment of eosinophils in addition 
to its effects on mast cells and Ig class switching (Coffman et al., 1989).  
 
1.5.3 T Regulatory Cells 
A third regulatory subset of CD4+ T cells (Treg) plays an essential role in the 
maintenance of a balanced response that is not harmful to the host while effectively 
resisting infection (Vignali et al., 2008). Treg cells are typically defined by high 
expression of the IL-2 receptor # chain (CD25), and transcription factor forkhead 
box P3 (Foxp3) (Askenasy et al., 2008). Regulatory T cells are thought to operate 
primarily at sites of inflammation, modulating immune reactions via cell-to-cell 
contact (Piccirillo et al., 2002). Using mechanisms such as perforin/granzyme, or 
Fas-ligand, Treg cells can directly kill effector cells either in the lymph nodes or in 
the target tissues; and thus deplete T cell effector functions (Banz et al., 2002; 
Gondek et al., 2005; Weber et al., 2006). Additionally, Treg cells can inhibit effector 
cell production or secretion of cytokines, such as IL-2, which are involved in the 
maintenance of an immune reaction (Piccirillo and Shevach, 2001; Thornton and 
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Shevach, 2000) as well as contributing their own immunomodulatory cytokines to 
the inflammatory environment (Cottrez and Groux, 2001; Zheng et al., 2004). 
 
1.5.4 Th17 
More recently, a new subset of effector CD4+ T cells with an independent 
lineage from Th1 and Th2 has been discovered, named Th17 cells. Studies have 
shown that these cells likely play a critical role in the defence against certain 
microbial pathogens, such as extracellular bacteria and fungi (Weaver et al., 2006), 
as well as in cancer and autoimmunity (Langrish et al., 2005). Th17 cells are 
generated in the context of IL-6 and TGF-! and subsequently produce IL-17A, IL-
17F, IL-21 and IL-22 in conjunction with the transcription factors ROR-"t (Ivanov et 
al., 2006; Yang et al., 2008) and STAT3 (Ouyang et al., 2008; Yang et al., 2007; 
Zhu and Paul, 2008). Although the precise function of Th17 cells in different disease 
settings remains unclear, there is increasing evidence that IL-17 promotes 
recruitment, activation, chemokine and cytokine production of both M%s and, 
particularly, neutrophils (Dragon et al., 2008; Mills, 2008; Ye et al., 2001a; Ye et al., 
2001b).  
 
1.5.5 Diversity of subsets 
 It should be noted that the examples previously given of various CD4+ T 
helper subsets represent the extreme cases in each category, and provide a somewhat 
simplistic overview of the known Th cell subsets. In addition to their effector 
functions, CD4
+
 T lymphocytes must also regulate both innate and adaptive immune 
responses. Typically, this has been attributed to the cross-regulation between subsets, 
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such as the down-modulation of Th2 functions through the production of IFN-" by 
Th1 cells, and conversely the dampening of Th1 responses by IL-10 secretion of Th2 
cells (Abbas et al., 1996; Coffman and Mosmann, 1991). That Th1 cells can, in some 
settings, produce IL-10 (Del Prete et al., 1993), even in conjunction with IFN-" 
secretion by the same Th1 cell (Jankovic et al., 2007), demonstrates the extent to 
which T helper cell function can be modified as a consequence of an ongoing 
immune response. Indeed, the CD4
+
 T cell response to any pathogen typically 
resolves in a ‘spectrum’ of T helper cells, marked both by the presence of multiple 
subsets, and the secretion of multiple cytokines within a subset. Furthermore, as 
research in this area continues, it is likely that our knowledge of different CD4
+
 T 
cell subsets will increase. The recent proposal of a possible ‘Th9’ subset of CD4
+
 T 
cells (Veldhoen et al., 2008) is an illustration of how we are still expanding our 
knowledge of potential CD4
+ 
T cell fates and the plasticity of their functions. 
 
1.6 Tissue microenvironment and complexities in vivo 
 Of course, a substantial amount of our knowledge of APC generated Th 
responses was derived from reductionist in vitro approaches, specifically designed to 
remove the complexities of an in vivo immune response. During live infections, 
interactions between APCs and T cells occur in the context of an entire network of 
cell types, all of which are capable of altering APC activation and the immune 
environment. The impact of tissue factors, such as thymic stromal lymphopoietin 
(TSLP) or IL-25, on the activation and function of DCs have only recently been 
investigated (Fort et al., 2001; Ito et al., 2005; Liu et al., 2007; Wang et al., 2007; 
Ziegler and Liu, 2006). Cytokine secretions by, or cell-to-cell interaction with, 
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epithelial cells, natural killer cells, basophils and others, all add an additional layer of 
complexity to the process by which DCs become activated. The fact that these 
environmental influences upon DC function are so poorly understood may, in part, 
explain our inability to identify mechanisms by which DCs drive Th2 responses. The 
investigation of these additional layers of complexity could be crucial for the 
discovery of these mechanisms. 
 
1.7 Effector Immunity to Complex Pathogens 
 Once the context of the adaptive immune response has been established, T 
effector cells facilitate pathogen termination or removal. The exact mechanisms 
employed are dependent upon the specifics of the infectious agent, whether it is viral, 
bacterial, protozoal, fungal, helminth, or any other form of disease. However, the 
complexities involved in an ongoing infection are often difficult to replicate in vitro. 
Many pathogens possess methods of immune system evasion, such as Salmonella 
(Bueno et al., 2007) or trypanosomes (Donelson et al., 1998). Larger metazoan 
pathogens, such as the helminth Schistosoma mansoni, present an especially complex 
challenge to the immune system due to multiple life cycle stages within the host 
(Gryseels et al., 2006; Pearce and MacDonald, 2002), a diverse array of potential 
Ags (Perona-Wright et al., 2006), and even the sheer size of the parasite presents a 
mechanical disruption to the immune system and facilitates tissue damage (Wynn et 
al., 2004). Ascertaining the impact of these additional complexities in vivo on the 
activation and function of APCs is essential for our understanding of the overall 




There are an estimated 200 million people in the developing world who are 
chronically infected with trematodes of the genus Schistosoma resulting in as many 
as 200,000 deaths a year (Chitsulo et al., 2000; Chitsulo et al., 2004; Pearce and 
Freitas, 2008). Females lay hundreds to thousands of eggs per day once a male-
female pair is established. These eggs are excreted in the urine or faeces and upon 
contact with water, hatch to release a free living stage called the miracidium 
(Gryseels et al., 2006). The miracidia then locate and infect the intermediate host, 
freshwater snails, and multiply asexually into cercarial larvae (Gryseels et al., 2006). 
Following 4-6 weeks of development, and at the cue of light, cercariae rupture out of 
the snail and swim in search of the definitive mammalian host. The cercariae attach 
to and penetrate the skin, and then migrate through the blood to the lungs before 
making their way to the portal vein of the liver (Gryseels et al., 2006). Once in the 
vasculature, schistosomes mature (about 4-6 weeks post-infection) and mate, starting 
the lifecycle over again. Accumulation of the egg stage of the parasite within tissues 
eventually causes the immunopathology that can ultimately be fatal (Chitsulo et al., 
2004; Pearce and MacDonald, 2002). 
 
1.8.1 Schistosomiasis and the Immune System 
The initial stages of schistosome infection provoke a mixed and muted 
Th1/Th2 response from the host immune system. Absence of host IL-7 or CD4
+
 cells 
both impairs schistosome growth and reduces egg burden (Davies et al., 2001; 
Davies and McKerrow, 2003; Pearce and Freitas, 2008; Wolowczuk et al., 1999). 
However, it is the production of eggs by female schistosomes, intended to pass 
through the body via the intestinal (S. mansoni and S. japonicum) or bladder (S. 
haematobium) lumen, which causes the most severe immunopathology during 
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schistosomiasis (Pearce and MacDonald, 2002). Following egg deposition, the 
overall immune response begins to categorically shift and by 8 weeks post-infection 
is strongly Th2 in character (Grzych et al., 1991; Pearce et al., 1991). The 
granulomatous inflammation and fibrosis around the parasite eggs lodged in the liver 
and intestines is the principle source of the cell-mediated immune reaction to S. 
mansoni (Pearce, 2005). From these eggs, proteolytic enzymes are secreted which 
provoke eosinophilic inflammatory reactions leading to fibrosis. The severity of 
pathology is dependent both on the extent of the infection and the intensity of the 
individual’s immune response (Gryseels et al., 2006). 
The role of Th2 differentiation is something of a double-edged sword in the 
course of S. mansoni infection: mice that are deficient in either the production of IL-
4 cytokine (Brunet et al., 1997; Fallon et al., 2000) or expression of IL-4 receptor 
(Herbert et al., 2004) suffer increased mortality following egg production. However, 
it has been shown that the inflammation induced by the eggs and the resulting host-
protective granulomas are dependent on Th2 differentiated CD4
+
 T cells, while the 
root cause of fibrosis is due to the cytokine IL-13, itself produced in abundance by 
Th2 cells (Pearce, 2005; Wynn et al., 2004).  
 
1.8.2 SEA 
A fundamental and as yet unanswered immunological question, is how DCs 
respond to Th2-inducing pathogens such as S. mansoni. Furthermore, it is currently 
unclear how such DCs then proceed to co-ordinate CD4
+
 T cell responses 
(MacDonald and Maizels, 2008). However, addressing this question is a daunting 
task, considering that all the life cycle stages of S. mansoni secrete a multitude of 
potential targets for immune recognition (Perona-Wright et al., 2006). Of the various 
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components produced by S. mansoni, soluble egg Ag (SEA) is the best characterised. 
SEA has been a particular focus of ongoing studies due to its ability to act both as an 
adjuvant (Okano et al., 1999; Okano et al., 2001) and for its remarkable capability to 
promote Th2 responses (Pearce and MacDonald, 2002; Perona-Wright et al., 2006). 
In contrast to bacterially derived stimuli, SEA induces very little DC upregulation of 
MHC II and no significant upregulation of cytokines or co-stimulatory markers such 
as CD80, CD86, CD54, CD40 or OX-40L (MacDonald et al., 2001). However, 
despite the lack of ‘classical’ signs of activation, SEA-pulsed DCs have proven to be 
potent initiators of SEA specific Th2 responses either following transfer into naïve 
mice (MacDonald et al., 2001), or through co-culture with ovalbumin-specific TCR 
transgenic T cells in vitro (Artis et al., 2005; Jankovic et al., 2004; Kane et al., 
2008). It remains unclear the mechanisms by which DCs are able to prime SEA-
specific Th2 responses, but the fact that SEA-pulsed DCs alone are sufficient to drive 
Th2 polarisation speaks both to the effectiveness of DCs as APCs and the 
immunogenicity of SEA. 
The lack of any known ‘signal 3’ candidates for the induction of Th2 
responses by DCs stands in stark contrast to the ever-increasing understanding of 
how DCs drive Th1 differentiation (MacDonald and Maizels, 2008). One explanation 
is that Th2 induction is merely a default pathway, the proscribed outcome in the 
absence of IL-12. However, during infections where Th2 responses are paramount 
for successful pathogen clearance, it would seem unlikely that host survival should 
depend entirely upon a default process. Identification of mechanisms by which DCs 
drive Th2 responses would answer many of the critical questions driving current 
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immunological research. A central theme of this thesis is determining whether Notch 
signalling may act as one of these mechanisms. 
 
1.9 Notch Background 
  Notch receptors and ligands provide an evolutionarily-ancient metazoan 
mechanism for signalling between neighbouring cells (Artavanis-Tsakonas et al., 
1999). First discovered in 1917, its name was derived from the notched wing 
phenotype apparent in partial loss of function Drosophila mutants (Mohr, 1919; 
Morgan, 1917). However, the field of Notch signalling would later be defined by its 
role as a ‘neurogenic’ gene, named for the mutant embryos displaying excessive 
neuronal differentiation at the expense of the epidermis (Lehman et al., 1983; 
Poulson, 1937). It was these studies that laid the foundation for further investigations 
establishing the core components of the Notch signalling apparatus. The Notch 
signalling pathway later became renowned for its extensive versatility. Over the 
years, analysis of genetic deficiency in both vertebrates and invertebrates has 
demonstrated the extraordinary extent to which metazoan development relies on 
Notch signalling, being utilized for exchanging amplification signals, determining 
molecular differences and even inducing apoptosis (Artavanis-Tsakonas et al., 1999).  
Notch-like proteins have been characterized in species as diverse as 
Caenorhabditis elegans, insects, sea urchins, mice and humans and, in all cases so 
far, mutations in the Notch receptor invariably result in developmental abnormalities 
that are usually lethal (Artavanis-Tsakonas et al., 1999). The first mammalian Notch 
homolog (Notch1) was discovered as a partner in a recurrent chromosomal 
translocation in a rare subtype of human T-cell acute lymphoblastic leukaemia 
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(Ellisen et al., 1991). In development, Notch signalling is thought to act as a tool 
used to direct cell fate in neurogenesis, differentiation of the epidermis and 
hematopoiesis (Artavanis-Tsakonas et al., 1999; Miele and Osborne, 1999). As a 
result of its fundamental role in a wide array of functions, Notch has been nicknamed 
by Miele and Osbourne, the “arbiter of differentiation and death” (Miele and 
Osborne, 1999).  
 
1.9.1 Elements of Notch Signalling 
The primary components of Notch signalling include ligands, receptors and a 
transcription factor of the CBF1/Su(H)/Lag1 (CSL) family (Figure 1.4). Each of the 
Notch receptors and ligands are conserved, single pass transmembrane proteins that 
are expressed on the cell surface. In mammals there are 4 types of receptor, Notch 1-
4, and two distinct families of ligand, Delta (1, 3 and 4) and Jagged (1 and 2) (Table 
1.1). The large extracellular domain of the Notch receptors and ligands contain 
multiple tandem EGF-like repeats as well as Notch/LIN 12 repeats. The intracellular 
region (N
ICD
) contains 6 tandem ankyrin repeats, a glutamine-rich domain and a 
PEST sequence (Artavanis-Tsakonas et al., 1999).  
One of the most fascinating aspects of the Notch pathway is its unique 
mechanism of signalling. Upon activation by Notch ligand, the intracellular domain 
of the Notch receptor is cleaved by presenilin-1 and the Notch intracellular domain 
(N
ICD
) is then transported to the nucleus. Rather than operating through a true 
cascade of signals, Notch utilizes a remarkably direct mechanism, wherein a portion 
of the receptor itself is directly involved in the nuclear activation of gene 
transcription (Lai, 2004). Once inside the nucleus, the N
ICD 
binds to the gene 
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repressor CSL/RBP-J& with the recruitment of additional proteins and modifies it to 
become an activator of gene transcription activating the Hairy-enhancer of split 
(HES) genes and other transcription factors (Robey and Bluestone, 2004).  The 
simple elegance of this arrangement has enabled the Notch pathway to function in an 
extraordinarily broad range of biological systems. 
 For successful Notch signalling three distinct cleavage events must occur. 
The first is mediated by a furin-like protease just external to the transmembrane 
subunit during transit to the outer membrane (Maillard et al., 2005). This creates a 
receptor with two noncovalently associated subunits (Maillard et al., 2005). The 
other two cleavage events are a direct result of ligand binding. In mammals, the 
metalloprotease ADAM10  (Kuzbanian in Drosophila) has been implicated in 
separating the extracellular domain from the transmembrane region (Tian et al., 
2008), while a presenilin-containing multiprotein complex with "(secretase  activity 
releases the N
ICD 
(Fortini, 2002). Following translocation to the nucleus, the N
ICD
 
binds the transcriptional activator CBF1/RBP-J& and  recruits Mastermind-like 
proteins (MAMLs) through its ankyrin repeats, creating a large protein complex 
capable of transcriptional activation (Maillard et al., 2004). Inhibition of either "-
secretase activity (Wolfe, 2001) or MAMLs ability to recruit other co-activators 
disables transcription of downstream targets (Maillard et al., 2004; Weng et al., 
2003). 
 Additional components are also important in the regulation of Notch 
signalling including Fringe, Deltex (Dt), Numb and others (Artavanis-Tsakonas et 
al., 1999; Maillard et al., 2003). At the extracellular level, Notch signalling can be 
modified by the Fringe family of proteins, glycosyl transferases which add N-
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acetylglucosamine to certain epidermal growth factor–like repeats of Notch 
receptors, promoting Notch signalling in response to Delta ligands and inhibiting 
Jagged-mediated Notch signalling (Haines and Irvine, 2003). The best studied of 
these proteins is Lunatic Fringe (Lnfg), which coordinates the timing and localization 
of Notch signalling during specific developmental processes, such as the somite 
segmentation clock during embryogenesis and is also important in thymopoiesis 
(Fleming et al., 1997; Haines and Irvine, 2003; Visan et al., 2006). Crucially, the 
glycolsylation of the extracellular domain of the Notch receptor by fringe proteins 
regulates the relative affinity for Notch ligands (Artavanis-Tsakonas et al., 1999; Lai, 
2004; Miele, 2006; Moloney et al., 2000). In contrast, Deltex and Numb are both 
intracellular modulators of Notch signalling. It is believed that Numb acts upstream 
of Notch and prevents nuclear translocation of the N
ICD 
(Berdnik et al., 2002)
 
while 
in mammalian cells Deltex has been shown to have both positive and negative upon 
Notch signalling (Izon et al., 2002; Matsuno et al., 1995; Matsuno et al., 1998; 
Ordentlich et al., 1998). Within the nucleus, N
ICD 
can be targeted for degradation by 
proteins such as SEL-10 and other kinases (Wu et al., 2001a). The vast majority of 
these Notch signalling proteins and other contributing factors are critical to the 
successful development of any metazoan organism. 
 
1.9.2 Notch Signalling Mechanics 
Although the basic core of the Notch signalling pathway is reasonably well 
understood, the mechanisms that regulate the transduction of that signal, or 
determine the downstream phenotype as a result of Notch signalling, is far more 
complex and less well characterized. Often, dramatic differences in signalling 
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between cells do not correlate with substantial differences in the expression levels of 
either Notch ligands or receptors (Maillard et al., 2005). The relative levels of Notch, 
Delta and Jagged ligands between interacting cells regulate the polarity, intensity and 
duration of signalling, highlighting the importance of gene dosage (Lai, 2004). 
Further, the full involvement of how Notch ligands activate Notch receptors remains 
unclear. It is believed that Notch signalling is confined to neighbouring cells due to 
the membrane tethering of both receptors and ligands (Lai, 2004). However, there is 
some evidence that soluble forms of various Notch ligands exist and that they are 
able to activate the Notch pathway (Sun and Artavanis-Tsakonas, 1997). 
A further complication with regards to Notch signalling pertains to the 
possibility of Notch receptors and ligands binding on the same cell (Artavanis-
Tsakonas et al., 1999). The mechanism underlying this cis-interaction between 
Notch proteins is not well understood. However, evidence suggests that it may act to 
inhibit Notch signalling with other cells (D'Souza et al., 2008; Glittenberg et al., 
2006; Jacobsen et al., 1998; Ladi et al., 2005; Micchelli et al., 1997; Sakamoto et al., 
2002). It is possible that cis-interactions would compete with trans-interactions for 
the same binding sites on Notch receptors (Glittenberg et al., 2006).  
Other complications include the prospect of CSL-independent mechanisms 
for Notch signalling, since analysis of mutant Notch receptors within mammalian 
cells has indicated that aberrant Notch signalling unable to activate a CSL-reporter 
gene was still able to mediate the downstream function of Notch signalling (Bush et 
al., 2001). The existence of CSL-independent Notch signalling remains controversial 
but, it has been proposed that an alternate pathway for Notch signalling may involve 
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elements of the Wingless pathway (Axelrod et al., 1996; Lai, 2004; Ramain et al., 
2001). 
One of the most intriguing aspects of Notch signalling lies in trying to 
understand how two different ligand families can drive two separate signalling 
responses, as they share the same mechanism for transcriptional activation. It 
remains largely unclear how N
ICD
 could retain “ligand memory” given that both 
Jagged and Delta ligands should lead to essentially the same intracellular signal 
within cells. The very observation that different ligands have specific, and often non-
overlapping expression patterns (Lindsell et al., 1996), and are not always 
interchangeable (Huppert et al., 1997; Jaleco et al., 2001), in addition to enzymes 
that selectively alter Notch receptor specificity, suggests unique functions of these 
molecules (Amsen et al., 2004; de La Coste and Freitas, 2006; Justice and Jan, 
2002).  
 
1.9.3 Notch and Immunity 
 Having noted that the notch1 gene was expressed in the developing 
mammalian thymus (Weinmaster et al., 1991, 1992), the first group to address the 





 T cell lineage decision (Robey et al., 1996). Constitutive 
expression of activated N
ICD
 within the thymus was found to encourage a bias 
towards CD8
+
 T cell lineage fate (Robey et al., 1996). In contrast, experiments using 
an inducible transgenic system, wherein a loxP flanked notch1 gene was under the 
control of an interferon-inducible promoter, demonstrated that the absence of notch1 
21 days after birth resulted in a dramatically reduced thymus size, as well as a 
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decrease in mature thymocytes (Radtke et al., 1999). These studies confirmed the 
speculation that Notch signalling may play an integral role in the development of the 
mammalian immune system, and formed a basis on which long-standing questions 
on lymphocyte development and peripheral immunity could be addressed.  
 
1.9.4 Notch in T cell development 
The question of how progenitor cells with equivalent potential for lineage 
differentiation commit to different cell fates has been integral to our understanding of 
lymphocyte development (Allman et al., 2002). Notch signalling has now been well 
established as a mechanism by which cell fate decisions can occur during 
lymphopoiesis (Maillard et al., 2005). Multiple studies have also demonstrated the 
importance of Notch signalling within the T cell versus B cell lineage decision (Han 
et al., 2002; Hozumi et al., 2004; Jaleco et al., 2001; Radtke et al., 1999). 
Inactivation of the Notch1 receptor was shown to completely block T lineage 
development and promote differentiation into B cells (Radtke et al., 1999). The 
inducible knockout of the transcription factor RBP-J& resulted in a similar phenotype 
(Han et al., 2002). Conversely, mice reconstituted with bone marrow constitutively 
expressing Notch1 blocked B cell development and promoted the emergence of an 
immature T cell population (Pui et al., 1999). The Notch2 receptor has been 
determined to be indispensable to the development of marginal zone B cells (MZB) 
and their precursors (Saito et al., 2003). It is noteworthy that the complete blockade 
of T cell development induced by notch1 deficiency suggests that other Notch 
receptors are unable to compensate for this loss. Why this is the case remains 
unclear.  
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Further studies have determined that the involvement of Notch signalling in 
lymphocytes extends beyond the T cell and B cell lineage decision. It is a 
contributing factor in the lineage choice between #! versus "$ T cells (Tanigaki et 
al., 2004), with reduced Notch1 activity favouring a "$ T cell fate (Washburn et al., 




 T cell development 
(Robey et al., 1996). Notch signalling both initiates and sustains T-cell lineage 
programmes throughout their differentiation, and the presentation of Notch ligands 
by stromal cells is considered a key element during T cell development in vitro 
(Schmitt and Zuniga-Pflucker, 2002). Indeed, N
ICD
 is the only transcriptional 
regulator that demonstrably promotes T cell development when over-expressed, 
although on its own Notch signalling is insufficient in determining these lineage 
decisions (Rothenberg et al., 2008). 
 
1.9.5 Notch in DC and M%  Differentiation 
Notch signalling is also thought to be involved in the differentiation and 
development of haematopoietic cells other than lymphocytes, such as DCs and MØs 
(Cheng et al., 2006; Cheng et al., 2003; Kumano et al., 2003; Ohishi et al., 2001). 
DC differentiation is critically dependent on bone marrow microenvironment; 
including a complex network of cytokines, as well as direct physical interaction 
between haematopoietic progenitor and stem cells with bone marrow stroma (Cheng 
et al., 2007). Although notch1 deficiency does not appear to affect myeloid 
development (Radtke et al., 2000; Radtke et al., 1999), constitutive expression of 
N
ICD 
reportedly inhibits the differentiation of myeloid progenitors into DCs (Bigas et 
al., 1998; Milner et al., 1996; Schroeder and Just, 2000a). However, a different 
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approach to examining DC phenotype in murine notch1 conditional knockouts 
concluded that DCs generated from Notch-deficient hematopoietic progenitor cells 
(HPCs) displayed reduced MHC II and co-stimulatory molecules, and concluded that 
Notch signalling was necessary, but not sufficient, for DC differentiation (Cheng et 
al., 2003). Further work supported the suggestion that interaction between 
differentiating myeloid cells and the bone marrow stroma employs Notch molecules 
in order to determine cell fate. Expression of a peptide mimicking human Jagged1 by 
a stromal cell line was shown to influence the cell fate decision of granulocytic 
differentiation, as well as inhibiting DC differentiation (Li et al., 1998). In a different 
study, soluble Jagged1 was able to induce maturation of monocyte-derived human 
DCs (Weijzen et al., 2002). In contrast, addition of immobilized Delta1 to myeloid 
precursors in the presence of M-CSF resulted in apoptosis, whereas Delta1 and GM-
CSF led to stable DC differentiation; suggesting that Delta1 drives precursor cells 
towards a DC fate and inhibits MØ differentiation (Ohishi et al., 2000). The presence 
of several apparently contradictory reports on the impact of Notch signalling on DC 
differentiation highlights the difficulty of drawing firm conclusions from such 
studies. The combination of several distinct methods of investigation, with a 
signalling pathway renowned for it’s sensitivity to dose and signal strength, likely 
contributes to this overall lack of understanding.  
 
1.9.6 Notch in Peripheral Immunity 
The initial suggestion that Notch signalling may be a direct mechanism by 
which APCs can influence T cell polarisation was proposed by Hoyne et al. (Hoyne 
et al., 2000a). Splenic APCs were transfected with human serrate1 (jagged1) by 
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retroviral mediated gene transfer and then used to immunise recipient mice (Hoyne et 
al., 2000b). In this model, overexpression of jagged1 by APCs suppressed the 
proliferation and cytokine production in CD4
+
 T cells (Hoyne et al., 2000b). Other 
direct evidence for an interaction between TCR and Notch signalling came from the 
observation that NICD1 over-expression in thymocytes reduced CD25 and CD69 
expression; indicating that Notch signalling inhibited activation (Benson et al., 2004; 
Izon et al., 2001). Additional work has suggested that pre-exposure of T cells to 
delta1-expressing cell lines inhibits transplantation rejection (Wong et al., 2003). 
However, the addition of Delta1 fusion protein to T cells stimulated with anti-CD3 
and CD28 mAbs promoted Th1 differentiation (Maekawa et al., 2003). In humans, 
overexpression of jagged1 by B lymphocytes inhibited the classical response to 
Epstein Barr Virus (EBV) Ag and promoted differentiation of IL-10 producing T 
regulatory cells (Vigouroux et al., 2003; Yvon et al., 2003). Other studies have 
promoted a role for Notch signalling in T cell proliferation, demonstrating that both 
gain of function, and Notch inhibition experiments affected T cell expansion 
following TCR activation (Adler et al., 2003; Palaga et al., 2003). Thus, the role of 
Notch in peripheral T cell function is complex, and may be context-dependent.  
Based on the growing knowledge of Notch ligand expression in the mature 
immune system, Amsen et al. (2004) hypothesized that, in addition to cytokine 
signalling and the surface expression of co-stimulatory factors, the Notch pathway 
may be a key factor in the differentiation of CD4
+
 effector cells. Expression of the 
Notch ligand family Delta, by APCs, was proposed to prime Th1 differentiation, 
while the Jagged family induced Th2 differentiation in vitro (Amsen et al., 2004). A 
subsequent in vivo study found that blocking signalling ability of Notch receptors 1-4 
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resulted in an impaired Th2, but not Th1, response (Tu et al., 2005). Although 
evidence is emerging that Notch has a function in immunity beyond its 
developmental role, the exact nature of Notch signalling and the relative contribution 
of the two ligand families in the adaptive immune response is far from clear. 
 
1.9.7 Notch and Human Disease 
 In addition to its evolutionarily conserved nature, unique signalling 
mechanism and surprisingly diverse array of functions, the Notch signalling pathway 
is also of keen interest due to its importance in several human diseases (Table 1.3). 
Due to its roles in cell differentiation and growth, as well as embryonic development 
and immunity aberrant Notch signalling has been implicated in cancer, neurological 
disorders and even autoimmunity. Notch receptors were recently identified as having 
oncogenic potential when a truncation of the notch1 transcript which induced a 
constitutively-active Notch1-intracelular domain was found in a subset of T-cell 
lymphoblastic leukemias (Ellisen et al., 1991). Further research indicated that 
constitutively active Notch1 or Notch3 signalling has a role in development of T-cell 
Acute Lymphoblastic Leukemia (T-ALL) in both animals and humans (Aster et al., 
2008; Chiaramonte et al., 2005; Jundt et al., 2008). 
 Notch signalling is also involved in human pathological conditions involving 
the vasculature including the congenital diseases CADASIL (cerebral autosomal 
dominant arteriopathy with subcortical infarcts and leukoencephalopathy) and 
Alagille syndrome (AGS) (Roca and Adams, 2007). CADASIL is an inherited small 
vessel disease caused by mutations in the notch3 gene, which leads to recurrent 
ischemic stroke and vascular dementia (Chabriat et al., 1995; Dichgans et al., 1998; 
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Opherk et al., 2004). Mutations that cause the onset of disease invariably affect the 
quantity of cysteine residues within the EGF regions of the Notch3 extracellular 
domain (Dichgans et al., 2000; Joutel et al., 2000). The aberrant Notch3 extracellular 
domain then self-associates and its accumulation within the small arteries is thought 
to induce the degeneration of the vascular smooth muscle cells (Opherk et al., 2009). 
AGS is a genetically heterogeneous disorder caused by mutations in the human gene 
jagged1, whose symptoms include abnormalities of the heart, eye, liver and skeleton 
(Li et al., 1997; Oda et al., 1997). Although it is not understood the exact role of 
Jagged1 in affected tissues, evidence suggests that within the liver Jagged1 controls 
hepatocyte growth factor (HGF), a critical protein for regulation of hepatic stem 
cells, and that this may be the mechanism by which liver disease occurs in AGS 
(Yuan et al., 2006).  
 Multiple sclerosis (MS) is a human demyelinating disease wherein lesions are 
formed within the central nervous system, which are focal areas of myelin 
destruction (Mastronardi and Moscarello, 2005). It has also been found that elevated 
levels of Notch1 and Jagged1 are present in an MS brain and that the increase in 
these amounts were consistent with disease severity (Lubetzki and Stankoff, 2000). It 
is thought that the Notch1 signalling pathway may play a role in the timing and 
spatial regulation of myelination by oligodendrocytes and that the increased 
expression of both Notch1 receptor and the ligand Jagged1 may inhibit re-
myelination (Genoud et al., 2002).  
 The potential role of Notch signalling in human diseases such as these further 
exemplifies the need to understand the roles and functions of this dynamic signalling 
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pathway in both our understanding of basic biology and for the possible 
improvement of public health. 
 
1.10 AIMS 
 Previous studies have examined the impact of Notch signalling on T cell 
differentiation from the perspective of signal reception. The experimental work 
performed in this thesis fundamentally focuses on determining the extent to which 
Notch proteins may be used by DCs as ‘signal 3’ to direct T cell polarisation, 
addressing whether Notch ligand provision by APCs is associated with specific CD4+ 
T cell outcomes. Ultimately, determining whether Notch ligands are relevant in this 
context, or can act as markers for APC stimulation by diverse pathogens, may 
provide exciting new diagnostic or even therapeutic targets.  
Hypothesis: That Notch ligands are utilized by antigen presenting cells, 
specifically dendritic cells, in the process of antigen presentation. 
 The specific questions addressed in this thesis are: 
 1) Is the expression of a distinct cohort of Notch ligands associated with 
pathogenic stimuli? (Chapter 3) 
2) Do expression profiles of cytokines, co-stimulatory markers and Notch 
ligands by BM-DCs and BM-M%s, in response to complex-pathogen derived Ags, 
accurately portray CD4+ priming capacity? (Chapter 3) 
 3) Is the expression of Notch ligands by DCs required for their activation and 
function either in vivo or in vitro? (Chapter 4) 




Figure 1.1 Peptide Loading and Presentation by MHC I and MHC II.  
MHC I is loaded with peptide within the ER following degradation of intracellular 
proteins by the proteasome. Peptide fragments are transported into the ER through 
the TAP transporter. Peptide-loaded MHC I is then transported directly to the cell 
surface where it presents antigen to CD8+ T cells. In contrast, MHC II is formed in 
the ER with the invariant chain preventing premature loading of peptide. The nascent 
MHC II is then transported to the phagolysosome containing degraded endocytosed 
proteins. The invariant chain is then degraded leaving a small fragment called CLIP, 
which continues to block the peptide-binding cleft. The CLIP fragment is then 
replaced with endocytosed peptide with the aid of HLA-DM. Stable MHC II is then 
transported to the cell surface where it presents antigen to CD4+ T cells.
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Figure 1.2 TLR signalling. TLRs use a variety of signalling mechanisms in order 
to activate downstream transcription factors. All TLRs, with the exception of TLR3 
utilize the adaptor MyD88. MyD88 then binds IRAK4, which in turn activates 
TRAF6. TRAF6 then proceeds to phosphorylate I&B via TAK1 leading to its 
degradation and the release of NF&B. TLRs 7, 8 and 9 can leads to activation and 
nuclear translocation of IRF-7. A MyD88 independent signalling pathway involving 
the adaptor TRIF is utilised by TLRs 3 and 4 which can lead to the nuclear 
translocation of IRF3.  
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Figure 1.3 Overview of CD4+ T helper cell subsets. Functions, transcription 
factors, as well as cytokines both produced by and crucial for the determination of 
different T helper cell subsets. Adapted from (Zhu and Paul, 2008) 
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Figure 1.4 Components of the Notch signalling pathway. Mammals 
possess 4 receptors (Notch1-4) and five different ligands derived from two different 
families (jagged1-2 and delta 1, 3, and 4), all of which are expressed on the cell 
surface. Following ligand binding, a cleavage event mediated by presenilins with "-




 is then 
translocated to the nucleus, where it binds to the transcriptional repressor CSL and, 
with the help of MAML proteins and other coactivators, initiates transcription. This 
pathway is regulated at several stages. Lnfg modifies the EGF domains of Notch 
receptors, altering their affinity for ligand binding. Deltex and Numb influence the 




and SEL-10 can target the N
ICD 





Component C. elegans D. melanogaster Mammals 
Ligand DSL-1 Delta Delta1 
   Delta3 
   Delta4 
    
 LAG-2 Serrate Jagged1 
 APX-1  Jagged2 
    
Receptor GLP-1 Notch Notch1 
 LIN12  Notch2 
   Notch3 
   Notch4 











Gene Deficiency Phenotype Reference 
notch1
-/-
 Embryonic Lethal 
<E11.5 
Defective formation of 
hematopoietic stem cells 
(Conlon et al., 1995; Huppert et 
al., 2000; Kumano et al., 2003; 
Swiatek et al., 1994) 
notch2
-/-
 Embryonic Lethal 
<E11.5 
(Hamada et al., 1999) 
notch3
-/-
 Normal embryonic 
development 
(Krebs et al., 2003) 
notch4
-/-
 Normal embryonic 
development 
(Krebs et al., 2000) 
jagged1
-/-
 Embryonic Lethal 
<E11.5 
Defect in vasculogenesis 
(Xue et al., 1999) 
jagged2
-/-
 Perinatal death due to 
craniofacial 
morphogenesis 
Also defects in limb, 
thymic development and 
"$  T cell differentiation 
(Jiang et al., 1998) 
delta1
-/-
 Embryonic Lethal E10-
E12 
Defects in somite 
borders 
(Hrabe de Angelis et al., 1997) 
delta3
-/-
 Defects in somite 
borders and disruption 
of segmentation clock 
(Dunwoodie et al., 2002; Kusumi 
et al., 1998) 
delta4
-/-
 Embryonic Lethal 
<E11.5 
Defect in vasculogenesis 
(Gale et al., 2004) 




Common Human Notch 
Mutations 
 
Subsequent Disease Reference: 
NOTCH1: activating 
mutations which lead to high 




Activating mutations are 
found in >50% of T-cell 
acute lymphoblastic 
leukemias 
(Ellisen et al., 1991; 
Weng et al., 2004) 
NOTCH3: mutations 
affecting the number of 
cysteine residues in the EGF 
domain of Notch3 
CADASIL - accumulation 
of Notch3 extracellular 
domain leading to disruption 
of the vasculature. Late-
onset symptoms include 
stroke, migraine, dementia, 
and death 
(Opherk et al., 2009; 
Opherk et al., 2004; 
Roca and Adams, 
2007) 
JAGGED1: several 
identified mutations found 
in the EGF domain, cysteine 
rich region and the DSL 
domain 
Alagille Syndrome involves 
abnormailities in the liver, 
heart, skeleton, eye and 
facial features 
(Oda et al., 1997; 
Ropke et al., 2003; 
Yuan et al., 2006) 




Materials and Methods 
2.1 Animals and Reagents 
 
WT C57BL/6 mice were bred and maintained in the Ann Walker Animal 
Facility, University of Edinburgh. Six – Eight week old mice were used as bone 
marrow donors for DC and M% culture. Numerous antigens were used for 
stimulation of the APCs in culture and were chosen for physiological relevance and 
for correlation with previously published work. Heat-killed Propionibacterium acnes 
(P. acnes) was supplied by Professor Ian Poxton (University of Edinburgh), and 
heat-killed Salmonella typhimurium was supplied by Maurice Gallagher (University 
of Edinburgh), while SEA was prepared in house from schistosome eggs isolated 
from livers of S. mansoni infected C57BL/6 mice. LPS and PGE2 were obtained 
commercially (Sigma Aldrich, Poole, USA). Concentrations of antigens used were 
based on experiments previously carried out in-house, or taken from published 
papers.  
2.1.2 SEA production 
Generation of SEA requires isolation of schistosome eggs from livers of 
infected mice. Mice were infected percutaneously with 200 cercariae in a 200 ml 
volume of carbon-filtered water. 7 weeks later, livers were collected into PBS 
containing antibiotics and washed with 70% ethanol for 5 min before 3 washes with 
sterile PBS. Livers were then placed in a sterile Petri dish, and minced with sterile 
surgical blades. Minced livers were transferred to 50 ml tubes (4 livers per tube) then 
PBS was added to a total volume of 40 ml. To this solution, 5 ml of a 0.5% solution 
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of Collagenase D (Roche, Welwyn, UK) in PBS was added, as well as 0.5 ml 100X 
Penicillin-Streptomycin, 0.5 ml Polymyxin B Sulfate (Sigmab Aldritch), 5x10
6 
U 
diluted in 6 ml sterile water. After incubation overnight at 37° C on a rocker, 
supernatants were removed following centrifugation at 300 g for 5 min. After 2 
washes with PBS, the pellet was removed, poured into a petri dish and then mashed 
with a monoject 30 cc syringe to break up the remaining fragments of liver. This was 
then resuspended in PBS and centrifuged for 5 min at 300 g. Pellets were 
resuspended in 10 ml PBS, then each layered over a Percoll gradient (20 ml 0.25 M 
sucrose, 10 ml Percoll in a 50 ml falcon, 5 ml of liver homogenate per gradient). 
After centrifugation at 300 g for 5 min, the upper layer was carefully removed with a 
pipette and discarded. Egg pellets were then pooled into one tube and counted. After 
centrifugation at 300 g for 5 min at 4° C, the supernatant was discarded and then the 
eggs were snap frozen before storing at -80° C. 
 
2.2 Macrophage and Dendritic Cell Culture 
Bone marrow-derived DC culture was performed essentially as previously 
described (Lutz et al. 1999). Femurs were extracted from killed mice and washed in 
70% ethanol and PBS. Bone marrow was expelled with PBS using a syringe and 25G 
needle (Becton Dickinson, Mountain View, USA). DC culture medium was 
composed of RPMI-1641 medium (Sigma Aldrich), 100 units/mL penicillin-
streptomyocin (GIBCO, Life Technologies, Paisley, UK), 10% FCS (Labtech 
International Ltd., Ringmer, East Sussex, UK), 2mM L-Glutamine (GIBCO) and 20 
ng/ml GM-CSF (Peprotech, Rocky Hill, NJ, USA). Cells were seeded in standard 
bacteriological petri dishes (Philip Harris Scientific, Cheshire, UK) in 10 mL of 
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medium at a concentration of 2x10
5
 cells/mL and cultured at 37°C, 5% CO2. On day 
3, 10 mL of additional medium was added to each plate, while on days 6 and 8, 9 mL 
medium was carefully removed from the plate and replaced gently with 10 mL of 
fresh medium. On day 11, DCs were harvested by gentle expulsion of medium over 
the dish to gather all semi-adherent DC, and then counted using a haematocytometer, 
and re-plated in 24-well plates (Corning Incorporated, Corning, NY) in 1 mL of 
medium at a concentration of 1x10
6
 cells/mL.  
M%s were grown essentially as described (Fischer et al., 1988). M% culture 
medium consisted of RPMI-1641 medium (Sigma Aldrich), 2mM L-Glutamine 
(GIBCO), 10% FCS (Labtech International Ltd.), and 20 ng/ml M-CSF (Peprotech). 
M%s were seeded in 6-well non-tissue culture plates (Becton Dickinson Labware) in 
4 mL of medium at a concentration of 1x10
6
 cells/well. Cells were cultured at 37°C 
in 5% C02. On days 4 and 6, 2 mL of medium was removed from each well and 
replaced with 2 mL of fresh medium. M%s were harvested on day 7 by the addition 
of the disodium salt of ethylenediamine tetraacetate (EDTA) solution as a calcium 
ion chelator (10 mM Glucose and 3 mM EDTA in PBS) to the wells after removal of 
the supernatant. Following incubation at 37° C for 15 min, adherent M%s were 
removed from the bottom of the well, washed and resuspended in RPMI 1640 
medium containing 10% FCS as described (Segura et al., 1997).  
DCs and M%s were then exposed to an array of antigens, as stated in the text, 
and at specified time points after addition of the antigen, cells were harvested by 
gentle washing, centrifuged at 200 g for 5 min, and the supernatants stored at –20° C 
for ELISA analysis. Harvested cells were resuspended in 1 mL of RNAzol (AMS 
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Biotechnology, Oxam UK) and stored at –80°C and/or assessed for phenotypic 
activation by Flow cytometry. 
 
2.3 ELISAs 
All ELISA antibodies, reagents and protocols had been previously optimized 
in house. A list of antibodies, coating buffers, recombinant cytokine standards and 
detection substrate can be found in Table 2.1. Briefly, F96 MaxiSorp Nunc-
Immunoplates (Nalgene Nunc International, Hereford, UK) were incubated at 4° C 
overnight with coating antibodies. Between each step, plates were washed 4-8 times 
with PBS containing 0.1% Tween. The following day, plates were blocked for two 
hours at room temperature in PBS containing 10% FCS or 1% BSA (for TNF# only). 
Samples and recombinant cytokine standards were added in duplicate and incubated 
overnight at 4° C. Standard curves involved doubling dilutions of recombinant 
cytokines. Biotinylated detection antibodies were added for 2 hours at 37° C and 
peroxidase-streptavidin (Kirkegard and Perry Laboratories, Maryland, USA) was 
added for 30 min at 37°C. ELISAs were developed using TMB Microwell Perox 
(Kirkegaard and Perry Laboratories) with the reaction stopped with 0.18M H2SO4 or 
ABTS (Kirkegaard and Perry Laboratories). Plates developed using TMB were read 
at 450 nm, while plates developed in ABTS were read at 405 nm, using Multiscan 
Ascent) Labsystems equipment and software. TMB substrate was used for detection 
of lower levels of cytokine given its superior resolution, while ABTS was allocated 
for more robust cytokine production. Absolute concentrations were derived from 
optical densities using the two site binding (hyperbola) equation on the standard 
curve using Prism software. From this graph the sensitivity of the ELISA for each 
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experiment was determined by calculating the lowest point within the linear phase of 
the curve. Therefore the sensitivity measured was dependent upon the quality of the 
standard curve for each experiment. This result may differ from manufacturer’s 
instructions as the observed sensitivity was calculated depending on the quality of 
each individual experiment. 
 
2.4 Flow cytometry  
Approximately 2x10
5
 cells in 200 µL medium were added to V-bottomed 96 
well FACS plates (Costar), incubated with #FcR block (2.4G2, 1 µg/well) for 20 min 
on ice and then for 30 min with antibodies specific for phenotypic markers of interest 
at 4° C. Antibodies used are detailed in Table 2.2. Samples were acquired using 
FACSCalibur (Becton Dickinson) and Cell Quest software and analysed using 
FlowJo software.  
Live cells were gated using forward scatter versus side scatter (Figure 2.1A). 
Unstained controls were first used to calibrate for auto-fluorescence. All samples 
were then acquired on the FACSCalibur including isotype controls for each sample. 
Gating on fluorescence was determined by gating out 98% of the isotype control for 
each sample. DC purity was assessed by CD11c staining, while M% purity was 
assessed by F4/80 staining (Figure 2.1). DCs were considered of acceptable purity if 
they constituted > 90%  CD11c
+
 while M%s were required to be at least 85% F4/80+. 
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2.5 RNA Extraction 
0.2 mL of Chloroform was added per mL of RNAzol to cells and shaken for 
30 sec. After 5 min incubation in ice, cells were centrifuged at 13,000 g at 4° C for 
15 min. Afterwards, the aqueous phase was removed from the organic phase, 0.25 
mL of isopropanol was added and allowed to incubate at room temperature for 5 
min. After centrifugation at 13000 g for 15 min at 4° C, the pellet was washed with 1 
mL of 75% ethanol. After a final 5 min spin at 6000 g, the pellet was dried under a 
heat lamp to remove any residual alcohol before resuspension in 30 µl of RNAse free 
water (Promega). RNA was converted to cDNA following the manufacturer’s 
protocol using Promega Reverse Transcription System (Promega, Madison, USA). 
Briefly, 9 µl RNA and 1 µl Random Hexamer primers were heated for 10 min at 55° 
C. Once the RNA and primer mix had cooled to room temperature, a reverse 
transcription mix was added including MgCl2 (5 mM), 10x Reverse Transcription 
buffer (1x), dNTP mixture (1 mM), RNAase inhibitor (1 u/µl), AMV-Reverse 
Transcriptase (0.75 u/ml) and RNAase free water. This reaction was incubated at 42° 
C for 1.5 hours, heated to 99° C for 5 min and cooled to 5° C. The resulting cDNA 
was then stored at –20° C. All RNA work was performed using pipettes and filter 
tips reserved for RNA use only (Axygen Scientific).  
2.6 RNA extraction from tissue 
 Tissue samples isolated from naïve or S. mansoni infected mice were frozen 
in 500 µL of Trizol* and stored at -80° C. For homogenisation, tissues were placed 
in a SafeLock Eppendorf (Qiagen) containing stainless steel beads (5 mm, Qiagen) 
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and vibrated using a Tissue Lyser (Qiagen) at 30 Hz for 2 min. RNA was then 
extracted as described above. 
2.7 Quantitative PCR 
PCR amplifications were performed in a 20 µl volume containing 10 µl of SYBR 
Green I mix (Invitrogen), 0.4 µl of both 10 µM reverse and forward primers and 7.6 
µl of water. Reaction conditions optimised in the lab for RNA amplification were 
94° C for 15 min, 94° C for 20 sec, 55° C - 65° C (annealing temp varied according 
to primer pair) for 20 sec, and 72° C for 20 sec. After 40 cycles, samples underwent 
melting curve analysis and were taken from 55° C to 94° C with an assay of SYBR 
Green fluorescence at every degree. Analysis and reaction was carried out using a 
Chromo4 Real Time Machine and Opticon Monitor software (GRI). When 
determining mRNA expression of a target gene from either DCs or M%s three 
separate wells were cultured per treatment group and then each well was duplicated 
for Real Time PCR giving a total of six repeats per treatment group. 
The following primers were purchased from Invitrogen unless otherwise stated: 
 
Jagged1 Forward: GCAACGACCGTAATCGCATC 
   Reverse: TGCCTGAGTGAGAAGCCTTTTC 
Provided by Dr. Png Loke 
Jagged2 Forward: GTCGTCATTCCCTTTCAGTTCG 
   Reverse: AGTTCTCATCACAGCGTACTCG 
Designed in house using www.ensembl.org and http://align.genome.jp/ 
DLL1   Forward: GCACTACTACGGAGAAGGTTGCTC 
   Reverse: TCACACCCTGGCAGACAGATTG 
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Provided by Dr. Png Loke 
DLL3   Forward: GTAGTGAAACCTCTGGCTCCTTTG 
   Reverse: CCATTGAAGCAGGGTCCATCTG 
Provided by Dr. Png Loke  
DLL4    Forward: AGGTGCCACTTCGGTTACACAG 
   Reverse: CAATCACACACTCGTTCCTCTCTTC 
Based on Amsen et al. (2004) (Amsen et al., 2004) 
18s   Forward: GTAACCCGTTGAACCCCATT 
   Reverse: CCATCCAATCGGTAGTAGCG 
Based on Schmittgen et al. (2000) (Schmittgen and Zakrajsek, 2000) 
CD86    Forward: CACGAGCTTTGACAGGAACA 
   Reverse: TTAGGTTTCGGGTGACCTTG 
Designed in house using www.ensembl.org and http://align.genome.jp/. Primers 
were validated both by running PCR reactions on a gel and by using a melting curve 
analysis following Quantitative Real Time PCR. PCR products were run on a 2% 
agarose gel and the size of the product was checked for conformity with the expected 
product size and no additional bands. Melting curve analysis involves steadily raising 
the temperature on the PCR product and reading the quantity of double-stranded 
DNA after each 1°C increase. The expected melting temperature can be calculated 
based upon product size and in this manner the product quality can be checked. 
Additionally any additional products, such as primer/dimer pairs, can be assessed by 
either melting curve analysis or by 2% agarose gel.  
The units used for determining the quantity of PCR product were calculated 
using a standard, which accompanied each Real Time PCR run. This standard 
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consisted of a pool of cDNA that was then serially diluted with each tube containing 
a quarter of the quantity of cDNA of the tube preceding it. The top concentration was 
assigned the value of 100, with the next concentration of 25, the next 6.25 and so 
forth. This approach allows the Opticon+ software program to calculate the actual 
rate of amplification. In order to determine the value of mRNA expression of the 
gene of interest the average is taken from the repeats and then this is divided by the 
average value for the mRNA expression of 18s. 
A different, and at the time of experiments, more common approach, involves 
calculating the difference between the cycle at threshold for the gene of interest 
versus the corresponding cycle at threshold for the internal reference. This result is 
quantified using the formula 2
-,,cT where the resulting quantity of mRNA for the 
gene of interest is represented as a fraction of the reference transcript. The advantage 
of this strategy is that a specific value can be attributed to each sample and thus 
cross-experimental comparisons can be easily made. However, this formula makes 
the assumption that the Taq polymerase is operating at 100% efficiency and that each 
cycle represents a complete duplication of material. By using a diluted standard as a 
reference, values can be used to take into consideration the real rate of amplification. 
When using Quantitative Real-Time PCR my question usually pertains to fold 
increase of expression under a variety of different conditions. The absolute quantity 
of transcript was less important than obtaining a more accurate approximation of the 
overall changes to mRNA expression and thus the diluted standard model was 
predominantly used when calculating mRNA expression. 
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2.8 DC/T cell Co-culture in vitro 
DCs were grown as described above in Chapter 2.2 and either stimulated 
overnight with various antigens (typically heat-killed P. acnes and SEA) or 
concurrently with the addition of T cells and OVA antigen (synthesized by Advanced 
Biotechnology Centre, Imperial College, London and a gift from Prof. D. Gray, 
University of Edinburgh, Edinburgh, UK). The following day, CD4
+
 cells were 
extracted from spleens and lymph nodes of OT-II mice and purified as described in 
Chapter 2.9. A total of 2 x 10
4




 OT-II T cells were co-
cultured in 96-well round bottom plates in 200 µl RPMI containing 100 units/mL 
penicillin-streptomycin, 2 mM L-Glutamine and 5 mM 2-Mercaptoethanol (Gibco). 
Either whole OVA protein (200 µg/ml) or OVA323-339 peptide (10 ng/mL) was added 
per well as a source of antigen. In some experiments, the "-secretase inhibitor N-[N-
(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) was 
included at a concentration of 5 mM to determine the effect of wholescale Notch 
signalling inhibition on the polarisation and proliferation of OT-II cells. Several 
different protocols were conducted to optimise proliferation and polarisation assays.  
To test whether we were observing optimal cytokine production, DC and OT-II 
CD4
+
 cells were co-cultured for 5 days at 37° C and 5% CO2, after which 
supernatants were stored for further analysis by ELISA, and cells were analysed by 
flow cytometry.  
For optimal IL-4 intracellular staining, DCs were cultured with OT-II T cells 
and OVA323-329 peptide at a 10:1 ratio of T cells:DCs together with 25 µg/ml SEA. 
Co-cultures were incubated for 3 days at 37 C, 5% CO2 before harvest and then 
intracellular staining was carried out as described in Chapter 2.10 
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2.9 CD4+ T cell Purification 
 CD4
+
 T cells were purified using CD4 (L3T4) MicroBeads (Macs) as per 
manufacturer’s instructions. Single cell suspensions of spleen and LN cells were 
prepared using sterile sefar nitex ribbon (Sefar Ltd., Bury, UK) and forceps in 35 
mm petri dishes (Cell Star). Following centrifugation at 300 g, spleen cells were 
resuspended in 3 mL of Red Blood Cell Lysis Buffer (Sigma Aldrich) for 2 min and 
then washed in RPMI containing 10% FCS. Cells were resuspended at 10
7 
cells per 
90 µl to which 10 µl of Macs beads were added. These were incubated at 4°C for 15 
min, washed and separated over a MACS LS separation column. Positively selected 
cells were retained on the magnetic column, which was removed from magnetic 
apparatus and washed with PBS. CD4
+
 T cells were routinely > 85% pure by flow 
cytometry (Figure 2.2). 
 
2.10 Intracellular Staining 
Cells were stimulated with 20 ng/ml phorbol ester phorbol myristate acetate 
(PMA) and 1 mg/ml Ionomycin for a total of 4.5 hours. In some experiments, 50 
mg/ml Brefeldin A (BFA) was also added 2.5 hours post PMA/ionomycin 
stimulation, while in other experiments, BFA was added at the same time. BFA, 
PMA and ionomycin were purchased from Sigma Aldritch. Following stimulation, 
cells were incubated with FcR block as previously described (Chapter 2.4) and were 
stained for 20 min on ice with APC-conjugated CD4 antibody. Samples were then 
fixed and permeabilized using a BD Cytofix/Cytoperm kit following manufacturer’s 
instructions. Briefly, cells were resuspended in 100 µl BD Cytofix/Cytoperm and 
incubated overnight at 4° C. Cells were then stained for intracellular cytokines 
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(either IL-4 PE or IFN-" FITC as detailed in Table 2.2), in the saponin-containing 
BD Perm/Wash* buffer in the dark for 30 min at 4° C. Cells were washed twice in 
BD Perm/Wash* and resuspended in staining buffer prior to acquisition and 
analysis.  
 
2.11 CFSE Staining of T cells 
Following purification of CD4
+
 cells from spleens and lymph nodes, cells 
were washed and resuspended at a concentration of 10
7
/mL in PBS containing 2% 
FCS (Sigma Aldrich). A dessicated 500 mg CFSE pellet (carboxyfluorescein 
diacetate succinimidyl ester, Molecular Probes, Oregon) was resuspended in 90 ml 
DMSO (Sigma Aldrich). An aliquot of this was diluted to a 100 mM working 
solution in PBS containing 2% FCS. CFSE was then added to cells to give a final 
concentration of 5 mM in solution, and dispersed thoroughly by inversion of the tube 
(Lyons and Parish, 1994). Samples were then incubated at 37°C, 5% CO2 for 15 min, 
mixing every 5 min. Cells were washed and resuspended in 5 mL of RPMI prior to a 
further 30 min incubation at 37° C. Following a final wash with RPMI, cells were 
resuspended to a concentration appropriate for co-culture with DCs. 
 
2.12 RNA inhibition 
 Stealth* siRNA oligonucleotides and scrambled controls were purchased 
from Invitrogen using their own software for determining the most effective 
sequence for mRNA knockdown. siRNA oligonucleotides were stored at -20° C in 
the dark. Lipofectamine2000* (Invitrogen) was used for transfection of siRNA 
oligonucleotides into recipient cells. Cells were transfected in 24-well plates as per 
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manufacturer’s instructions. Briefly, 1 µl of Lipofectamine was diluted in 50 µl of 
serum free medium per culture well and allowed to mix for 5 min. Alternatively, 
HiPerFect Transfection Reagent (Qiagen) was used according to manufacturer’s 
instructions. However, comparisons between the two separate transfection reagents 
demonstrated a comparatively poorer ability for HiPerFect to successfully transfect 
fluorescent oligonucletodies (data not shown). siRNA oligonucleotidess, or 
fluorescent nucleotides were added to the transfection reagent at a final concentration 
of 150 nMol and incubated for 20 min at room temperature before the combination 
was added to recipient cells. This concentration was determined by titration, 
measuring maximum transfection efficiency as assessed by fluorescent 
oligonucleotides without triggering DC phenotypic activation (data not shown).  
 Transfection efficiency was assessed by flow cytometry using fluorescent 
oligonucleotides, which fluoresced in the FITC channel (Figure 4.1). It is important 
to note that this measurement does not distinguish whether oligonucleotides are free 
within the cytoplasm. It is possible that the fluorescent oligonucleotides are 
sequestered into liposomes and, though detectable, are not necessarily representative 
of the quantity of freely available RNA interfering oligonucleotides. 
siRNA sequences ordered from Invitrogen are as follows 
Stealth CD86:  GCACCAUGGGCUUGGCAAUCCUUAU 
Control CD86: GCAGGUAUUCGACGGCCUAUCCUAU 
Stealth Delta4: GGGAAGUACUGUGACCAGCCUAUAU 
Control Delta4: GGGCAUGGUGUACCAUCCGAAAUAU 
Stealth Jagged2: GCUGCUAUCACUCAGAGAGGAAAUA 
Control Jagged2: GCUAUCUCACUGAGAGAAGACGAUA 
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2.13 S. mansoni infection of naïve mice 
Mice were anesthetized before percutaneous infection with 75 cercariae. 
Mice were culled 7.5 weeks postinfection during the period of the acute Th2 
response (Pearce and MacDonald, 2002). Spleen, mesenteric LN, liver and gut 
samples were then harvested for RNA extraction. 
 
2.14 Assessment of DC or M%  Priming Ability in vivo 
3 x 10
5
 DCs or M% activated overnight with SEA, St or Pa were injected i.p. 
into 6-10 week old naïve recipient mice. Cell suspensions were prepared from 
spleens removed 7 days later.  Spleen cells were cultured in X-Vivo* 15 serum free 
medium (Cambrex Bio Science, Wokingham, UK) containing 2 mM L-glutamine 
and 50 µM 2- Mercaptomethanol with or without SEA at a final concentration of 15 
µg/ml, Pa at 1 µg/ml and St at 1 µg/ml. Supernatants were harvested after 72h for 
cytokine analysis by ELISA. Results did not differ significantly when transferred DC 
had been activated with SEA or Pa for 6 h rather than overnight (data not shown). 
Concentrations of Ag, number of cells transferred and time before cell and 
supernatant harvest has been optimized previously in the lab. 
 
2.15 Construction of Foetal Liver Chimeras 
jagged2 deficient BM was a generous gift from Dr. Caetano Reis e Sousa’s 
laboratory (Cancer Research UK, London). The process by which they were derived 
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matings, which were 
removed from day-14.5 embryos. jagged2
-/-
 embryos were identified by PCR (Jiang 
et al., 1998). Sub-lethally irradiated Ly5.1
+





 womb mates in a similar fashion to Washburn et al. 
(1997) (Washburn et al., 1997). DC were grown from BM harvested from chimeras 
8-20 weeks later. Donor origin was then verified by flow cytometry (Figure 4.5).  
 
2.16 Statistical Analysis 
 The Student’s unpaired t-test was used to determine whether means 
significantly differed in comparison to a standardised control value. Statistical 
significance was assigned to data returning a ‘P value’ of less than 0.05. t-tests were 
performed using Prism+ software.  
 All experimental results shown involving Quantitative Real Time PCR or 
ELISAs derive error bars mean and SEM from three separate culture wells. Samples 
are duplicated on ELISA plates and on Real Time PCR reactions, the average of 
these two values is taken as the reading per sample. Three independent samples for 
each condition then constitute the basis for related statistics. For in vivo animal 
experiments, each data point indicates an individual mouse and errors bars indicate 
mean + SEM from the individual mice. In cases where only one culture well for each 
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Clone Isotype Host Dilution 
MHC II (IA/IE) FITC M5114 
(in house)  
IgG2b Rat 1:200 









IgG2b Rat 1:400 
CD40 PE 3/23 
(Pharmingen) 
IgG2a k Rat 1:100 
CD80 PE 16/10A1 
(Pharmingen) 
IgG2 k Armenian 
Hamster 
1:100 
CD86 PE GL1 
(Pharmingen) 
IgG2a k Rat 1:100 
 
CD4 APC RM4-5 
(Pharmingen) 
IgG2a k Rat 1:400 





IFN-g FITC XMG 1.2 
(Pharmingen) 
IgG1 k Rat 1:100 
Isotype APC RTK4530 
(Pharmingen) 
IgG2b, k Rat 1:200 
Isotype FITC RTK2071 
(Pharmingen) 
IgG1, k Rat 1:200 












Figure 2.1 DC and M%  cell gating and purity assessment. A) Live DCs and 
M%s were gated based on Forward and Side scatter. B) Cultured cells were assessed 





, while M% were >85% F4/80high and CD11clow. C) Gates on individual 




Figure 2.2 Representative staining of purified CD4
+
 cells. Following manual 
disruption of either spleen or lymph node, and addition of magnetic beads as 
described in 2.9, cells were analysed for CD4
+
 staining prior to and after selection.  
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Chapter 3 
Activation and function of DCs and MØs responding to 
diverse pathogens 
3.1 Introduction 
Notch ligands expressed by APCs have been proposed to play a role in the 
differentiation of CD4
+
 T cells (Amsen et al., 2004; Maekawa et al., 2003; Maillard 
et al., 2003) and may act as an additional indicator of APC maturation status. 
Currently, there are two well-characterised signals provided to naïve T cells by 
APCs. The first is the antigenic epitope presented by its MHC receptors to the TCR. 
The second are the co-stimulatory molecules CD80 and CD86, which bind to CD28 
or CTLA-4 receptors on the T cell. However, it has been suggested that there is a 
“third signal” expressed by APCs, either cytokines or surface bound molecules, 
which predominantly influences T cell polarisation (Kalinski et al., 1999; Valenzuela 
et al., 2002) and that the Notch pathway could fulfil this function (Amsen et al., 
2004; Hoyne et al., 2000a; Maekawa et al., 2003).  
Preliminary studies have investigated the effect of Notch signalling on T cells 
in the peripheral immune system (Eagar et al., 2004; Hoyne et al., 2001; Maekawa et 
al., 2003; Maillard et al., 2003). However, the current literature is as yet inconclusive 
as to the precise impact of distinct Notch ligands. Since the impact of signalling 
through Notch receptors on peripheral T cells was already being investigated (Amsen 
et al., 2004; Maillard et al., 2005), my research instead focussed on the relationship 
between APC maturation and the expression of Notch ligands. If Notch ligands are 
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expressed by APC to provide an additional signal to naive T cells as has been 
suggested (Adler et al., 2003; Eagar et al., 2004; Hoyne et al., 2000a; Maillard et al., 
2003), and if these Notch ligands can drive distinct Th differentiation profiles 
(Amsen et al., 2004; Maekawa et al., 2003; Tu et al., 2005), then it stands to reason 
that the expression of particular Notch ligands by APCs should be associated with 
specific activation profiles. The main hypothesis we examined was whether profiles 
of Notch ligand expression by APCs might reflect the nature of the stimulus given. 
Our intention was to investigate the patterns of Notch ligand expression by APC, in 
addition to more conventional markers of activation, to elucidate any association 
between specific Notch ligand expression by APCs and their Th polarisation 
potential. 
APCs such as DCs and MØs influence the outcome of the entire adaptive 
immune response by directing CD4
+
 T cells into a Th1, Th2, Th17 or regulatory T 
cell commitment (Zhu and Paul, 2008). Understanding the mechanisms underlying 
this process and assessing their subsequent downstream effect on the adaptive 
immune system has been a key question in immunology. In terms of T cell 
stimulating potential, DCs are often considered the “professional” APC, uniquely 
specialised to initiate T cell polarisation in the most efficient manner (Banchereau et 
al., 2000; Steinman and Hemmi, 2006) while MØs are generally ascribed a primary 
role in microbicidal activity (Hope et al., 2004; Yrlid et al., 2000). However, it 
remains unclear exactly what DCs express that may make them so exceptional in 
their capacity to drive T cell responses. It has been shown that M%s express lower 
levels of MHC II and the co-stimulatory molecules CD80 and CD86, both of which 
are further upregulated following exposure to IFN-" (Yrlid et al., 2000). Kalupahana 
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et al. (2005) demonstrated that while both bone marrow-derived DC and J774 M%s 
were capable of nitric oxide secretion and induction of T cell proliferation in vitro, 
the subsequent expression of T-cell proliferation cytokines (such as IL-2), as well as 
T cell proliferation itself, as measured by thymidine incorporation, was 10-fold 
greater when Ag was presented by DCs (Kalupahana et al., 2005). Although it has 
been demonstrated that MØs can stimulate primed CD4
+
 T cells in vitro (Askonas et 
al., 1968; Hsieh et al., 1993a; Hsieh et al., 1993b), direct evidence that MØs prime 
naïve T cells has proven more elusive. Much of the early evidence suggesting that 
DCs, but not MØs, were found to stimulate primary T cell responses were in vitro 
studies typically involving MLR (Inaba and Steinman, 1984; Steinman and Witmer, 
1978). However, in the MLR assay T cell stimulation is due to polymorphisms of the 
MHC complex, which may not account for variability in innate Ag processing 
capability or non-MHC parameters of the activation status of either DCs or MØs. 
In contrast, the work detailed in this chapter involved exposing bone-marrow 
derived DCs and MØs to biologically relevant pathogen preparations (as opposed to 
single TLR ligands or model antigens such as OVA protein) and then characterising 
cytokine production, co-stimulatory markers and Notch ligand expression. We then 
tested whether our expectation of APC ability based on this characterisation was an 
accurate prediction of DC or MØ ability to prime Ag specific responses in vivo. 
Bone-marrow derived DCs and MØs were chosen as the model cells for this study 
due to their demonstrable functional plasticity, and the ease with which a large 
quantity of immature cells can be cultured. Additionally, by culturing both DCs and 
MØs in this manner, both growth conditions and activation status can be rigidly 
controlled and held to be as equivalent as possible for the purposes of comparison. 
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In order to compare the activation profiles of both DCs and MØs in response 
to physiologically relevant Th1 antigens we used heat killed Salmonella 
typhimurium, heat killed Propionibacterium acnes and lipopolysaccharide (LPS). S. 
typhimurium and P. acnes were used as Ag because of their ability to activate DCs to 
promote a Th1 response (Balaram et al., 2008; Matsui et al., 1997), in addition to the 
physiological and pathogenic relevance of using whole bacterium. S. typhimurium is 
a Gram-negative bacterium, while P. acnes, in contrast, is a Gram-positive bacterium 
and a well established model for generating IFN-" dependent immune responses 
(Balaram et al., 2008; Matsui et al., 1997). We reasoned that a comparison of DC 
activation by these two different bacteria might reveal subtle differences in Notch 
ligand expression, cytokine profile or co-stimulatory molecule expression. LPS, as a 
conventional control stimulus, is a cell wall component of Gram-negative bacteria 
which activates APCs predominantly through TLR4, resulting in increased MHC II, 
IL-1, IL-12 and TNF# (Eisenbarth et al., 2002; Medzhitov, 2001). LPS was also the 
Th1 stimulant used by Amsen et al. (2004) (Amsen et al., 2004) and so provides a 
reference control. 
Although the mechanisms by which bacterial pathogens drive Th1 responses 
are reasonably well understood (Kalupahana et al., 2005; Sundquist et al., 2003), our 
knowledge of how Th2 responses are induced by APCs is much less robust. Th2 
responses are critical for protection against pathogens such as helminths, yet it 
remains unclear which Th2-specific mechanisms are utilized by DCs in this process 
(MacDonald and Maizels, 2008). DCs fail to upregulate conventional markers of 
activation in response to stimulation by S. mansoni soluble egg antigen (SEA) and 
yet are potent inducers of Th2 responses both in vitro and in vivo (Jankovic et al., 
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2004; MacDonald et al., 2001). By stimulating both DCs and MØs with a range of 
Th2 driving Ags, we could assess whether the potent, yet muted, phenotype 
exhibited by Th2 driving DCs was also true of MØs. Additionally we investigated 
the possible association of jagged family ligands with Th2 stimulation as proposed 
by Amsen et al. (2004) (Amsen et al., 2004). For this purpose, SEA, filarial 
nematode excretory-secretory product 62 (ES62) (Goodridge et al., 2005) and 
ProstaglandinE2 (PGE2) (Kalinski et al., 1997) were all used for their Th2 driving 
ability. ES62 is a secreted phosphorylcholine-bearing filarial worm glycoprotein that 
acts as an antagonist to Th1 responses by limiting MØ production of IL-12, and 
broadly biases towards a Th2 response (Goodridge et al., 2005; Harnett and Harnett, 
2006). PGE2 can act as a Th2 promoting factor by limiting APC production of IL-12 
(Kalinski et al., 1997; Kapsenberg, 2003). 
 
AIMS 
1) To establish whether DCs and MØs display defined expression profiles of 
Notch ligands in response to Th1 or Th2 stimuli 
2) To assess the comparative ability of DCs and MØs to activate a polarise 
CD4
+
 T cells in vivo 
 
3.2 How are DCs and M%s activated in response to distinct pathogen 
challenges? 
Before assessing expression profiles of Notch ligands, we first tested the 
comparative responses of BM-DCs or BM-MØs to complex pathogens or their 
products. Cytokine levels were assessed over a time course, with DC or M% 
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secretion of IL-10, TNF#, IL-6, IL-12p40 and IL-12p70 measured after exposure to 
biologically relevant pathogens or their products. Initial dose curves were previously 
conducted to establish the necessary quantity for each stimuli to illicit a robust 
cytokine response, whilst maintaining cell viability and the capacity to drive T cell 
responses in vivo. Over the course of multiple experiments a variety of different 
stimuli were used at several different time points. Following exposure to either Th1 
(St, Pa, LPS) or Th2 (SEA) stimuli, supernatants from DC and MØ cultures were 
collected at 1.5, 12 or 24 and representative data for each cytokine measured is 
shown in Figure 3.1. In keeping with previous reports, DCs exposed to SEA 
produced similar levels of cytokine to unstimulated controls (MacDonald et al., 
2001). Similarly, we found that MØ activation in response to SEA was also muted. 
In contrast, both DCs and MØs responded to exposure to Th1 pathogens or their 
products by producing a range of cytokines. On a per cell basis, DCs produced more 
IL-12p40, as well as the biologically active heterodimer IL-12p70, than MØs, 
although the kinetics of cytokine expression remain largely the same. DCs and M%s 
also shared a similar pattern of expression for IL-6 and TNF# secretion, again with 
comparably greater levels of this cytokine produced by DCs than MØs while IL-10 
expression between the two cell types was more directly comparable. This data is in 
agreement with the perception that DCs tend to be the foremost cell type involved in 
the priming of CD4
+ 
T cells during a Th1 immune response, where it is 
understandable that DCs might benefit from elevated production of cytokines such as 
IL-12 (Robson et al., 2003). 
We then tested whether DCs and MØs displayed similar co-stimulatory 
molecule expression profiles in response to stimulation with diverse pathogens. DCs 
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and MØs were identified by flow cytometry using the markers CD11c and F4/80 
respectively. CD11c is an integrin involved in cell adhesion (Stacker and Springer, 
1991). Although its exact function is unknown, F4/80 may have a role in 
immunological tolerance (van den Berg and Kraal, 2005), and has widely been used 
as a murine MØ marker (van den Berg and Kraal, 2005). Measurement of high levels 
of CD11c expression, low autofluoresence and high levels of MHC II and co-
stimulatory molecules is sufficient to characterize cells as DCs (Vakkila et al., 2005). 
M%s, in contrast, express F4/80 with low levels of CD11c and MHC II and co-
stimulatory molecules (Vermaelen and Pauwels, 2004).  
24 hours after stimulation with St, Pa or SEA, cells were analysed by flow 
cytometry for CD11c, F4/80, MHC II, CD40, CD80 and CD86 expression (Figure 
3.2, Table 3.1). Consistent with previously published reports, we observed higher 
basal MHC II expression by DCs, both unstimulated and in response to bacterial Ag, 
than similarly stimulated MØs (Vermaelen and Pauwels, 2004; Yrlid et al., 2000). 
DCs also expressed a greater level of CD80 and CD86 than MØs. Notably, 
consistent with what was seen with DCs, MØ stimulation by SEA had no measurable 
impact on cell surface phenotype. Unexpectedly, and in contrast to other molecules 
examined, MØs displayed a comparable level of CD40 upregulation to their DC 
counterparts. Together this data supports the consensus that DCs generally express 
greater levels of both co-stimulatory markers and cytokines than MØs, with the 
exception of CD40. Further, they reveal that MØs, like DCs, fail to be overtly 
activated by the Th2 stimulus provided by SEA. 
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3.3 Does the low activation phenotype of M%s relate to their ability to 
prime T cell responses in vivo? 
 Although it was clear from these experiments that BM-DCs secreted greater 
quantities of cytokine and expressed generally higher levels of activation markers 
than MØs, it was important to determine whether this accurately reflected their 
respective T cell priming capacities. APC priming ability in vivo was assessed by 
adoptive transfer, a method previously developed and optimised in the laboratory for 
DCs but not previously applied to MØs (MacDonald et al., 2001; MacDonald et al., 
2002b). Following overnight stimulation with Ag, 5x10
5
 DCs or MØs were injected 
intra peritoneally (i.p.) into naïve recipient mice. One week later, splenocytes were 
removed, stimulated with Ag and then assessed for cytokine production by ELISA. 
Previous reports have shown that DCs stimulated with SEA prime potent IL-4, IL-5 
and IL-13 recall responses in splenocytes from recipient mice, while DCs matured in 
the presence of Th1 polarising Ag induce elevated IFN-" production (MacDonald 
and Pearce, 2002; MacDonald et al., 2001; MacDonald et al., 2002b). 
Given the diminished capacity of MØs to secrete T cell polarising cytokines 
(Figure 3.1) or upregulate co-stimulatory molecules (Figure 3.2), we predicted that 
MØs would be significantly less capable than DCs at induction of CD4
+
 T cell 
responses. Since both DCs and MØs stimulated with SEA were indistinguishable 
from unstimulated cells by the parameters measured, it was not clear whether there 
would be a difference in their ability to prime an SEA specific Th2 response.  
Astonishingly, although SEA specific IL-4 elicited by MØs was reduced in 
comparison to DC primed IL-4 (Figure 3.3A), MØs stimulated with St were found 
to be as competent at inducing an IFN-" response as similarly activated DCs (Figure 
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3.3B). These results suggest that, when stimulated with SEA, DCs are indeed more 
capable at priming a Th2 response, as indicated by significantly greater levels of Ag-
specific IL-5 and IL-13 induced by DCs in comparison to MØs. However, when 
stimulated with S. typhimurium, both APC types appeared equally proficient at 
inducing a Th1 response. This was especially surprising given the limited MØ 
cytokine, co-stimulatory marker and MHC II expression in comparison to similarly 
treated DCs (Figure 3.1 and 3.2). Interestingly, Pa stimulated M%s did not display a 
similarly competent ability to generate an IFN-" response (Figure 3.3C).SEA-treated 
DCs also drove a greater production of Th2 cytokines than SEA-treated MØs 
following restimulation of spleen cells with plate-bound #CD3. However, IFN-" 
production by spleen cells stimulated with #CD3 was comparable following 
exposure to either DCs or MØs treated with Pa or St. This result indicates that the 
discrepancy between Th2 cytokines driven by SEA-treated DC or SEA-treated MØs 
may be due to the greater inherent capacity of DCs to drive T cell Th2 cytokines 
rather than an inherent ability to process and present SEA antigen, whereas both DCs 
and MØs share a roughly equivalent capacity to drive Th1 responses. It should be 
noted that the quantity of IFN-" produced by spleen cells restimulated with #CD3 
following exposure to St-treated DCs or MØs is expected to be much higher. Further 
experiments are needed to confirm the quantity of IFN-" secreted by spleen cells 
following transfer St-treated APC and restimulation by #CD3. 
These results highlight the importance of functional assays to address 
hypotheses generated from in vitro studies. Often assumptions about an APC’s 
aptitude for induction of effector T cell responses are derived solely by measurement 
of cytokine production or co-stimulatory molecule expression in vitro. However, the 
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data presented here (Figure 3.3) clearly illustrates that such assumptions may be 
misleading, and that between in vitro culture of APCs, and actual function in vivo, 
there remain several variables either not measured, not accounted for, or simply not 
yet known. 
 
3.4 Do separate but similarly polarising pathogenic stimuli drive 
distinct DC cytokine expression profiles? 
As DC and MØ comparisons demonstrated that DCs generated the greatest 
production of cytokine in vitro, and superior Th2 inductive capacity in vivo, we then 
focussed on this APC type. DC activation was assessed in greater detail in an 
additional time course study utilizing a more exhaustive array of pathogen-derived 
products. DCs were exposed to either Th1 (St, Pa, LPS) or Th2 (SEA, PGE2, ES62) 
associated stimuli for 1.5, 6, 12 and 24 hours and cytokine secretions measured by 
ELISA (Figure 3.4). 
While optimal IL-12p70 cytokine production took at least 12 hours, IL-12p40, 
IL-6 and TNF# attained peak production by 6 hours post stimulation with Th1 Ags 
(Figure 3.4). IL-10 meanwhile typically peaked at 12 hours following exposure to St 
and Pa stimulation and then decreased over the remainder of the time course. 
Although all Th1 polarising pathogens assessed triggered similar levels of DC IL-
12p40, IL-6 and TNF#, there was a substantial difference in the profile of IL-10 and 
IL-12p70 secretion. Of the Th1 associated Ag preparations, stimulation via Gram-
positive P. acnes yielded the highest IL-10 production and the lowest IL-12p70, 
while exposure to Gram-negative S. typhimurium triggered elevated IL-12p70 and 
comparably less IL-10. LPS induced moderate levels of IL-12p70 but no more IL-10 
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than unstimulated controls. Th2 polarising pathogens or Th2 associated molecules, 
meanwhile, failed to provoke secretion of any of the cytokines measured above the 
level produced by unstimulated control DCs. 
 
3.5 Notch: A DC activation marker associated with specific pathogens? 
Not only have Notch ligands been suggested to play a role in translating the 
recognition of microbial products into specific signals instructing T cells responses, 
(Amsen et al., 2004; Hoyne et al., 2001; Maekawa et al., 2003; Osborne and Minter, 
2007; Wong et al., 2003) but distinct Notch ligand families have been associated 
with induction of either Th1 or Th2 differentiation (Amsen et al., 2004; Maekawa et 
al., 2003; Tu et al., 2005). We wished to examine whether the association of delta 
ligands with Th1 and jagged with Th2 remained consistent when DCs were treated 
with complex pathogen-derived Ag preparations as opposed to the single TLR 
agonists that had previously been studied (Amsen et al., 2004). In order to determine 
if Notch ligand expression by APCs might relate to their ability to provide ‘signal 3’ 
to CD4
+
 T cells, quantitative PCR was used to assess delta1, delta3, delta4, jagged1 
and jagged2 mRNA levels in APCs exposed up to 24 hours to various Th polarising 
stimuli.  
Measurement of mRNA by quantitative PCR required optimising primers, 
reagents and temperatures necessary for this technique. For optimisation, reactions 
were run repeatedly across a temperature gradient and the conditions that produced 
the most reliable measurements with a satisfactory melting curve were subsequently 
used. jagged2 primers were designed in house using Ensembl genome browser 
(www.ensembl.org), delta4 and delta3 primers were the same as used by Amsen et 
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al. (2004), while jagged1 and delta1 primers were designed by Dr P Loke. However, 
throughout these studies, no evidence of delta3 expression was found in either DCs 
or MØs (data not shown).  
After stimulation, 10
6
 DCs or MØs were stored in Trizol (Invitrogen) at -80° 
C and cDNA was generated and stored at -20° C. Initially, cDNA copies were 
produced using Oligo(dT)15 and the housekeeping gene !-actin was used as an 
indicator of total RNA extracted. Oligo(dT) primers are the most widely used 
method for conversion of mRNA into cDNA as they anneal to the poly(A) sequences 
present at the 3’ end of the majority of mRNA sequences (Hagenbuchle et al., 1979; 
Nam et al., 2002; Verma, 1978; Weiss et al., 1976). !-actin is a cytoskeletal protein 
whose mRNA is ubiquitously expressed at moderate levels in most cell types and 
was one of the RNAs to be used as an internal standard (Bustin, 2000). However, it 
was later found that !-actin was not a reliable normalization tool as it is differentially 
expressed upon APC activation (Bustin, 2000). Instead, 18s, a ribosomal RNA 
component, was used for all subsequent quantitative PCR experiments as it is 
thought to remain at a constant proportion to the total RNA (Bustin, 2000). As a 
result of this alteration in protocol, the technique for cDNA synthesis was also 
changed and Random Hexamers (Promega) were used instead of Oligo(dT), since 
18s is a ribosomal component and thus does not have a poly(A) tail. Intriguingly, 18s 
real time amplification was conducted on cDNA generated with Oligo(dT) primers 
and an abundant product was constitutively observed despite the supposed absence 
of a 18s poly(A) tail (data not shown). Although there is very little literature 
discussing the possibility of polyadenylated ribosomal RNA there have been some 
studies indicating the existence of 18s rRNA-like mRNAs (Mauro and Edelman, 
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1997) or polyadenylated rRNA (Slomovic et al., 2006). Nevertheless, as the 
reliability of 18s measurement using Oligo(dT) was not sufficiently established, 
further work was conducted with cDNA synthesised using Random Hexamers.  
RNA was extracted from 10
6
 DCs stimulated for 6, 12 or 24 hours with either 
medium alone (open bars), SEA (black bars), St (grey cross-hatched bars) or Pa 
(grey bars), and then quantitative PCR was performed to assess mRNA levels of 
jagged1, jagged2, delta1 and delta4 (Figure 3.5). Across multiple experiments 
delta4 expression was significantly increased over unstimulated controls when 
activated by Pa or St, beginning at 6 hours and maintained throughout the time 
course, although St induced delta4 returned to levels comparable to medium controls 
by 24 hours post Ag exposure. delta1 showed a trend for elevated expression at 6 
hours before returning to control levels by 12 hours in both St and Pa stimulated 
DCs. It is important to note that delta1 and delta4, although both upregulated in 
response to Th1 stimuli, did not display the same expression kinetics, indicating that 
Notch ligand family members are not necessarily regulated in the same manner. 
Surprisingly, given the suggestion that Jagged ligands are associated with Th2 
stimuli (Amsen et al., 2004), jagged1 also displayed a trend for upregulation at 6 
hours in response to Pa and St. jagged2 was significantly decreased 6 hours 
following bacterial stimulation across multiple experiments in comparison to 
controls, but returned to unstimulated levels by 12 hours (Figure 3.5).  
In contrast to Pa, SEA stimulation showed no significant upregulation of any 
of the Notch ligands measured over that of unstimulated controls. Although there 
was a trend for upregulation of jagged2 6 hours after SEA stimulation, this was not 
consistent across multiple experiments. This suggests that, contrary to expectation, 
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jagged1 and jagged2 expression are not indicative of DCs stimulated by Th2 
pathogens.  
In order to generate a better picture of the overall Notch ligand expression 
profile, the fold change in expression between unstimulated DCs and those exposed 
to Ag were compiled (Figure 3.6). One of the more striking observations from these 
results was the maintenance of jagged2 expression following SEA stimulation 
compared to the distinct downregulation of jagged2 by Pa stimulated DCs. 
Additionally, this presentation format highlights the dramatic increase in delta4 
expression by DCs that are bacterially activated. 
MØs were also assessed for expression of Notch ligands. However, during 
DC and MØ comparisons quantitative PCR methods had not yet been optimised and, 
consequently, results were variable. Across several experiments MØs showed 
increased expression of jagged2 in response to St and SEA, but not Pa stimulation 
(Figure 3.7). delta4 was substantially increased by St stimulation at both 1.5 and 24 
hours, although apparently not at 6 hours. Unfortunately, in these experiments data 
was not generated for MØs exposed to Pa for 24 hours.  
Although further study is required for a more comprehensive overview of 
M% Notch ligand expression, this initial comparison of DCs and MØs does suggest 
that different APCs may utilise Notch ligands in distinct manners. Indeed, it appears 
that activation with the same stimuli may trigger entirely different patterns of Notch 
ligand expression between the two cell types, suggesting that Notch ligand 
expression profiles may not only be subject to timing and stimulation, but also to 
APC type. Additionally, more work is needed in determining the impact of activation 
on Notch ligand protein expression. There may yet be substantial regulation of 
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surface expression of Notch ligands subsequent to mRNA expression, however, at 
the time of experiments reliable antibodies were unavailable. 
 
3.6 Is Notch ligand expression altered during infection? 
As an initial assessment of jagged2 expression during Th2 immunity we 
examined samples isolated from Schistosoma mansoni infected mice. Mesenteric 
lymph node, spleen, liver and gut ileal samples were removed from mice infected 
with 75 S. mansoni cercariae 8 weeks post infection, at the peak of the Th2 response, 
and expression of jagged2 was then measured by quantitative PCR (Figure 3.8). 
Interestingly, spleens of infected mice displayed abundant expression of jagged2 
whereas expression levels in uninfected mice were undetectable. In mesenteric 
lymph nodes and ileal samples, there were detectable levels of jagged2 expression, 
but no significant difference was observed between infected or non-infected animals. 
There were no detectable levels of jagged2 from liver samples (data not shown).  
Although this is a very preliminary insight into the affect of Th2 driving 
pathogen on jagged2 expression, it appears to indicate that, at least in the spleen, S. 
mansoni infection does have a substantial impact on the overall expression profile of 
jagged2. This suggests an association between jagged2 expression in some tissues 
and Th2 infections. Whether or not this upregulation is due to DCs or other cell types 
is unclear, and future studies in which cells could be isolated ex vivo for Notch ligand 







 T cells orchestrate many of the activities of the adaptive immune 
system, but in order to exercise their function they must first be provided instruction 
by cells displaying their specific Ag in the context of MHC II. Unlike MHC I, which 
is expressed ubiquitously, MHC II has a much more confined distribution and is 
restricted to APCs such as B cells, MØs and DCs. However, these APCs do not 
merely serve to provide signalling through the T cell receptor (TCR), but also modify 
and adapt the T cell response to suit the invading pathogen. Thus APCs behave as the 
“conductor to the immune orchestra” dictating the tone of the adaptive immune 
response through a range of secreted and surface bound molecular signals tailored by 
the APC’s innate capacity to recognise pathogens. DCs are considered more effective 
than either MØs or B cells at activating naïve T cells (Banchereau and Steinman, 
1998; Mellman and Steinman, 2001; Mellman et al., 1998; Steinman and Inaba, 
1989).  
Culturing both DCs and MØs from bone marrow under similar conditions 
allowed us to directly compare the extent of cytokine and co-stimulatory marker 
expression in response to a variety of Th1 and Th2 pathogens or their products. 
Although a further comparison involving B cells would have been of interest, it was 
not possible to carry out such experiments due to time constraints. Furthermore, 
work of others has disregarded B cells as potential professional APCs since they 
concentrate self antigen too readily and, if allowed to activate a virgin T cell to the 
same extent as other APC, may overload the immune system with autoreactive 
antigens (Epstein et al., 1995).  
 One advantage of comparing DCs and MØs in the manner outlined in this 
chapter is that the culture conditions used to generate the cells were extremely 
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controlled. DCs grown in the presence of recombinant GM-CSF (Lutz et al., 1999) 
yielded CD11c
+
 cells of high purity in a predominantly immature state. MØs were 





cells that were also immature (Fischer et al., 1988). L929 medium 
is commonly used to grow MØs. However, rM-CSF was chosen instead amidst 
concerns that components within L929 medium might influence MØ activation. A 
recent study comparing the two culture methods found slight differences in the 
activation status of MØs grown either using rM-CSF or L929 medium, which was 
attributed to soluble factors secreted by the fibroblasts (including IL-1!, IL-2, IL-12, 
GM-CSF, IFN-", VEGF and RANTES) (Gersuk et al., 2008). By limiting the 
possibility of exogenous activation factors in the growth of these two APC types, the 
expression of T cell polarising signals should be specifically derived from exposure 
to pathogen derived Ags. 
Assessment of the response of the different APCs over a detailed time course 
clearly indicated that BM-DCs expressed greater levels of cytokines and co-
stimulatory molecules compared to their BM-derived MØ counterparts, on a per cell 
basis. DCs produced greater levels of IL-12, TNF# and IL-6 relative to MØs, as well 
as expressing a more pronounced up-regulation of MHC II, CD80 and CD86. One 
possible explanation is that the manner in which these MØs were grown inherently 
biased the cells towards an alternatively activated state in which MHC II expression 
and overall APC function was reduced. Early studies have demonstrated that MØs 
grown with M-CSF exhibit transient antigen-presentation capability when compared 
to MØ grown using GM-CSF, or when cultured with IFN-" (Fischer et al., 1988; 
Germann et al., 1992). Lee et al. (2005) observed that MØs grown from BM with M-
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CSF in the culture medium yielded cells that were F4/80
+





 but were unable to induce proliferation of anti-CD3 mAb-primed T cells. 
However, proliferation of T cells was significantly enhanced if chemokines such as 
Lkn-1 are added to the MØ culture media (Lee et al., 2005). A more recent study 
investigated the impact of colony stimulating factor – 1 (CSF-1) on the MØ 
expression of the Notch ligand jagged1 (Goh et al., 2008). Interestingly, it was 
shown that BM-MØs are able to express more jagged1 than BM-DCs in response to 
SEA, however this jagged1 expression was impaired by the presence of CSF-1 (Goh 
et al., 2008). This study highlights the fact that DC and MØ activation, including 
expression of Notch ligands, are susceptible to the presence of cytokine and tissue 
factors in culture. 
Nevertheless, when Ag-activated DCs and MØs were transferred into C57BL/6 
mice, not only did the MØs stimulate an immune response, but when MØs were 
activated with heat-killed S. typhimurium prior to transfer, recipient mice produced 
similar levels of IFN-" to mice that had received St pulsed DCs. While in vitro data 
would suggest that DCs are far more proficient at initiating primary immune 
responses, this in vivo data argues that, depending on the Ag, MØs can be fully 
capable of stimulating T cells to the same extent as DCs. This view is supported by 
recent publications demonstrating that MØs can directly stimulate T cells in vivo to 
proliferate and mature into both effector and memory cells (Pozzi et al., 2005) and 
that both DCs and MØs can present live Salmonella enterica antigen to T cells 
(Kalupahana et al., 2005). In these studies MØs were either grown using L929 
conditioned medium (Pozzi et al., 2005) or were a cell line (Kalupahana et al., 2005) 
and thus a direct comparison to BM-DC cultured with GM-CSF should be treated 
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with caution. Pozzi et al. (2005) found that both DCs and MØs were equally 
proficient at driving Tg T cell proliferation as well as stimulating the generation of 
effector T cells capable of producing IFN-" (Pozzi et al., 2005). These findings using 
transgenic T cells are in accordance with the data presented in this chapter using the 
heat-killed Gram-negative bacterium St. Since MØs grown using M-CSF do produce 
significantly less IL-12p70 (Figure 3.1) and express very little MHC class II (Figure 
3.2) compared to DCs, and yet stimulate an St-specific Th1 immune response as 
efficiently (Figure 3.3), then there must be some as yet poorly understood 
mechanism occurring in vivo that allows efficient antigen presentation which has not 
yet been revealed by in vitro phenotyping experiments. 
It is possible that IFN-", other cytokines, or migratory chemokines produced by 
the recipient mouse and not recreated in vitro, induce further DC cytokine production 
and MHC II expression, promoting the innate antigen presenting capability of M%s 
(Germann et al., 1992). Injection of cells into a recipient mouse causes local 
inflammation, encouraging the release of IFN-" by NK cells (Kobayashi et al., 1989) 
or peripheral T cells (Skeen and Ziegler, 1995). One alternative explanation is that 
transferred M%s act as a reservoir of antigen and, although they themselves do not 
directly activate T cells, other APCs within the recipient mice might internalize Ag 
released from lysed injected cells for presentation to T cells. However, previous 
work from our laboratory has shown that DCs deficient in MHC II are not able to 
induce Ag specific Th responses after in vivo injection (MacDonald et al., 2001). 
This suggests that Ag is being directly presented by the cells injected and not by 
resident cells that obtained Ag from the injected cells. This experiment has not yet 
been repeated using MHC II deficient M%s.  
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Time courses of DC activation by an array of pathogen derived products revealed 
two things. Firstly, kinetic patterns of separate cytokine and co-stimulatory 
molecules were distinct depending upon the stimuli. Secondly, diverse stimuli, even 
if they are associated with similar CD4
+
 T cell polarisation, displayed discrete 
profiles of maturation. Early expression of some cytokines (such as TNF# and IL-
12p40) versus the later peak of expression found in IL-12p70 (and to some extent IL-
6) (Figure 3.4) emphasizes shifting cytokine secretion profiles of DCs over time. 
Interestingly, stimulation with broadly similar Th polarising pathogens or products 
yielded variable levels of cytokine secretion. This result exemplifies the notion that 
DCs are able to specifically tailor their response to the unique pathogen profile they 
encounter. It should be noted, however, that there remains a great deal of difficulty in 
directly comparing cellular responses to different whole heat killed bacteria. In this 
case, the quantity and diversity of TLR agonists provided by each bacterium is 
difficult to elucidate. Furthermore, the engagement of multiple different PRRs may 
yield entirely different outcomes than would otherwise be expected from a single 
PAMP (Napolitani et al., 2005). Of course it is the very complexity endowed by 
whole pathogen derived Ag that is of interest, since the more closely the APC 
stimulus resembles what the immune system would naturally encounter, the more 
relevant the induced response is likely to be. 
Although the signalling mechanisms APCs employ to drive Th1 polarisation 
is relatively well characterised, how APCs promote Th2 differentiation remains 
unclear (MacDonald and Maizels, 2008; MacDonald et al., 2001). Adoptive transfer 
of Th2 polarised DCs initiates a Th2 recall response in a manner dependent on MHC 
II (MacDonald et al., 2001), NF-kB (Artis et al., 2005), CD40 (MacDonald et al., 
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2002b), and OX40L (Jenkins et al., 2007). However, the precise mechanisms 
underlying this interaction have proven elusive. Importantly, levels of expression of 
these molecules remain unchanged following DC stimulation with SEA. So, although 
the presence of these molecules is critical, none of them require significant 
upregulation in order to drive Th2 differentiation. Discovery of that would indicate 
an APC primed for induction of Th2 responses has been an ongoing goal of our 
laboratory and others for many years. It is in this context that we investigated the 
potential role for Notch ligands as markers of Th2 activation of DCs, particularly 
given the recent suggestion that the Jagged family of Notch ligands could potentially 
be a mechanism of Th2 instruction by APC to naïve T cells (Amsen et al., 2007; 
Amsen et al., 2004; Tu et al., 2005). 
The Notch ligand expression data presented in this chapter demonstrates that 
DCs can express both the Delta and Jagged family of ligands concurrently in either 
Th1- or Th2-priming conditions, but their relative expression changes depending on 
the stimulus encountered. Previous work had demonstrated enhanced expression of 
the Notch ligands delta4 and jagged1 by BM-DC in response to stimulation by LPS, 
whereas stimulation with the ‘Th2 inducers’ cholera toxin and PGE2 promoted 
jagged2 expression (Amsen et al., 2004). However, this work only examined 
expression after a single time point (6 hours post stimulation) and the Th2 nature of 
these stimuli is open to question. Our results agree with the suggestion that Th1 
related Ags induce delta4 expression and early delta1 in DCs. However, DCs 
stimulated with the Th2 Ag SEA only displayed a trend for enhanced jagged2, and 
this was solely evident at 6 hours following exposure and not later time points. 
Intriguingly, there was a significant decrease in jagged2 expression by DCs in 
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response to stimulation by heat-killed P. acnes, a trend that was also consistent in St-
activated cells. Conceivably, the ratio of different Notch ligands expressed by APCs 
may ultimately determine the manner in which Notch signalling affects the 
differentiation of a naïve T cell. Although these results do not support the simplistic 
association of Jagged ligand expression by APCs exposed to all Th2 pathogens, it is 
clear that the relative expression profile of Notch ligands is influenced by the 
activation status, and may relate to the Th priming capacity, of the DC. Therefore, it 
remains a distinct possibility that Notch ligands expressed by APC are utilized as an 
additional mechanism to provide “signal 3” for driving a T helper cell response. 
By examining the effect of S. mansoni infection on jagged2 expression in 
immunologically relevant sites we could begin to assess whether Notch ligands may 
be relevant during Th2 dominated disease. The liver and gut are the primary sites of 
the immune response during S. mansoni infection while the mesenteric lymph nodes 
and spleen are secondary lymphoid tissues facilitating the interaction of APCs and 
lymphocytes. Intriguingly, there did appear to be an increase in overall expression of 
jagged2 in the spleen of S. mansoni infected animals, although which cell types 
account for this increase is unclear. If, as this data suggests, there is no significant 
increase in jagged2 expression at the site of egg deposition in the gut ileum, or any 
detectable jagged2 in liver, then the proposition that jagged2 expression is directly 
affected during interaction with pathogen products seems unlikely. Rather, the 
evidence that jagged2 is upregulated in lymphoid tissues, such as the spleen, 
suggests that, if Notch ligands do fulfil an immunological role, it is likely involved in 
the induction of adaptive immunity. However, given that no significant difference 
was found between the expression of jagged2 in mesenteric lymph nodes from 
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infected or non-infected mice, the particular environment of the spleen may be more 
conducive to fluctuation in the expression of Notch ligands.  
Ideally, the use of Notch ligand specific antibodies and 
immunohistochemistry could provide a more detailed insight into the cell-specific 
surface expression of Notch ligands during infection. Unfortunately, due to the 
highly conserved nature of Notch proteins throughout mammalian species, the 
generation of antibodies suitable for flow cytometry, western blotting or 
immunohistochemistry was unreliable at the time of these experiments. Future 
studies into the cell-specific in vivo expression of Notch ligands during 
immunological challenge would prove invaluable to our understanding of these 







Figure 3.1 Comparison of cytokine production by DCs and M%s in response to 
a variety of stimuli. 10
6
 DCs or M%s were stimulated with medium alone 
(medium), St (2 µg/ml), LPS (50 ng/ml) Pa (10 µg/ml) or SEA (25 µg/ml) and 
supernatants harvested 1.5 (open bars), 12 (grey bars) or 24 hours later (black bars) 
for analysis by using ELISA. Bars represent mean + standard error from triplicate 











Figure 3.2 Phenotypic activation of DCs and M%s in response to diverse 
pathogens. 10
6
 DCs or M%s were cultured with medium alone (medium), St (2 
µg/ml), Pa (10 µg/ml) or SEA (25 µg/ml) for 24 hours. Surface expression of CD11c 
(DCs), F4/80 (M%s) MHC class II, CD40, CD80 and CD86 were then analysed by 
flow cytometry. Dark histograms depict isotype control staining while lighter 
histograms indicate cells stained against the marker indicated. DCs were gated on 
live CD11c
+
 cells while M% were gated on live cells F4/80+ cells. Figures provided 
in the upper right hand corner of each graph refers to percentage positive and 
geometric mean fluorescence intensity for the marker indicated. Data shown are 






Figure 3.3 T cell polarisation by DCs and M%s in vivo. 5 x 105 bone marrow-
derived DCs or M%s stimulated with medium alone (M), A) SEA (S, 25 µg/ml), B) 
St (2 µg/ml) or C) Pa (P, 10 µg/ml) and injected intraperitoneally (i.p.) into naïve 
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wild type recipient mice. A week later, splenocytes were cultured for 72 hours with 
medium (open bars), St (1 µg/ml, grey cross-hatched bars), Pa (5 µg/ml, grey bars), 
SEA (15 µg/ml, black bars) or plate-bound #CD3 antibodies (16.6 µg/ml, labelled 
#CD3). Supernatants were then harvested for cytokine measurement by ELISA. 
Error bars represent mean + SEM from 3 mice per group. Data shown are 







Figure 3.4 Stimulation with diverse pathogen preparations induces distinct 
cytokine production profiles by DCs.  2x10
6 
DCs were stimulated for either 0, 1.5, 
6, 12, 24 or 48 hours with St (2 µg/ml), Pa (10 µg/ml), LPS (50 ng/ml), SEA (25 
µg/ml), PGE2 (10
-6
 Mol) or ES62 (2 µg/ml). Supernatants were harvested and 
analysed for cytokine production by ELISA. Data represents mean + SEM of 









Figure 3.5 DC Notch ligand expression in response to SEA, Pa or St. 2x10
6 
DCs 
were stimulated for 6, 12 or 24 hours with medium alone (open bars), A) SEA (25 
µg/ml, black bars), B) St (2 µg/ml, grey cross-hatched bars), or C) Pa (10 µg/ml, 
grey bars). jagged1, jagged2, delta1, and delta4 mRNA was assessed by quantitative 
PCR, normalised against 18s rRNA. A) and C) Errors bars indicate mean + SEM of 
triplicate culture wells and are representative of four separate experiments. B) data 
shown are representative of three separate experiments derived from single culture 







Figure 3.6 Relative expression of Notch ligands by DCs in response to SEA or 
Pa stimulation.  Expression of jagged1, jagged2, delta1 and delta4, as determined 
by quantitative PCR, were normalised to 18s RNA. Data indicate fold change of 
expression over unstimulated cells (dotted line) by DCs exposed to SEA (25 µg/ml, 
black bars) or Pa (10 µg/ml, grey bars) for 6, 12 or 24 hours. Data are mean + SEM 
of three to six combined experiments. * = p < 0.05, *** = p < 0.001 comparing 




Figure 3.7 M%  Notch ligand expression in response to SEA, St and Pa.  
Expression of jagged2 and delta4 were measured by quantitative PCR and 
normalised to 18s RNA. Data indicate fold change of expression over unstimulated 
cells (dotted lines) by M%s exposed to SEA (25 µg/ml, black bars), St (2 µg/ml, grey 
cross-hatched bars), or Pa (10 µg/ml, grey bars) for 6, 12 or 24 hours. Data are 
representative of three experiments comparing expression of SEA-, St- or Pa-





Figure 3.8 jagged2 expression in Schistosoma mansoni infection. The expression 
of jagged2 was determined in mesenteric lymph nodes (MLN), spleen (SPLN) and 
gut ileum from samples of uninfected controls (U, 2-3 mice) or S. mansoni infected 
animals (I, 5 mice). Data points represent individual mice. 
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Dendritic Cells 
MHC        
  Expt 1 Expt 2 Expt 3 Expt 4 Expt 5 Average STD 
Medium 43.8 73.6 81.2 24.8 36.9 52.06 24.26042044 
St 65.3 104 46.2 221 47 96.7 73.33157574 
Pa 94.3 75.8  202 43.3 103.85 68.74525438 
SEA 36.3 116 77.3 26 29.3 56.98 38.8904487 
        
CD40        
  Expt 1 Expt 2 Expt 3 Expt 4 Expt 5 Average STD 
Medium 4.8 16.8 2.38 21.3 7.95 10.646 8.080073019 
St 9.35 30.3 25.5 199 14 55.63 80.59044298 
Pa 12 24.9  146 9.94 48.21 65.52861258 
SEA 6.1 23.2 10.6 27.4 5.51 14.562 10.10780491 
        
CD80        
  Expt 1 Expt 2 Expt 3 Expt 4 Expt 5 Average STD 
Medium 105 97.9 21.2 323 44.2 118.26 107.158156 
St 222 330 27.6 1273 286 427.72 435.097407 
Pa 302 229  775 124 357.5 249.2092494 
SEA 129 110 20.2 424 101 156.84 138.6593754 
        
CD86        
  Expt 1 Expt 2 Expt 3 Expt 4 Expt 5 Average STD 
Medium 74.3 82 22.5 276 42 99.36 90.91610638 
St 364 224 43.6 1207 265 420.72 406.6006316 
Pa 494 231  931 173 457.25 299.0722112 





MHC        
  Expt 1 Expt 2 Expt 3 Expt 4 Expt 5 Average STD 
Medium 7.28 49.9 4.31 11.6 12.6 17.138 18.6168558 
St 4.76 13.5 5.49 20.7 3.47 9.584 7.353796978 
Pa 7.55 35.7  16.2 10.2 17.4125 12.71733561 
SEA 6.06 22.1 5.05 10.7  10.9775 7.812470267 
        
CD40        
  Expt 1 Expt 2 Expt 3 Expt 4 Expt 5 Average STD 
Medium 6.95 37.3 3.22 11.4 23.2 16.414 13.88401887 
St 7.47 66.9 17.8 162 91.7 69.174 62.40178187 
Pa 8.97 46.6  98.1 52.1 51.4425 36.53636396 
SEA 6.33 39.6 6.69 11.6  16.055 15.87968199 
        
CD80        
  Expt 1 Expt 2 Expt 3 Expt 4 Expt 5 Average STD 
Medium 12.7 58.3 4.31 42.5 36.9 30.942 22.13356772 
St 14.7 57.8 14.2 60.9 62.7 42.06 25.26584651 
Pa 15.8 47.6  48.2 50.9 40.625 16.61211907 
SEA 15.4 61.4 13.3 53.4  35.875 25.08324474 
        
CD86        
  Expt 1 Expt 2 Expt 3 Expt 4 Expt 5 Average STD 
Medium 11.1 54.7 4.91 30.2 51.6 30.502 22.70544032 
St 6.09 55.7 19 146 43.6 54.078 54.98951646 
Pa 10 62.4  158 39.4 67.45 64.06275569 
SEA 9.7 52.7 18.7 49.7  32.7 21.71021265 
 
 Table 3.1 Combined Data from DC and M%  flow staining. 106 DCs or M%s 
were cultured with medium alone (medium), St (2 µg/ml), Pa (10 µg/ml) or SEA (25 
µg/ml) for 24 hours. Surface expression of CD11c (DCs), F4/80 (M%s) MHC class 
II, CD40, CD80 and CD86 were then analysed by flow cytometry. Mean 
fluorescence Intensity is shown as gated on live CD11c
+
 DCs or F4/80+ M% from 
each of five independent experiments.  The average of these values and the standard 
deviation is show n at right.  Experiments 3 did not include Pa stimulation, and 






Does the expression of Notch Ligands by Dendritic Cells 
affect their ability to prime a CD4
+ 




Given its ubiquity in expression, and diversity of function, identifying the 
relationship between Notch signalling and the establishment of an immune response 
presents a complex and daunting challenge. Interest in the role of Notch signalling 
during peripheral immunity has been present since the first human notch1 was 
isolated from a T cell-leukaemia (Ellisen et al., 1991; Hoyne et al., 2000a; Milner 
and Bigas, 1999; Robey, 1999). In addition to the considerable research examining 
the function of the Notch pathway during haematopoiesis it was Hoyne et al. (2000) 
who first postulated that Notch ligand expression by APC may have a direct impact 
on the differentiation of naive T cells in the periphery (Hoyne et al., 2001; Hoyne et 
al., 2000a; Hoyne et al., 2000b). With the observation that both Notch receptors and 
ligands are differentially expressed by CD4
+
 T cells and DCs in response to tolerance 
induction, Hoyne et al. (2000) suggested that by expression of serrate1 (now called 
jagged1 in mammalian cells) DCs may promote tolerance (Hoyne et al., 2000b). As 
further studies examined the distinctive expression patterns of Notch ligands on 
APCs (Yamaguchi et al., 2002) and the impact of Notch receptor signalling on 
peripheral T cells (Maekawa et al., 2003; Vigouroux et al., 2003; Wong et al., 2003; 
Yvon et al., 2003) the possibility that APCs may directly regulate their Notch ligand 
expression profile to influence T cell polarisation became evident. Several studies 
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now suggest that signalling through Notch receptors has an effect on both T cell 
proliferation and mature T cell commitment (Amsen et al., 2004; Hoyne et al., 2001; 
Hoyne et al., 2000b; Maekawa et al., 2003; Vigouroux et al., 2003). In the context of 
CD4
+
 T cell polarisation, a recent in vivo study showed that blocking the ability of T 
cells to respond to signalling in Notch receptors 1-4 resulted in impaired Th2, but not 
Th1, responses (Tu et al., 2005). In addition, studies in vitro have suggested that both 
Delta and Jagged ligand families may be associated with T cell differentiation but 
that Delta ligands promote Th1 whereas Jagged ligands promote Th2 polarisation 
(Amsen et al., 2004; Maekawa et al., 2003; Napolitani et al., 2005). However, this 
contention remains controversial, with other reports suggesting that no such 
association exists, that Delta can inhibit T cell cytokine production rather than 
promote Th1 differentiation (Stallwood et al., 2006; Wong et al., 2003), or that 
Jagged may induce Treg, rather than Th2, differentiation (Dallman et al., 2003; 
Hoyne et al., 2000b; Minter et al., 2005; Vigouroux et al., 2003; Wong et al., 2003; 
Yvon et al., 2003), or even blockade Th1 (Sun et al., 2008). The contrasting nature 
of these separate studies indicate that proper analysis of a pathway as complicated as 
Notch in a system as sophisticated as peripheral immunity will require insights from 
both multi-variant in vivo approaches as well as reductionist in vitro experiments. 
Following the apparent association between relative expression of Notch 
ligands and Th1 or Th2 inducing stimuli (Figure 3.6), we went on to test their 
relevance in these systems by manipulating the expression pattern of Notch ligands 
on DCs. DCs were used primarily for these experiments as they are considered the 
most proficient APC at activating naïve T cells (Steinman, 2007), a reflection 
supported by our own experiments comparing DCs and M%s in (Chapter 3). Their 
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ability to dictate the tone of the developing CD4
+ 
T cell response is thought to be 
largely determined by the nature of the stimulus they encounter (Banchereau and 
Steinman, 1998). However, particularly in the case of Th2 development, the 
molecular mechanisms utilized by DCs to influence and instruct T cell polarisation 
are not completely understood (MacDonald and Maizels, 2008; Reis e Sousa, 2006).  
Initially, RNA interference (RNAi) was used in an attempt to manipulate 
expression of Notch ligands by DCs. RNAi is an evolutionarily conserved gene 
silencing mechanism present in a vast array of eukaryotic organisms that serves as a 
safeguard against the threat of exogenous DNA either from viral infection or mobile 
genetic elements. First reported in 1990 as an inducible process for suppression of 
gene expression (Napoli et al., 1990; van der Krol et al., 1990), the mechanism of 
RNAi was finally unravelled in 1998 (Fire et al., 1998) as short double stranded 
RNA was used to inhibit expression of complementary RNA sequences. Since then, 
RNAi has become an invaluable technique for the targeted silencing of specific 
genetic expression in a variety of tissues and organisms. Once introduced, long 
double stranded RNAs are processed by an RNase-III like enzyme known as Dicer 
into smaller 20-25 nucleotide segments known as small interfering RNAs (siRNA). 
These siRNAs then activate the RNA-induced silencing complexes (RISC) pathways 
which cleave and degrade complementary RNA strands (Hammond et al., 2000; 
Hannon, 2002). Unfortunately, in mammals, the addition of long double stranded 
RNA activates innate anti-viral mechanisms resulting in nonspecific inhibition of 
protein synthesis and RNA degradation (Gao and Zhang, 2007). However, the direct 
addition of siRNA to the cell can bypass this potent anti-viral response (Stallwood et 
al., 2006). There are several possible techniques for taking advantage of the RNAi 
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mechanism in order to achieve targeted gene knockdown including direct application 
of siRNA or through the expression of short hairpin RNA (shRNA) using vectors 
which are then cleaved into the necessary siRNA sequence (Gao and Zhang, 2007).  
Recent reviews suggest that more effective, and perhaps more consistent, 
gene expression knockdown can be achieved by transfecting shRNA using viral 
vectors (Gao and Zhang, 2007). However, this method entails the cultured generation 
of cell lines with incubation of the vector-mediated shRNA transfection. In contrast, 
siRNA would allow for the inhibition of any combination of Notch ligands at any 
point during the experiment once the appropriate complementary RNA strands are 
constructed and optimal transfection method ascertained (Stallwood et al., 2006). 
Furthermore, siRNA has been successfully demonstrated in primary immune cells 
such as T cells and DCs (Hill et al., 2003; Laderach et al., 2003; Liu et al., 2004; 
McManus et al., 2002; Stallwood et al., 2006).  
Transgenic mice provide an alternative approach for investigation into the 
function of Notch ligand expression by DCs. Unfortunately, induced deficiency in 
any of the Notch pathway genes is almost universally embryonic lethal (Maillard et 
al., 2005). However, this technical difficulty can be bypassed through the use of 
foetal liver chimeras. Briefly, foetal livers are taken from embryonic day 15 in mice 
and then injected into irradiated recipient mice, resulting in notch gene deficient 
haematopoietic cells (Jiang et al., 1998; Washburn et al., 1997). The caveat of this 
system is that only cells whose progenitors arise from a haematopoietic origin will be 
deficient in gene expression.  
Additional techniques used for interfering with the Notch pathway during the 
process of antigen presentation include the addition of a pharmacological blockade to 
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disrupt signalling. Several studies have investigated the role of Notch signalling in 
immune cells through the use of " secretase inhibitors which block Notch receptor 
cleavage and the release of the Notch intracellular domain (N-IC), disabling the 
classical CSL-dependent pathway (Adler et al., 2003; Eagar et al., 2004; Stallwood 
et al., 2006). Importantly, the use of " secretase inhibitors, such as N-[N-(3,5-
difluorophenacetyl)-L-alanyl]-(S)-phenylglycine t-butyl ester (DAPT), do not 
discriminate between the effects of different Notch ligands in their signalling 
inhibition (Geling et al., 2002). This pharmacological blockade serves as a whole-
scale inhibition of the entire Notch pathway. It is possible that there are cleavage 
independent forms of Notch signalling, in which case " secretase inhibitors may only 
disrupt a subset of Notch functions (Stallwood et al., 2006). 
Although many fascinating avenues of research present themselves in the 
investigation of Notch signalling in the immune system, we focussed first on the 
specific role, if any, Notch signalling has when Notch ligands are presented by DCs 
to Notch receptors on naïve T cells. A major goal of this thesis was to attempt to 
understand whether DCs utilize these molecular tools during antigen presentation. 
Specifically, do the changes in Notch ligand expression by stimulated DCs play an 
active role in the process of conferring specific Th differentiation? 
AIMS 
1) To devise a successful method for the manipulation of Notch ligand 
expression by DCs  
2) To assess whether the manipulation of Notch ligand expression by DCs 
influences their development or activation  
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3) To determine whether Notch ligand expression by DCs is required, redundant 
or irrelevant in regard to their ability to prime a Th response  
 
4.2 Can RNA interference be used to inhibit Dendritic cell expression of 
Notch ligands? 
 
Successful post-transcriptional inhibition of gene expression by RNAi has 
only recently been demonstrated in mammalian DCs (Hill et al., 2003; Laderach et 
al., 2003; Liu et al., 2004; Stallwood et al., 2006). Employing RNAi in DCs is 
particularly difficult since not only can double stranded RNA elicit a type-1 IFN 
response, inducing non-specific inhibition of transcription and cell death, but it can 
also activate PRRs, such as TLR3 (Kadowaki et al., 2001). For this reason we chose 
to use Stealth* RNAi technology (Invitrogen), which utilizes proprietary chemical 
modifications specifically designed by the manufacturer to enhance knockdown of 
expression while avoiding innate activation of the recipient cell. To assess the 
precise contribution of the Notch ligand targeted for knockdown, it was first essential 
to exclude the possibility that the process of RNA interference influences the 
activation status of the DC. DCs receiving siRNA treatment were checked by ELISA 
and flow cytometry for hallmarks of activation (MHC II, CD86, IL-12, IL-10 and IL-
6) to monitor whether the addition of the siRNA oligos themselves induced DC 
maturation. To determine whether successful knockdown was achieved, initial 
experiments used siRNA complementary to the gene encoding CD86 using the 
companies own algorithm software. Since DC surface expression of CD86 can be 
easily measured by flow cytometry, it was chosen as a useful target for determining 
the efficiency of the RNA inhibition, as opposed to Notch ligands, for which there 
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were no specific antibodies available for flow cytometry at the time of the 
experiments.  
Several parameters required optimisation before RNA interference could be 
used for determining the specific effects of reduced DC Notch ligand expression. For 
maximum transfection efficiency and efficacy, the concentration of siRNA oligos, 
transfection reagent and timing of siRNA addition had to be calibrated. Furthermore, 
RNAi techniques had to be optimised to reduce additional activation of DCs. 
Assessment of RNAi effectiveness by quantitative PCR demonstrates the overall 
reduction of mRNA expression across a population of cultured DCs. However, it 
does not demonstrate either the efficacy of siRNA on a per cell basis, or whether 
knockdown of gene transcription correlates with knockdown of protein expression. 
To address these details, DCs were exposed to fluorescent RNA oligonucleotides 
under the same conditions as standard siRNA in order to determine the transfection 
efficiency of the system (Figure 4.1A). Back-gating from fluorscent-oligo positive 
cells indicates that the majority of successfully transfected cells were a discrete 
population of live cells. However, by 24 hours the proportion of living fluorescent-
oligo containing cells had decreased, potentially indicating that the transfection 
process may negatively impact long-term cell viability (Figure 4.1B). Additionally, 
DCs treated with siRNA were assessed by flow cytometry to measure MHC II as a 
marker of activation (Figure 4.1C). There were no significant differences in MHC II 
expression under all treatment conditions used indicating little change in DC 
activation status due to siRNA treatment. However, treatment did appear to have 
differing effects on fluorescent oligonucleotide transfection rate depending on 
whether cells were stimulated, and the time point at which they were assessed. S. 
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typhimurium was used as a control to test for the impact of DC activation on 
transfection efficiency. At each time point, a greater percentage of DCs incorporated 
fluorescent oligonucleotides when siRNA was given prior to bacterial stimulation. 
Cytokine production was also measured to observe whether siRNA treatment 
activated DCs, but no significant difference in cytokine secretion between control 
siRNA oligonucleotides, functional siRNA oligonucleotides or the absence of 
oligonucleotides was found (Figure 4.2). 
To determine both the effectiveness and duration of expression knockdown, 
siRNA specific for CD86 was added to DCs either concurrently or previous to 
treatment with either medium alone or S. typhimurium. Then, CD86 mRNA 
expression was measured by quantitative PCR after 6 or 24 hours (Figure 4.3). As 
introduced in the previous chapter, S. typhimurium strongly activates DCs and thus 
markedly up-regulates CD86 expression. siRNA appeared to successfully inhibit 
CD86 mRNA expression by 24 hours in culture (Figure 4.3A and 4.3B). Addition of 
siRNA prior to stimulation with S. typhimurium appeared to improve the 
effectiveness of expression knockdown (Figure 4.3A and 4.3B). However, as 
samples were derived from single culture wells, statistical analysis was not possible. 
Although S. typhimurium stimulated DCs expressed greater levels of CD86 mRNA 
than media controls at 6 hours, 24 hours after stimulation these results were reversed. 
This may be due to a feedback mechanism whereby after an initial increase in CD86 
mRNA expression following stimulation, this mRNA expression is then reduced. It 
is unclear what exactly influences this change in expression at a later time point, but 
the result exemplifies the importance of timing when assessing mRNA expression. 
Unfortunately, elevated CD86 expression by DCs exposed to scrambled siRNA 
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controls indicated that addition of RNA alone was encouraging DC activation (data 
not shown). 
Since the extent of expected gene knockdown was unknown, it was thought 
that inhibiting CD86 expression during its peak production would more easily reveal 
the success of RNAi as opposed to homeostatic conditions. However, it is unclear 
whether addition of siRNA simultaneously with antigen disrupts the RNAi pathway 
during such a transcriptionally active and dynamic period as DC maturation.  
To complement the quantitative PCR approach, flow cytometric analysis was 
used to address whether RNAi affected the cell surface expression of CD86 protein 
(Figure 4.4). Although by 24 hours CD86 mRNA expression was reduced (Figure 
4.3), the cell surface expression of CD86 by DCs treated with siRNA oligos was 
equivalent to DCs with no siRNA treatment as measured by flow cytometry (Figure 
4.4). One possible reason for the discrepancy between mRNA expression and cell 
surface protein expression may be retention of CD86. Even in the presence of siRNA 
complementary to CD86 mRNA, there may be a reservoir of protein, which has 
already transcribed and is awaiting deployment to the cell surface. If so, cell surface 
expression would potentially be unaffected by recent mRNA inhibition. 
 We also tested whether the siRNA approach might still be valid for inhibition 
of expression of Notch ligands by DCs. Once the quantity of lipofectamine and 
siRNA concentration had been optimised for transfection efficiency, siRNA specific 
for both jagged2 and delta4 were transfected into DCs and knockdown assessed by 
quantitative PCR. These two genes were chosen since these displayed the most 
dramatic change in expression in differentially activated DC (Figure 3.6) and have 
been implicated in other studies as influencing naïve CD4
+
 T cell differentiation 
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(Amsen et al., 2004). When effective knockdown was not achieved (data not shown), 
additional transfection reagents were tested including Hipofectamine 2000 
(Invitrogen), as well as alternative siRNAs specific for the same Notch ligands. All 
together 16 separate experiments were conducted in order to both optimise 
conditions and attempt to attain successful and consistent knockdown of expression, 
however no significant knockdown of expression of any targeted gene was achieved. 
 There are several possibilities for why Notch ligand expression by DCs was 
not impaired by siRNA, but most likely a combination of factors was the cause of 
such inconsistent results. As measured by fluorescent siRNA, transfection efficiency 
typically varied between 70-85%. However, according to manufacturer’s instruction, 
such quality of transfection is on the borderline of effectiveness. If the siRNA oligos 
used to inhibit mRNA expression of targeted genes were also sub-optimal, then this, 
in combination with mediocre transfection, may explain the marked variation in 
effectiveness of attempted gene knockdown between experiments. Potentially, the 
use of a broader range of siRNA oligonucleotides would have yielded more 
successful results. 
 
4.3 Does the absence of jagged2 have an impact on the development 
and activation of DCs? 
Given the lack of success of the siRNA approach, we attempted an alternative 
method for generating DCs deficient in expression of specific Notch ligands. jagged2 
deficiency is embryonic lethal (Jiang et al., 1998) and, Notch signalling is required 
for the development of many haematopoietic cell types (Cheng et al., 2003; Olivier 
et al., 2005). jagged2 was targeted for gene knockout both due to its potential 
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association with distinct Th responses (Amsen et al., 2004) and the fact that, unlike 
jagged1 or delta1, it is not thought to be essential for DC differentiation (Ohishi et 
al., 2001; Olivier et al., 2005; Schroeder and Just, 2000b). In order to circumvent the 
difficulties of generating viable Notch deficient mice, jagged2 deficient bone 
marrow was generated from foetal liver chimeras, and kindly supplied by Caetano 
Reis e Sousa. Foetal livers from Ly5.2+ jagged2+/- x jagged2+/- matings were removed 
from d14.5 embryos, and jagged2-/- tissues were identified by PCR (Jiang et al., 
1998; Washburn et al., 1997). Irradiated Ly5.1+ recipients were reconstituted with 
cells from jagged2-/- or jagged2+/+ womb mates. DCs were grown from BM isolated 
from chimeras 8-20 weeks later. Donor origin of DCs was verified by flow 
cytometry (Figure 4.5) to ensure that DCs grown from jagged2 deficient bone 
marrow were Ly5.2+ but not Ly5.1+. After standard ten day culture, cell yields of 
jagged2-/- BM-DC were equivalent to jagged2+/+ controls, suggesting that the growth 
and development of DCs from this bone-marrow was not impaired by jagged2 
deficiency (data not shown). 
To ensure that DCs were jagged2 deficient, quantitative PCR was used to 
assess the level of jagged2 mRNA (Figure 4.6). Analysis of Notch ligand expression 
by these DCs revealed that they neither expressed jagged2 mRNA, nor was 
expression of other Notch ligands upregulated as a compensatory mechanism. The 
lack of jagged1 up-regulation, for example, suggests that any effect upon 
development, activation or function of these DCs would solely be the result of 
jagged2 deficiency.  
In addition to possible effects on the expression of other Notch ligands, the 
issue of whether the absence of Jagged2 made an impact on more classical indicators 
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of DC activation was examined. Both jagged2+/+ and jagged2-/- DC were analysed for 
secretion of cytokines and expression of co-stimulatory molecules (Figures 4.7 and 
4.8) in response to stimulation with a heat-killed preparation of P. acnes, or SEA. 
For all parameters measured, the markers of activation were unaffected by the 
absence of jagged2. Thus, jagged2-/- DC appeared similar to their wildtype 
counterparts other than lacking jagged2 expression.  
  
4.4 Are jagged2-deficient DCs impaired in their ability to influence T cell 
activation and proliferation? 
 Once it had been established that the absence of jagged2 had no major effect 
on DC development or activation, we set out to determine whether the absence of 
jagged2 alone impacts the DC’s ability to prime a T cell response. In order to dissect 
whether expression of jagged2 specifically impacts proliferation and polarisation of 
CD4
+
 T cells, we first used an in vitro co-culture system of DCs and transgenic OVA 
specific OTII T cells.  
DCs exposed to SEA or Pa were pulsed with either whole OVA protein or 
OVA peptide323-329, then co-cultured with purified CD4
+
 T cells from OTII mice, 
which express a T cell receptor (TCR) specific for ovalbumin peptide. Co-culturing 
DCs with OTII Tg T cells provides a reductionist experimental system, removing the 
possible influence of other cell types such as B cells, M%s or NK cells. Thus, any 
differences observed using jagged2 deficient DCs are attributable solely to the 
expression of Notch ligand by the APC. At first, a similar protocol was used to that 
reported by Jankovic et al. in 2004 (Jankovic et al., 2004) wherein BM-DC where 






 T cells from OTII mice in a volume of 0.2 ml with 
OVA323-329 and co-cultured for 5 days, with the addition of rIL-2 for the last 2 days. 
However, using this method Th2 specific induction of IL-4 as assessed by 
intracellular staining or supernatant ELISA was not achieved.  
 Over the course of subsequent experiments, several parameters of the 
protocol were altered, including timing of DC stimulation, comparison of OVA 
protein to peptide, DC:T cell ratio, and variation of the period of time DCs were 
incubated with T cells in co-culture, in order to optimise the system. Throughout this 
process of optimisation, only DCs derived from wild type C57BL/6 mice were used, 
as the supply of jagged2 deficient bone marrow was limited. The use of either 
OVA323-329  peptide (50 ng/ml) or whole OVA protein (200 µg/ml) was compared in 
order to determine whether optimal T cell polarisation by DCs required the 
processing of entire protein or, should protein degradation and MHC loading 
interfere with the maturation process, the use of OVA323-329. In addition, fewer DCs 
were cultured with CD4
+
 T cells in accordance with Artis et al. (2005) (Artis et al., 
2005). Initial experiments showed enhanced T cell proliferation in response to whole 
protein (Figure 4.9A). However, significant T cell expansion occurred even in the 
absence of DC maturation. Based on this, OVA323-329 was used for subsequent work, 
as the resulting proliferation profile was the clearest for all stimulation conditions 
carried out, including the extension of co-culture to 5 days (Figure 9B). 
 Once the in vitro co-culture csystem had been optimised with wild type 




DC to activate and polarise 
OTII TCR Tg T cells was assessed. Although both were equally proficient in 




DC displayed a dramatic impairment in their ability to induce SEA specific 
IL-4 production in comparison to their jagged2
+/+ 
counterparts (Figure 4.11). The 
absence of jagged2 expression by DCs reduced the proportion of IL-4 producing 
CD4
+
 T cells from 11.8% to 4.5%, or from 10.8% to 5.2%. Interestingly, the 
proportion of IFN-" producing CD4+ OTII cells was marginally increased by both P. 
acnes and SEA treated jagged2 deficient DC in comparison to jagged2 sufficient 
counterparts (Figure 4.11).  
 
4.5 How is T cell polarisation and proliferation affected by the inhibition 
of Notch receptor signalling?  
As an additional approach to manipulate Notch signalling in vitro, the "-
secretase inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-(S)-phenylglycine t-
butyl ester (DAPT) was used (Dovey et al., 2001). DAPT inhibits the protein 
complex involved in one of the key cleavage events required for Notch receptor 
signalling (Geling et al., 2002; Sastre et al., 2001). Addition of DAPT thus prevents 
all signalling through the Notch receptor pathway, and addresses the question of how 
Notch signalling influences T cell activation independent of specific Notch ligand 
expression. When added to co-culture wells (5 µM) containing DCs (2x104/well), 
OTII T cells (2x10
5
/well), OVA323-329 (50 ng/ml) and SEA (50 µg/ml), there was a 
marked impairment of SEA-specific IL-4 production compared to culture wells in 
the absence of DAPT (Figure 4.12). It is interesting to note that the blockade of 
Notch receptor signalling was comparable to the absence of DC jagged2 expression 
as measured by this in vitro co-culture system (Figure 4.11 and 4.12).  
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These combined results indicated that the process by which Notch signalling 
affects Th2 differentiation in vitro is critically dependant on jagged2 expression by 
DCs despite it’s lack of significant upregulation by Th2 stimuli. It is unclear, 
however, whether the Notch ligand jagged2 alone is required for Th2 induction, or if 
the absence of any individual Notch ligand would impair Th2 induction in this 
setting. 
 
4.6 Does the absence of jagged2 expression by DCs affect their ability 
to prime an immune response in vivo?  
We then asked whether expression of jagged2 was also important for 
polarisation of Th cells by DCs in a more complex, and arguably more relevant, in 
vivo setting. jagged2+/+ or jagged2-/- DCs were stimulated with Pa or SEA and then 
injected into the footpads of naïve C57BL/6 mice. Four days later, draining LN were 
removed and examined for cytokine secretion following restimulation with Ag in 
vitro. Pa activated DC induced a marked Th1 response with Pa-specific IFN-" 
detected in culture supernatants irrespective of whether transferred DC were 
jagged2+/+ or jagged2-/- (Figure 4.13). Contrary to expectation, SEA stimulated 
jagged2-/- DCs induced an equivalent or higher IL-4 response after transfer into naïve 
wild type animals. This was irrespective of the route of immunization as jagged2+/+ 
and jagged2-/- DCs given i.p. also showed equivalent ability to induce a Th2 response 
whether measured by IL-5, IL-13 or IL-10 (Figure 4.13). Thus, despite the fact that 
DCs maintain expression of jagged2 after exposure to SEA in vitro (Figure 3.5), and 
jagged2-/- DCs are severely impaired in their ability to instruct Th2 polarization in 
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vitro (Figure 4.11), these data suggest that DC expression of this Notch ligand is not 
essential for the establishment of a Th2 response in vivo. 
 
4.7 Discussion 
Current literature strongly suggests that Notch signalling plays a role in the 
development of an adaptive immune response (Amsen et al., 2007; Amsen et al., 
2004; Dallman et al., 2003; Maekawa et al., 2003; Maillard et al., 2003; Rutz et al., 
2008; Tu et al., 2005). Our intention was to first use RNA interference to 
systematically deplete DC expression of individual Notch ligands, or sets of ligands, 
in order to determine the importance of each one alone or in combination. 
Unfortunately, effective RNA inhibition was found to be difficult to achieve, perhaps 
because the DCs undergoing transfection were primary cells specialised in 
recognition and response to foreign RNA. In this project, achieving consistent 
measurable knockdown of DC protein expression using siRNA, while refraining 
from unnecessary DC activation, proved elusive.  
There are several main considerations when attempting to inhibit gene 
expression via RNA inhibition. First, the sequence of the interfering RNA must be 
sufficient to engage the RNA inhibitory pathway (Hannon, 2002). Secondly, the 
RNA interfering sequence must be effectively transported into the cell and allowed 
to engage with the RISC pathway (Tijsterman and Plasterk, 2004). Finally, effective 
gene knockdown must be achieved without activating the cell’s own anti-viral 
response (Gao and Zhang, 2007; Tijsterman and Plasterk, 2004). Although a great 
deal of time and effort was spent trying to optimise this system, reliable results were 
not obtained. 
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Inhibition of Notch ligand expression has now been carried out in human 
cells (Stallwood et al., 2006), where matured human monocyte derived DC were 
exposed to siRNA specific for delta1, jagged1 or jagged2 and then co-cultured with 
allogeneic T cells in a MLR. This study found that a reduction in DC expression of 
any of the three Notch ligands resulted in enhanced T cell IFN-" production and 
proliferation (Stallwood et al., 2006). However, it is important to note that in this 
study the DCs being transfected with siRNA were in no way primed to drive either a 
Th1 or Th2 response, but instead were matured by the addition of 20 ng/ml of TNF#. 
As shown in the previous chapter, DCs exposed to biologically relevant pathogens 
display distinct expression patterns of Notch ligands corresponding with their T cell 
polarising nature. Furthermore, no IL-4 was detectable in this report (Stallwood et 
al., 2006), so it remains to be seen whether the use of RNA inhibition of Notch 
ligand expression by DCs which are subsequently exposed to pathogens or their 
products influences their capacity to drive a T helper cell response, particularly Th2 
responses. 
 The advantage of a successful siRNA approach to reduce Notch ligand 
expression by DC would be that, with the appropriate specificity, any Notch ligand 
(or combination of ligands) could be targeted for study at the time of the 
investigator’s choosing. The disadvantages are that the effects may be transient and, 
furthermore, RNAi cannot guarantee complete knockout, only decreased expression 
(Gao and Zhang, 2007). Therefore, interpretation of any RNAi results would have to 
take into consideration that small amounts of protein expression may remain, or 
normal expression may resume later on during the course of the experiment. In the 
case of Notch signalling, a pathway that is particularly sensitive to small changes in 
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expression (Artavanis-Tsakonas et al., 1999), a reduction may yield a very different 
result from complete absence. Additionally, at the time these experiments were being 
conducted, reliable Notch ligand specific antibodies were unavailable, making 
confirmation of reduced Notch ligand expression at the protein level technically 
difficult. Reduction in Notch ligand mRNA may not necessarily correlate with 
reduction of Notch protein expression on the cell surface.  
 Having jagged2 deficient bone marrow available proved a key resource and 
addressed some of the questions RNAi would not be able to, even if it had worked. 
Importantly, jagged2
-/-
 DC were phenotypically similar to jagged2
+/+ 
for all the 
conventional markers of activation measured. Further, jagged2
-/-
 DCs did not 
compensate by up-regulating expression of jagged1, delta1, or delta4 in response to 
stimulation with either P. acnes or SEA. Therefore, jagged2 signalling does not 
intrinsically affect a DC’s ability to grow and develop, or interfere with the 
expression of cytokines or co-stimulatory markers following P. acnes or SEA 





 DCs are also more likely to be directly due to the presence 
or absence of jagged2 and not through a third party pathway.   
Our results clearly show that DC expression of jagged2 alone can be critical 
for Th2 polarization of naïve CD4+ T cells in vitro. The presence of the other Notch 
ligands could not compensate for the absence of jagged2 in this setting. This 
indicates that jagged1, delta1, and delta4 are all unable to fulfil the signalling 
requirement by Notch receptors on CD4+ T cells in the establishment a Th2 response 
in vitro. Interestingly, inhibition of Notch receptor signalling using in vitro DAPT 
had a similar effect on T cell activation to using jagged2 deficient DCs (Figure 
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4.12). This suggests that in a reductionist Th2 setting limited to DC and Tg T cells, 
jagged2 is the primary Notch ligand utilized by the DC in order to promote a Th2 
response. Since this DAPT experiment was only carried out once, additional repeats 
are needed to confirm and expand this surprising finding. 
In the more complex in vivo setting, by contrast, DC expression of jagged2 
was found to be dispensable for Th2 induction (Figure 4.13). Taken together, our in 
vitro and in vivo results suggest that jagged2 signalling is important for Th2 
polarisation, yet jagged2 expression need not be limited to the APC driving the 
response. For example, the important interaction in vivo may not actually be between 
a Notch ligand bearing APC and a naïve CD4
+
 T cell, but rather between APC and 
NKT cells, or a subset of memory CD4
+
 T cells capable of producing IL-4 rapidly 
and independently of STAT6 (Tanaka et al., 2006; van der Vliet et al., 2001).  It is 
therefore possible that, in vivo, the multivariant expression of Notch ligands by APCs 
involves interactions with multiple cell types, since both Notch receptors and ligands 
can be found in diverse cell types in addition to T cells and DC (Amsen et al., 2004; 
Baron, 2003).  
In future experiments, the importance of provision of jagged2 by 
haematopoietic cells could be addressed by adoptive transfer of WT or jagged2
-/-
 
DCs into chimeric recipient mice grafted with jagged2 deficient bone marrow, or by 
infecting such mice with a Th2 dominated infection such as S. mansoni or Trichuris 
muris. Another avenue of investigation in vitro could be to attempt to rescue the 
absence of SEA-specific IL-4 by CD4
+
 T cells stimulated by jagged2
-/-
 DC by 
providing soluble Jagged ligand or co-culturing with non-Ag loaded jagged2
+/+
 DCs, 
M%s or even epithelial cells. Successful induction of IL-4 by this method would 
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indicate whether jagged2 provision is required by the primary APC or if jagged2 
expression by adjacent cell types is sufficient.  
Our in vivo experiments, in which all such cells were present, revealed that 
DC expression of the Notch ligand jagged2 does not play a dominant role during 
SEA-specific Th2 induction. Whether this finding is indicative of the provision of 
jagged2 by additional cell types, a redundant pathway, or compensation via other 
Notch ligands remains to be determined. Even so, these results challenge the model 
that selective expression of Jagged ligands by DCs is responsible for determining 
Th2 differentiation, and suggest that reliance on reductionist in vitro systems to 





Figure 4.1 Optimal transfection efficiency occurs when DCs are 
exposed to siRNA prior to stimulation. 10
6 
DCs per well received 
siRNA complementary to CD86 either concurrently (Simultaneous) or 2 
hours prior (Pre-treatment) to stimulation with either medium alone 
(Medium) or Salmonella typhimurium (St, 2 µg/ml). A) Transfection 
efficiency was determined by DCs treated with fluorescent RNA 
oligonucleotides for 6 or 24 hours, and B) Forward and side scatter plots 
were back-gated for cells positive for fluorescent oligo expression. C) 
Flow cytometry was used to measure activation status via MHC II. 
Histograms are gated on live CD11c
+ 
DCs. Figures in upper right of 
graphs depict percentage positive and geometric mean fluorescence. 
Data shown is representative of three separate experiments. 
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Figure 4.2 Cytokine secretion by DCs is not affected by siRNA 
treatment. 1.5 x10
6 
DCs per well received either no RNA (open bars) 
scrambled control siRNA (gray bars, 150 nMol) or siRNA 
complementary to CD86 (black bars, 150 nMol) in addition to 
stimulation with either medium alone (M) or S. typhimurium (St, 1 
µg/ml) for 24 hours. Data shown is mean + SEM of cytokine measured 







Figure 4.3 Impact of siRNA on DC expression of CD86. DCs were 
stimulated with medium alone (M) or S. typhimurium (St, 2 µg/ml) for 
either 6 hours or 24 hours with either no RNA (open bars) or CD86 
siRNA (black bars) added A) simultaneously or B) 2 hours previous to 
antigenic stimulation. siRNA against CD86 was added at a concentration 
of 150 nM with 1 µg/mL lipofectamine (Invitrogen). CD86 mRNA 
levels were measured by quantitative PCR and normalised to 18s. Bars 
represent single culture wells and thus no error bars are applicable. Data 
















Figure 4.4 Impact of siRNA on cell surface expression of CD86 by 
DCs. 10
6 
DCs per well received siRNA complementary to CD86 either 
concurrently (Simultaneous) or 2 hours prior (Pre-treated) to stimulation 
with either medium alone (Medium) or S. typhimurium (St, 2 µg/ml) for 
6 or 24 hours. Histograms are gated on live CD11c
+
 DCs. Figures in the 
upper right of graphs depict percentage positive and geometric mean 



















 bone marrow is of donor origin. DC derived 






 matings were 
grown for 11 days in the presence of GM-CSF and then analysed by 
flow cytometry for expression of Ly5.1 and Ly5.2. Dot plots are gated 
on live CD11c
+







Figure 4.6 Notch ligand expression by jagged2
-/-
 DCs. Expression of 
jagged1, jagged2, delta1 and delta4 by DCs exposed to medium (open 
bars), Pa (gray bars) or SEA (black bars) was assessed by quantitative 
PCR. Data shown are mean + SEM of mRNA expression levels 




   
 
 
Figure 4.7 Cytokine production by jagged2-/- DCs. DCs were grown 
from BM derived from jagged2+/+ or jagged2-/- chimeras and exposed to 
either medium alone (M), Pa (P, 10 µg/mL) or SEA (S, 25 µg/ml) for 
24h. Cytokine production by jagged2+/+ (open bars) or jagged2-/- (black 
bars) DCs was measured by ELISA and data shown are mean + SEM of 








Figure 4.8 Phenotypic activation in jagged2-/- DCs. Surface expression 
of CD80 and CD86 on jagged2+/+ or jagged2-/- DCs.  Light grey filled 
histograms indicate unstimulated DC; black unfilled histograms, DCs 
stimulated with SEA or Pa.  Graphs are representative of two separate 





Figure 4.9 Comparison of whole OVA protein and OVA323-339  in the 
proliferation of OTII cells. 2x105 CD4 OTII cells were co-cultured 
with 2x104 DCs stimulated with either medium alone (Medium), P. 
acnes (Pa, 10 µg/ml) or SEA (50 #g/ml). Either whole OVA protein (200 
µg/ml) or OVA323-339 peptide (50 ng/mL) were also added to co-cultures 
for A) 3 days. B) An additional culture using OVA323-339 peptide (50 
ng/mL) was maintained for 5 days to assess the impact on proliferation. 
OTII cells were labelled with CD4 and CFSE. Data are representative of 
5 separate experiments 
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 Figure 4.10 jagged2-/- DCs are not impaired in their capacity to 
drive T cell proliferation. CD4+ OTII cells were co-cultured with 
jagged2+/+ or jagged2-/- DCs in the presence of OVA323-339 peptide (50 
ng/mL) alone (Medium) or in conjunction with SEA (50 µg/mL) or Pa 
(10µg/mL). OTII cells were labelled with CD4 and CFSE to assess 
proliferation. Dotted lines represent CFSE levels on cells cultured in the 
absence of peptide and figures refer to percentage of dividing cells. 
Results are representative of three independent experiments. 
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Figure 4.11 Impaired Th2 induction by jagged2-/- DCs in vitro. CD4+ 
OTII cells were co-cultured with jagged2+/+ or jagged2-/- DCs in the 
presence of OVA323-339 peptide (50 ng/mL) alone (Medium) or in 
conjunction with SEA (50 µg/mL) or Pa (10µg/mL). OTII cells were 
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examined for intracellular staining Plots depicting intracellular staining 
in are gated on live CD4+ cells and figures refer to cytokine producing 






Figure 4.12 Blockade of Notch signaling using DAPT impairs Th2 
differentiation. CD4 purified OTII cells were co-cultured with DC in 
the presence of OVA323-339 peptide (50 ng/mL) alone (Medium) or in 
conjunction with SEA (50 µg/mL) or Pa (10 µg/mL) with or without 
DAPT (5µM). OTII cells were labelled with CD4, IL-4 and IFN-" and 




Figure 4.13 DC expression of jagged2 is dispensable for Th2 or Th1 
induction in vivo.  jagged2+/+ or jagged2-/- DCs were exposed to medium 
alone (M), Pa (P, 10 µg/mL) or SEA (S, 25 µg/mL), then injected into 
the footpad A), or i.p. B) of naïve C57BL/6 recipient mice. Popliteal LN 
cells A) or splenocytes B) were removed 4d A) or 7d B) later and then 
stimulated in vitro with medium (open bars), SEA (black bars) or Pa 
(grey bars). Data shown are mean + SD of cytokine measured by ELISA 
of triplicate wells of combined LN cells A), or mean + SEM of cytokine 
measured by ELISA of three to five mice per group B). Data shown are 
representative of three A), or two B), separate experiments. This 




Alternative Strategies for identification of molecular 
requirements for DC polarisation of T cells in vivo 
 
5.1 Introduction 
There is an extensive difference between the environment in which DCs are 
stimulated in vitro and the signalling molecules, tissue factors, structural 
relationships and physiological conditions under which a DC would encounter the 
same stimulus in vivo. This is illustrated by the often-conflicting results of our in 
vitro and in vivo comparisons, as previously detailed (Figure 3.3 and Figure 4.13). 
These observations prompted assessment of the extent to which DC activation and 
function is affected by the presence of infection-associated tissue factors during 
exposure to Ag in vitro. However, determining which in vivo components play a 
critical role in the maturation process of DCs and how they may exert their influence 
is a daunting task, particularly in a Th2 setting. No clear molecular indicator of a Th2 
primed DC has yet been identified and Th2 conditioned DCs display no significant 
upregulation of any hallmarks of conventional maturation, and only minor increases 
in MHC II expression (MacDonald et al., 2001). Thus, determining whether external 
factors impact the Th2 maturation status of a DC at all is challenging. We 
hypothesized that candidates should be present in vivo in the context of Th2 
pathogens, and have the potential to influence DC maturation status. Since SEA has 
been the most consistently used Th2 stimulus throughout this work, we reasoned that 
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the in vitro addition of molecular factors commonly associated with S. mansoni 
infection would be most relevant.  
The development of an immune response varies considerably over the course 
of S. mansoni infection. However, we chose to focus on the host-parasite 
environment during the Th2 dominated stage of infection induced primarily by egg 
antigens (Pearce and MacDonald, 2002; Perona-Wright et al., 2006). Obvious 
molecular candidates present during a Th2 response, and whose absence in vitro may 
mask the ability to define a Th2 primed DC, include IL-4 and IL-13. Both cytokines 
predominate during the egg-laying stage of infection and are primarily responsible 
for the severe hepatic fibrosis that can occur during infection (MacDonald et al., 
2002a; Wynn et al., 2004).  
Although an important Th2 cytokine, IL-4 has been previously shown to play 
a more nuanced role in the maturation of APCs. Recent studies have shown that IL-4 
treatment of DC may upregulate IL-12 in response to LPS, which seems in 
contradiction with its established Th2 role (Kalinski et al., 2000; Yao et al., 2005). 
Importantly, however, these studies did not investigate whether IL-4 treatment of 
DCs affected their capacity to polarise T cell responses in vivo. Another study has 
demonstrated that DCs purified from lymph nodes from mice infected with 
Leishmania major and injected with IL-4 i.p. 8 hours later expressed greater levels of 
IL-12 mRNA, and that this IL-12 was responsible for an enhanced Th1 response 
(Biedermann et al., 2001). However, the prevailing immune response from L. major 
infected mice given IL-4 for 64 hours became strongly Th2 (Biedermann et al., 
2001). This highlights the pluripotent effect of these infection related cytokines, and 
emphasizes the need to ascertain the impact of environment on the maturation of 
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DCs. In this particular study the only readout for DC maturation was IL-12 
production (Biedermann et al., 2001). Assessment of a broader array of activation 
markers, including Notch ligands, may provide greater insight into the mechanisms 
by which Th2 associated tissue factors can influence DC activation and function. 
More recently identified Th2 tissue factors include cytokines such as TSLP 
and IL-25. TSLP is an epidermal derived IL-7 related cytokine, originally identified 
as a growth factor in the generation of immature B cells which is now implicated in 
the pathogenesis of dermatitis, asthma and may be associated with certain helminth 
infections (Astrakhan et al., 2007; Demehri et al., 2008; Huston and Liu, 2006; Zaph 
et al., 2007; Zhou et al., 2005). Predominantly secreted by barrier epithelial cells, 
TSLP is also thought to be a potent activator of myeloid cell types (including DCs), 
and thus may play a significant role in the initial milieu in which DCs encounter Th2 
Ags. IL-25 (IL-17E) was identified as being structurally related to IL-17 (IL-17A) 
but with markedly different biological activities both in vitro and in vivo (Fort et al., 
2001). IL-17 typically induces production of pro-inflammatory cytokines such as IL-
1!, IL-6 and TNF# in M%s (Jovanovic et al., 1998), whereas injection of mice with 
IL-25 induces IL-4, IL-5 and IL-13 expression and is predominantly expressed in 
Th2 polarised CD4
+
 T cells (Fort et al., 2001; Hurst et al., 2002). Although it has 
been suggested that IL-25 may directly regulate the Th2 differentiation of CD4
+
 T 
cells (Angkasekwinai et al., 2007; Wang et al., 2007) the extent of cell types 
receptive to IL-25 signalling remains unclear, and the impact of IL-25 on the Th2 
inductive potential of DCs is as yet unknown. 
 The addition of exogenous cytokines to DCs in vitro serves two aims. First, 
the co-administration of antigen with Th2 associated cytokines may reveal which 
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components of the host immune response are responsible for the discrepancies 
observed between co-culture experiments in vitro and DC transfer in vivo. Secondly, 
the presence of Th2 associated cytokines may be required to reveal changes in the 
expression of molecules indicating a Th2 primed DC, such as Notch ligands. For 
example, it is possible that upregulation of jagged2 in response to SEA may only be 
readily apparent in the presence of Th2 cytokines, such as IL-4.  
As an alternative strategy for investigating the in vivo requirements for DC 
function, we also assessed the antigen presenting capacity of DCs deficient in 
pathogen recognition. We reasoned that use of DCs derived from transgenic mice 
deficient in their ability to receive pathogen recognition signals may demonstrate 
what distinguishes the requirements for activation of Th1 driving DCs from Th2. 
TLRs are possibly the best studied of receptors responsive to such stimuli. The 
majority of TLRs, with the exception of TLR3, make use of the universal adaptor 
protein MyD88 to activate transcription factor NF&B (Medzhitov et al., 1998) and 
MyD88 deficient mice provide a useful gene target for impairing majority of TLR 
signalling. Given that MyD88 deficient DCs severely reduced responses to Th1 
stimuli (Kaisho et al., 2001), our expectation was that they would have a diminished 
capacity to drive Th1 responses in vivo. It has previously been shown in an in vitro 
system that when DCs stimulated with soluble T. gondii tachyzoite extract (STAg) 
are co-cultured with naïve CD4
+
 T cells from TCR Tg DO.11.10 X RAG2 knockout 
mice together with OVA323-329 peptide, the resulting induction of IFN-" producing 
CD4
+
 T cells was entirely MyD88 dependent (Jankovic et al., 2004). By contrast, 
SEA-DCs cocultured in a similar fashion induced IL-4 production by CD4
+
 T cells in 
a MyD88 independent fashion (Jankovic et al., 2004). However, whether this might 
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also be the case in vivo has yet to be shown. Thus, we investigated the requirements 
for DC function in vivo using multiple approaches, including cumulative addition of 
cytokines and reductionist gene knockout experiments, with a particular focus on 
mechanisms utilised by DCs in Th2 induction.  
A primary motivation for investigating the role of Notch proteins in DC 
function was to observe whether the upregulation of specific Notch ligands could act 
as a marker for Th2 maturation. Although SEA stimulated DCs did not enhance 
expression of any Notch ligands measured in either a significant or consistent 
manner (Figure 3.6), other molecules have recently been shown to be upregulated by 
M%s in a Th2 setting, including Ym1 and RELM# (Chang et al., 2001; Nair et al., 
2003; Nair et al., 2005). Ym1 and RELM# gained notoriety in the field of Th2 
immunology after M%s were found to secrete these two proteins in abundance 
during nematode infection (Chang et al., 2001; Falcone et al., 2001). Ym1 is a 
member of a family of mammalian proteins that share a homology with chitinases in 
other species which have recently been associated with development of allergic 
airways disease (Zhu et al., 2004). Chitin is the second most abundant 
polysaccharide in nature and typically acts as a protective layer separating the harsh 
environment of a host from a pathogen such as a parasitic nematode (Shahabuddin 
and Vinetz, 1999; Zhu et al., 2004) Since chitin itself is not utilized by mammals, it 
was assumed until recently that chitinases were also lacking. However the recent 
discovery of chitinases such as Acidic mammalian chitinase (AMCase) in humans or 
YM-1 (YM-2 in mice) and, particularly, their expression in Th2 inflammation, 
implies that these proteins may be directly involved the defence against chitin-
containing pathogens. Furthermore, BM-DC have been shown to upregulate Ym1 
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and RELM# in the presence of IL-4 (Nair et al., 2005). However, it is as yet 
unknown how pathogen stimulated DCs respond in terms of their expression of 
either Ym1 or RELM# and whether these molecules could act as an indicator 
demarking a Th2 primed DC.  
Thus, by focussing on Th2 associated cytokines, MyD88 and Notch ligands, 
we expanded our investigation of what might be the critical components for DC 




1) To test Th2 related tissue factors for their ability to alter DC activation and 
function. 
2) To determine whether activation and function of Th2 conditioned DCs is 
dependent upon MyD88 signaling. 
3) To ascertain if hallmarks of alternatively activated M%s, such as Ym1 or 
RELM#, may represent markers of Th2 primed DCs. 
 
5.2 Can exogenous cytokines measurably alter DC maturation status in 
vitro? 
Predominantly, we have conducted DC experiments by stimulating cells in 
vitro and then either directly observing their antigen presenting capacity in culture, 
or transferring matured DCs into recipient mice. In either circumstance, the in vitro 
process of DC activation is carried out in the absence of the environment in which an 
APC naturally encounters pathogens or their Ags. To better represent the tissue 
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environment in which DCs might be activated in vivo, IL-4 and #CD40 were added 
to DCs during Ag exposure in vitro. IL-4 is produced within tissues and detectable in 
sera during Th2 infection settings (Jankovic et al., 2001; Pearce and MacDonald, 
2002). Agonistic #CD40 antibody was also added to DCs stimulated by Ag to mimic 
CD154 provision by activated T cells or other tissue sources (Jenkins et al., 2008).  
In keeping with previous reports (Biedermann et al., 2001; Hochrein et al., 
2000; Kalinski et al., 2000; Koch et al., 1996; Yao et al., 2005), the addition of IL-4 
cytokine in conjunction with the strong Th1 stimulus of heat-killed P. acnes 
significantly enhanced DC secretion of IL-12p70 (Figure 5.1). A similar increase in 
IL-12p70 production occurred when Pa-DCs were treated with #CD40 antibody 4 
hours following Ag stimulation, again consistent with other studies (Schulz et al., 
2000). However, IL-4 and #CD40 antibody together shared strong synergy in this 
capacity dramatically increasing DC IL-12p70 secretion (Figure 5.1). Elevated 
cytokines production was not observed in all cases, IL-6 secretion was unaffected by 
the presence of either IL-4 or #CD40 antibody alone or in conjunction. However, IL-
10 secretion by Pa-DCs appeared to be impaired in the presence of IL-4, but not in 
the presence of agonistic #CD40 antibody. This trend was consistent across multiple 
experiments, but not significant when IL-4 was present at a concentration of 1 ng/ml.  
Although displaying a clear effect on the secretion of IL-12p70 by bacterially 
stimulated DCs, neither IL-4 nor #CD40 antibody exerted measurable effects on 
cytokine production by SEA treated DCs (Figure 5.1). There were, however, some 
observable differences in DC expression of Notch ligands (Figure 5.2). Intriguingly, 
the addition of IL-4 impaired delta4 expression by Pa-DCs, although there was no 
corresponding increase in jagged2 expression. SEA-DCs behaved somewhat 
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differently. Unlike Pa-DCs, SEA-DCs substantially increased expression of jagged2 
in response to IL-4 in conjunction with a slight decrease in delta4 expression 
compared to unstimulated controls. Stimulation of CD40 through the use of agonistic 
#CD40 antibody following either Pa or SEA stimulation dramatically increased 
expression of both delta4 and jagged2. However, it is difficult to draw any firm 
conclusions due to the preliminary nature of the data. 
 The presence of IL-4 during DC stimulation has been shown to influence the 
secretion of IL-12 (Hochrein et al., 2000; Kalinski et al., 2000; Yao et al., 2005) as 
well as the expression of Notch ligands (Figure 5.2). However, the impact of Th2 
associated cytokines on the ability of DCs to generate immune responses in vivo 
remains unclear. We went on to address whether IL-4 and additional Th2-related 
tissue factors may affect the T cell polarising capacity of DCs in vivo. Recent work 
had suggested a role for the cytokines IL-25 and TSLP in the generation of a Th2 
response (Huston and Liu, 2006; Perrigoue et al., 2008; Wang et al., 2007; Zhou et 
al., 2005; Ziegler and Liu, 2006). Thus, DCs were treated with IL-4, IL-25 or TSLP 
over a range of doses and in conjunction with P. acnes stimulation and their cytokine 
production measured (Figure 5.3). As shown previously (Figure 5.1), IL-4 
decreased IL-10, and increased IL-12p70 production, by Pa-DCs, whereas IL-6 and 
IL-12p40 remained unchanged. At higher doses of TSLP, there was a trend for 
enhanced DC IL-12p70 production, similar to that seen with IL-4, but this was not 
statistically significant. The intention was to go on to identify how IL-25 and TSLP 
impacted Notch ligand expression. Unfortunately, due to time constraints the data 
generated to date remain preliminary. 
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5.3 Do Th2 associated cytokines influence DC priming of T cell 
responses in vivo? 
To investigate whether DC treatment with Th2 related cytokines in vitro had 
influenced their in vivo function, DCs activated with Pa in the presence or absence of 
IL-4, IL-25 or TSLP were then transferred into naïve recipient mice. We reasoned 
that, since stimulation of DCs with IL-4 resulted in enhanced IL-12p70 production, 
we would expect to see elevated IFN-" in recall responses from mice that had 
received DCs stimulated with Pa and IL-4. Contrary to expectation, mice that had 
received DCs stimulated with Pa in conjunction with IL-4, IL-25 or TSLP all 
produced significantly lower levels of IFN-", in comparison to recipients of DCs 
stimulated with Pa alone (Figure 5.4). Furthermore, there was a significant decrease 
in the production of IL-17 by recipients of Pa-DCs treated with IL-25 or TSLP. This 
result demonstrates that, although the addition of IL-4 enhanced DC secretion of 
Th1-driving cytokines such as IL-12 in vitro (Figure 5.3), this was not translated 
into increased Th1 driving capacity by these same cells in vivo. Further, DC 
exposure to IL-25 and TSLP had a significant impact on in vivo Th1 responses 
despite having little impact on in vitro cytokine secretion. This data suggests that 
DCs stimulated in the presence of Th2 related cytokines have an impaired ability to 
drive a Th1 response by a mechanism that is yet to be determined. In addition, this 
data again challenges the wisdom of speculating T cell polarising ability of DCs 
based on in vitro cytokine production alone. 
 
5.4 What is the impact of MyD88 deficiency on DC function in vitro and 
in vivo? 
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In addition to determining the impact of exogenous cytokines on DC 
function, we assessed the effect of curtailing DC cytokine production on their T cell 
priming ability through the use of MyD88 deficient DC. MyD88 is a crucial adaptor 
protein for the majority of TLR signalling pathways, excluding TLR3, and plays an 
important role in DC function. (Eisenbarth et al., 2002; Kaisho and Akira, 2001; 
Kawai and Akira, 2007) When stimulated with Pa, MyD88
-/-
 DCs displayed a similar 
ability to upregulate MHC II, CD40, CD80 and CD86 to WT DC (Figure 5.5). In 
fact, MyD88 deficient DCs appeared to have a slightly greater basal activation status 
than WT DCs. However, cytokine secretion by MyD88
-/-
 DCs was strikingly 
impaired, as MyD88 deficient Pa-DCs failed to secrete any measurable IL-12p70, 
while 12p40, IL-6 and TNF# were all dramatically reduced (Figure 5.6). These 
results agree with previous studies showing that the impairment of MyD88 signalling 
in DCs either by small interfering RNAs (Zhu et al., 2008) or by transgenic 
deficiency (Kaisho et al., 2002; Kaisho et al., 2001; Tesar et al., 2004) dramatically 
reduces (although does not eliminate) Th1-associated cytokine production yet 
maintains co-stimulatory molecule expression.  
We then examined Notch ligand expression in MyD88 deficient DCs (Figure 
5.7). Interestingly, delta4 expression by Pa-DCs was completely abrogated in the 
absence of MyD88. It has been previously reported that LPS stimulation induces a 
MyD88 dependent enhancement of delta4 expression in addition to a MyD88 
independent jagged1 upregulation (Amsen et al., 2004). Down-regulation of jagged2 
by Pa stimulation, as described previously (Figure 3.6), was maintained in the 
absence of MyD88, indicating that the inhibition of jagged2 expression in response 
to Pa is not dependent upon MyD88 signalling. However, at 6 hours MyD88 
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deficient Pa-DCs and unstimulated DCs did express higher levels of jagged2 than 
their WT counterparts. Future assessment of jagged1 and delta1 expression by 
MyD88 deficient DCs would also reveal the extent to which other Notch ligands are 
responsive to stimulation and reliant on MyD88 signalling.  
The ability of WT and MyD88 deficient DCs to induce Th1 and Th2 
responses was then compared in vivo. As described in previous chapters, 5x10
5
 DCs 
were injected i.p. into naïve recipient mice, and splenic recall responses assessed one 
week later. Given that the absence of MyD88 mediated TLR signalling severely 
disrupted the bacterially triggered secretion of T cell polarising cytokines such as IL-
12 (Figure 5.6), in addition to the loss of Pa-specific delta4 expression, (Figure 5.7) 
our expectation was to observe dramatically diminished capacity for Pa-stimulated 
MyD88
-/- 
DCs to drive a Pa-specific IFN-" response, in comparison to WT DCs. In 
striking contrast to this expectation, Pa-DCs deficient in MyD88 signalling induced 
comparable IFN-" responses to Pa stimulated MyD88 sufficient DCs (Figure 5.8A). 
Additionally, in four separate experiments there was also a trend for increased IL-13 
induction by MyD88
-/- 
Pa-DCs, in comparison to WT controls. These results were 
surprising since the impaired pro-inflammatory cytokine secretion by Pa-DCs in the 
absence of MyD88 (Figure 5.6) appears to have had no measurable effect on their 
ability to induce an IFN-" response. This suggests that additional MyD88-
independent mechanisms must be responsible for Th1 induction by Pa-DCs.  
Importantly, in addition to displaying impaired IL-12p70 production, MyD88 
deficient DCs were also limited in their capacity to upregulate delta4 in response to 
Pa stimulation (Figure 5.7). As delta4 is the Notch ligand most closely associated 
with Th1 stimuli (Figure 3.5), it was of great interest to determine the role it may 
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play in the establishment of a Th1 response. Since the transfer of Pa stimulated 
MyD88
-/- 
DC yielded no discernible impairment of Th1 response induction, it can be 
argued by proxy that delta4 is also not likely a requirement for the induction of a Th1 
response by Pa-DC.  
Similarly to Pa-DCs, MyD88 signalling was not required for Th2 induction 
by SEA-DCs in vivo (Figure 5.8B), in agreement with previously published work 
using TCR Tg T cells in vitro (Jankovic et al., 2004). Thus, whichever mechanisms 
are utilised by SEA-DCs for the induction of SEA-specific Th2 responses must be 
invoked in a MyD88 independent fashion. This result argues against the requirement 
of TLR involvement in the activation of an DCs by SEA (Thomas et al., 2003; van 
der Kleij et al., 2002). 
 
5.5 What alternative candidates might there be for identification of Th2 
driving DCs? 
 One of the aims of the work articulated in this thesis was to ascertain whether 
or not Notch Ligands provide a mechanism for Th2 induction by DCs. 
Unfortunately, our data did not support a role for the specific Notch ligand we 
investigated (jagged2) in the determination of a Th2 response (Figure 4.13). 
However, Ym1 and RELM# are molecules that have been found to be highly 
expressed by alternatively activated M%s or M%s elicited from nematode infected 
mice (NeM%) (Falcone et al., 2001; Loke et al., 2002; Nair et al., 2003; Raes et al., 
2002b; Welch et al., 2002). Nair et al. (2005) demonstrated that DCs treated with IL-
4 have enhanced expression of Ym1 and RELM# (Nair et al., 2005). However, this 
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was only carried out with IL-4 alone and not in the context of stimulation with 
pathogens or their products.  
To address the relevance of these markers during stimulation with pathogens, 
DCs were first exposed to either Pa or SEA for 6 hours or 24 hours. Additionally, 
WT or MyD88
-/-
 mice were compared in order to assess whether any observed 
alteration in expression following Ag stimulation might be MyD88 dependent. The 
expression of Ym1 and RELM# were then measured by quantitative RT-PCR 
(Figure 5.9). Similar to what was observed for cytokines, co-stimulatory molecules 
and Notch ligands, neither Ym1 nor RELM# were measurably upregulated in a Th2 
Ag-dependant manner. Moreover, SEA alone did not significantly increase either 
Ym1 or RELM# expression over the level of unstimulated DC. However, Pa 
significantly decreased expression of both Ym1 and RELM# at 6 and 24-hour time 
points. Strikingly, this reduction in Ym1 and RELM# expression by DCs following 
Pa stimulation remained significant despite the absence of MyD88 signalling.  
 To test whether stimulation of DCs with SEA in conjunction with Th2 tissue 
factors or a T cell mimic might enhance expression of either Ym1 or RELM#, IL-4 
and/or #CD40 agonistic antibody were added to unstimulated, Pa or SEA activated 
DCs (Figure 5.10). As demonstrated by others (Nair et al., 2005), the addition of IL-
4 alone was sufficient to upregulate DC expression of Ym1. However, SEA 
stimulation yielded no greater expression of either Ym1 or RELM#. In contrast to 
previous reports (Nair et al., 2005), IL-4 alone did not significantly increase the 
expression of RELM# by  DCs. Addition of agonistic #CD40 antibody into culture 
had no discernible effect on the DC expression of either Ym1 or RELM#. 
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Whenever molecular expression profiles are inferred by mRNA readout alone 
there is always the risk that much of the regulation actually occurs post-
transcriptionally. Preliminary work was initiated to assess surface expression of Ym1 
and RELM# using Immunofluorescent antibody (IFA) staining, however time 




The work detailed in this thesis has shown that DC expression of defined 
Notch ligands is not necessarily critical to the establishment of an immune response 
in vivo (Chapter 4), and the expression pattern of Notch ligands are decidedly more 
nuanced than a simple delta/Th1 jagged/Th2 paradigm (Chapter 3). We then 
selectively exposed DCs in vitro to factors commonly present during Th2 infection in 
vivo, reasoning that their presence may provide greater insight into the behaviour of 
DCs in a more physiologically relevant setting. The curious result that addition of IL-
4 to DCs stimulated with a Th1 antigen enhances IL-12 production has been 
previously described (Biedermann et al., 2001; Yao et al., 2005) with those reports 
suggesting that IL-4 may actually assist in the establishment of a Th1 response under 
certain conditions; perhaps providing a feedback mechanism for endogenous 
regulation of Th2 responses. However, our results indicate that these IL-4 treated 
DCs, despite displaying elevated levels of IL-12 secretion, in fact exhibit impaired 
Th1 inductive ability in vivo. Although this result is in contradiction to a previous 
report suggesting that addition of IL-4 can promote DC Th1 induction (Biedermann 
et al., 2001), it should be noted that in this case mice were infected with L. major and 
then subsequently injected with IL-4 cytokine i.p. Thus, the addition of IL-4 in this 
study might influence the behaviour of many cell types in addition to DCs, such as 
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resident mast cells or basophils. In contrast, our results focus on the impact of IL-4 
specifically on DCs prior to their injection into recipient mice. Thus, the impaired 
Th1 response we have observed can be solely attributed to the influence of IL-4 on 
the DCs that were transferred. These results caution against making inferences on in 
vivo DC function based on restricted molecular readouts in vitro.  
In contrast to IL-4, TSLP and IL-25 did not significantly influence the 
cytokine profile of Pa-DCs, although there was a trend for increased IL-12 
production by DCs exposed to TSLP. Surprisingly however, both IL-25 and TSLP 
exposed Pa-DCs displayed impaired ability to induce IFN-" and IL-17 production in 
recipient mice, suggesting a possible role for both these cytokines in the inhibition of 
either Th1 or Th17 induction. These preliminary data have formed the platform for 
further work in the lab to define the role of these two cytokines in the establishment 
of a Th2 response. 
Crucially, we assessed the impact of Th2 associated cytokines on DC 
activation by measuring the production of an array of cytokines and Notch ligands as 
well as Ym1 and RELM#, as opposed to limiting readout of DC activation to a 
single cytokine. It was most unfortunate that time did not permit a full assessment by 
quantitative PCR of DC Notch ligand expression following exogenous cytokine-
mediated stimulation. However, the evidence gathered to date suggests cytokines 
such as IL-4 present during DC stimulation can have a direct impact on the 
expression of Notch ligands as well as Ym1, RELM# and cytokines.  
Experiments involving transfer of MyD88 deficient DCs were remarkably 
revealing in which aspects of measured maturation are actually relevant for T cell 
polarisation by DCs in vivo. Despite the impaired capacity of MyD88 deficient DCs 
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to produce IL-12, IL-6, TNF#, or delta4 in vitro, Pa stimulated MyD88-/- DC were 
just as able as WT DCs at inducing Pa-specific IFN-" following  in vivo transfer. It is 
also interesting that these experiments revealed a trend for increased IL-13 following 
in vivo transfer of MyD88 deficient Pa-DCs. Earlier evidence has indicated MyD88 
deficiency can be linked to enhanced IL-13 responses (Schnare et al., 2001). 
However, this was concluded to be a result of decreased IFN-" detected when 
stimulated with Mycobacterium tuberculosis. In our hands this could not be the 
explanation, since we saw no IFN-" deficiency when priming was carried out by 
MyD88 deficient Pa-DCs. In another study MyD88 deficient DCs stimulated with 
soluble antigen extract of Toxoplasma gondii (STAg) were impaired in their capacity 
to drive IFN-" production by OTII Tg T cells in an in vitro co-culture system 
(Jankovic et al., 2004). It has already been shown that DC IL-12 production is not 
necessarily required for the generation of a Pa-specific Th1 response (MacDonald 
and Pearce, 2002) and it is possible that the MyD88 independent maintenance of 
IFN-" production is unique to stimulation with Pa, or other Gram positive bacteria. 
We also found that MyD88 deficiency did not impair DC capacity to drive 
SEA-specific Th2 responses in vivo, in agreement with previous studies (Jankovic et 
al., 2004; Kane et al., 2008). Prior studies have shown that a lipid fraction from S. 
mansoni eggs promote DCs to induce Th2 differentiation through a TLR2-dependent 
mechanism (van der Kleij et al., 2002), or that a synthetic S. mansoni egg glycan 
promoted Th2 induction via TLR4 (Thomas et al., 2003). Potentially SEA binds to 
an as yet unknown PRR in order to promote Th2 differentiation. The effect of 
MyD88 signalling on DC Th2 induction, if involved at all, remains unclear as we 
still lack a defining indicator of a Th2 conditioned DC.  
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Finally, we measured mRNA expression of YM1 and RELM#, reasoning that 
it was possible that these molecules could provide an alternative readout of DC Th2 
activation. However, SEA exposure did not yield any more Ym1 or 
RELM# expression than was measured in unstimulated DCs. Thus, although the 
experiments detailed in this chapter have shown that Th2 associated cytokines can 
have a substantial impact on DC activation and function, they have not revealed a 
clear measure to distinguish SEA-primed DCs from unstimulated DCs in any of the 




Figure 5.1. Impact of cytokines or antibodies mimicking T cell interaction on 
DC cytokine production.10
6 
DCs were stimulated with medium alone (M), P. acnes 
(P, 10 µg/ml) or SEA (S, 25 µg/ml) and then 4 hours later with medium alone (open 
bars) or medium and IL-4 (1 ng/ml, grey), #CD40 (30 µg/ml, black bars) or IL-4 and 
#CD40 (grey with black stripes). Cells were left for 24 hours and then cytokine 
measured by ELISA. Data shown are mean + SEM of cytokine measured in 
supernatants from duplicate wells, and are representative of four separate 






Figure 5.2 Notch ligand expression in response to Ag stimulation is affected by 
other cytokines or antibodies mimicking T cell interaction. 10
6 
DCs stimulated 
with medium alone (M), P. acnes (10 µg/ml, grey bars) or SEA (25 µg/ml, black 
bars) and then 4 hours later medium alone (M), medium and IL-4 (1 ng/ml), or 
#CD40 (30 µg/ml) were added to culture. Cells were left for either 24 (jagged2) or 
48 hours (delta4) and delta4 or jagged2 mRNA were assessed by quantitative PCR 
normalised against 18s rRNA. Bars represent average of duplicate runs as a fold 





Figure 5.3 Th2 tissue factors can influence DC cytokine secretion. 10
6 
DCs were 
stimulated with P. acnes (10 µg/ml) in the presence of medium (M) or 3 separate 
doses of IL-4 (0.1 ng/ml low, 1 ng/ml med, 10 ng/ml high), IL-25 (2 ng/ml low, 20 
ng/ml med, 100 ng/ml high) or TSLP (1 ng/ml low, 10 ng/ml med, 50 ng/ml high). 
Cells were left for 24 hours and then cytokine in supernatant measured by ELISA. 
Data shown are mean + SEM of cytokine measured by ELISA and are representative 




Figure 5.4 Th2 tissue factors impair Th1/Th17 priming by bacterially 
stimulated DCs. 10
6 
DCs were stimulated with medium alone (M-DCs) or P. acnes 
(Pa-DCs, 10 µg/ml) in addition to IL-4 (1 ng/ml), IL-25 (20 ng/ml) or TSLP (10 
ng/ml). 24 hours later 5x10
5
 cells were injected i.p. into naïve recipient mice and 7 
days later spleens were removed and restimulated in vitro with either medium alone 
(open bars) or Pa (gray bars). Cells were cultured for 72 hours and then cytokine 
measured in supernatants by ELISA. Data shown are mean + SEM of cytokine 
measured by ELISA of five mice per group. *, P < 0.05. This experiment was carried 







Figure 5.5 MyD88 deficient DCs retain responsiveness to phenotypic activation 
by bacterial stimulation. 10
6 
DCs were stimulated for 24 hours with medium alone 
(Medium) or Pa (10 µg/ml). Surface expression of MHC II, CD40, CD80 and CD86 
was then analysed by flow cytometry. Light histograms depict isotype control 
staining while darker histograms indicate cells stained with the marker indicated. 
Plots shown are gated on live CD11c
+
 cells and percentage positive and geometric 






Figure 5.6 MyD88 deficient DCs display impaired cytokine production in 
response to bacterial stimulation. 10
6
 WT (open bars) or MyD88
-/-
 DCs (black 
bars) were stimulated for 24 hours with medium alone (Medium), SEA (50 !g/mL) 
or Pa (10!g/mL). Data shown are mean + SEM of cytokine levels in supernatants 




Figure 5.7 Pa specific delta4 upregulation by DCs is MyD88 dependent. 10
6 
WT 
(open bars) or MyD88
-/-
 (black bars) DCs were stimulated for either 6 or 24 hours 
with medium alone (M, open bars) Pa (P, 10 µg/ml) or SEA (S, 25 µg/ml). jagged2 
or delta4 mRNA were assessed by quantitative PCR and normalised against 18s 
rRNA. Error bars indicate mean + SEM of triplicate culture wells. Data shown are 






Figure 5.8 T cell polarisation by MyD88
-/-
 DCs in vivo. WT or MyD88 deficient 
DCs were exposed to medium alone (M), A) Pa (P, 10 !g/mL) or B) SEA (S, 25 
!g/mL). Cells were then injected i.p. into naïve C57BL/6 recipient mice. Splenocytes 
were removed 7d later and then stimulated in vitro with medium (open bars), SEA 
(black bars) or Pa (grey bars). Data shown are mean + SEM of cytokine measured by 









Figure 5.9 Pa stimulation downregulates RELM#  in a partially MyD88 
dependent manner. 10
6
 WT (open bars) or MyD88
-/-
 (black bars) DCs were 
stimulated for either 6 or 24 hours with medium alone (Medium), Pa (10 µg/ml) or 
SEA (25 µg/ml) and then Ym1 or RELM# mRNA expression measured by 
quantitative PCR and normalised to 18s RNA. Error bars indicate mean + SEM of 
triplicate wells of DCs. Data shown are representative of two independent 
experiments. * = P < 0.05, ** = P < 0.01, *** = p < 0.001 
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Figure 5.10 Pa prevents IL-4 mediated upregulation of Ym1 and RELM#  by 
DCs. 10
6
 DCs were stimulated for 24 hours with medium alone (M), Pa (P, 10 
µg/ml) or SEA (S, 25 µg/ml) and then 4 hours later were treated with medium alone 
(open bars) or IL-4 (1 ng/ml, grey bars), #CD40 (30 µg/ml, black bars), or both IL-4 
and #CD40 (grey bars with black cross-hatched). Ym1 or RELM# mRNA 
expression was measured by quantitative PCR and normalised to 18s rRNA. Error 
bars indicate mean + SEM of triplicate wells of DCs. Data shown are representative 






Chapter 6  
Final Discussion 
6.1 General Discussion 
 
 The processes by which APCs instruct T cell polarisation, particularly Th2 
differentiation, remain poorly understood. By most standard measures of maturation, 
DCs stimulated by Th2 pathogens such as S. mansoni are phenotypically 
indistinguishable from unstimulated DCs. The central hypothesis of this thesis was 
that Notch ligands may play a role in the “third signal” (Kalinski et al., 1999) 
provided by APCs to polarise naïve CD4
+
 T cells.  
 That SEA-treated DCs display few of the conventional markers of activation, 
and yet are able to potently drive SEA specific Th2 immune responses, is well 
established (Perona-Wright et al., 2006). Although DC expression of MHC II 
(MacDonald et al., 2001), NF-&B (Artis et al., 2005), CD40 (MacDonald et al., 
2002b) and OX40L (Jenkins et al., 2007) have been shown to be critical to the 
generation of a Th2 response, none of these molecules are significantly upregulated 
by SEA stimulation. However, Th2 priming by SEA stimulated DCs is not 
considered a “default” process, but rather an active induction, as evidenced by the 
fact that DCs co-stimulated by SEA and P. acnes drive separate, yet concurrent, Th1 
and Th2 responses (Cervi et al., 2004). Thus, the question remains: by which 
mechanisms are DCs able to actively drive Th2 differentiation when they appear to 
display no clear signs of activation when compared to immature DCs? This question 
is pertinent, as it not only addresses our fundamental understanding of DC biology 
and the invocation of adaptive immunity, but could also provide therapeutic targets 
for protection against helminth infection and other Th2 dominated disease settings. 
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6.2 Is DC Notch ligand expression associated with specific stimuli? 
The focus of the work in this thesis was to determine whether an association 
exists between Notch ligand expression and DC ability to polarise CD4
+
 T cells. 
Notch ligand expression by DCs was investigated for providing a novel ‘signal 3’ 
component for T cell polarisation. Although there is gathering evidence supporting a 
role for Notch receptor signalling in T cells (Amsen et al., 2007; Tu et al., 2005), it 
has not yet been determined if APCs provide the source of Notch ligand necessary to 
activate that signal. Enticingly, previous studies had proposed that not only might 
Notch receptor signalling be important for naïve CD4
+
 T cell differentiation (Adler et 
al., 2003; Eagar et al., 2004; Izon et al., 2001; Palaga et al., 2003; Vigouroux et al., 
2003; Wong et al., 2003; Yvon et al., 2003), but also that the precise Notch ligand 
profile displayed to T cells may instruct a specific polarisation fate (Amsen et al., 
2004; Maekawa et al., 2003; Tanigaki et al., 2004) with delta ligands directing Th1 
differentiation and jagged ligands Th2.  
Importantly, my work has demonstrated, in the context of biologically 
relevant pathogens, that the nature of the stimulus to which DCs are exposed does 
have an impact on the expression of Notch ligands (Figure 3.6). Although we did not 
find significant upregulation of jagged2 expression on SEA stimulated DCs, there 
was an association between elevated delta1 and delta4 expression, and decreased 
jagged2 expression, in DCs responding to Pa (Figure 3.6). Furthermore, these 
observed expression patterns were MyD88 dependent (Figure 5.7) supporting the 
notion that such changes in Notch ligand expression are a direct result of DC TLR 
signalling and thus influenced by pathogen recognition. Our results are similar to 
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those reported by Sun et al (2008), which suggest that the Notch ligands delta1 and 
delta4 may be used to actively suppress Th2 development in a MyD88 dependent 
manner (Sun et al., 2008). 
Our data demonstrating that complex pathogen preparations induce DC 
expression of a specific cohort of Notch ligands, and that the expression of distinct 
Notch ligands are not consistent within their family, emphasize the potential of these 
markers as precise indicators of DC stimulation. Further characterisation of Notch 
ligand expression in all APCs in both mice and humans may provide us with an 
invaluable tool for carefully defining the nature of an antigenic stimulus. Ideally, 
profiling Notch ligand expression could be used as a diagnostic tool for determining 
the exact maturation status of an APC in a more specific manner than cytokine 
secretion alone. 
 
6.3 Is DC jagged2 expression essential for Th2 differentiation in vitro or 
in vivo? 
Few studies have directly explored a role for Notch-Notch ligand interactions 
in vivo. In one case, where CD4
+
 cell specific Notch1 deficient mice were infected 
with Leishmania major, the authors found that the absence of Notch1 receptor on 
CD4
+
 T cells did not impair the host’s ability to mount a protective Th1 response 
(Tacchini-Cottier et al., 2004). More recently, a study utilized CD4
+ 
specific 
expression of a dominant negative mutant of the MAML protein (essential for the 
recruitment of RBP-J co-activators) thus disrupting RBP-J dependent Notch 
signalling via all Notch receptors, in CD4
+
 T cells (Tu et al., 2005). When these mice 
were infected with either T. muris or L. major they were able to mount a successful 
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Th1 response to L. major infection, but were susceptible to T. muris infection (Tu et 
al., 2005). Although this work did not specifically investigate the roles for specific 
Notch ligands in the promotion of a Th1 or Th2 response, it provided strong 
evidence that the Notch signalling pathway may be more crucial in the establishment 
of Th2 than Th1 adaptive immunity.  
Based on the proposed Jagged/Th2, Delta/Th1 paradigm (Amsen et al., 
2004), and within the limits of current technical ability, we directly assessed the 
importance of jagged2 expression by DCs in the process of Th2 induction by DCs in 
vitro and in vivo. Despite the absence of a clear enhancement of jagged2 expression 
by DCs in response to SEA stimulation, the inability of jagged2 deficient DCs to 
instruct SEA specific IL-4 production by CD4
+
 T cells in vitro suggests that 
provision of this Notch ligand is required for Th2 differentiation (Figure 4.11). 
However, adoptive transfer experiments revealed that DC expression of jagged2 was 
not required for an SEA specific Th2 response in vivo (Figure 4.13). These 
contradictory results suggest a more nuanced system of Notch provision in the 
activation and polarisation of CD4
+
 T cells than we might have expected.  
Potentially, Notch signal transduction maybe a redundant mechanism that 
reinforces the polarisation outcome predominantly determined by an alternate ‘signal 
3’ provision by APCs. Recent work by Ong et al. (2008) has shown that Chinese 
hamster ovary (CHO) cells transfected with either delta1 or jagged1 ligands were not 
able to redirect T cells towards a different cell fate than that which cytokine 
conditions would specify (Ong et al., 2008). For example, DO11.10 CD4
+
 T cells 
could not overcome Th2 polarising conditions, and still produced high levels of IL-4 
even when stimulated by CHO cells transfected with MHC II, CD80 and delta1 
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ligand (Ong et al., 2008). Although this study focused on artificial APCs in the 
absence of pathogen specific T cell polarising cytokines normally produced during 
APC maturation, it demonstrates that Notch signalling may be overruled by 
polarising cytokines.  
Another possibility is that Notch signalling is involved as a survival signal 
administered to previously polarised T cells rather than in the initial priming of T cell 
polarisation. Although our results show a requirement for DC jagged2 expression in 
the induction of SEA-specific IL-4 production by CD4
+
 T cells in vitro, the absence 
of jagged2, or presence of the presenilin inhibitor DAPT, did not completely abolish 
IL-4 production (Figure 4.11 and Figure 4.12). This implies that initial generation 
of IL-4 is still possible in the absence of Notch signalling, but the sustained 
production of this Th2 cytokine may require Notch signalling. A link between Notch 
receptor signalling and the transcription of GATA3, as well as the IL-4 gene locus 
has been established in other studies (Amsen et al., 2007; Amsen et al., 2004). 
notch1 and notch2 deficiency has been shown to dramatically reduce the expression 
of GATA3 in Th2 priming conditions, and RBP-J& binding sites were present in the 
upstream promoter region of GATA3 (Amsen et al., 2007). However, in the absence 
of GATA3 the addition of NICD enhanced Th1 responses (Amsen et al., 2007). An 
interpretation of these studies is that transcription factors such as GATA3 or T-bet 
may exert a greater influence on Notch signalling than Notch signalling has on 
transcription factor expression. With more time for additional experiments, 
assessment of Notch signal transduction in OTII CD4
+
 T cells by Q-PCR, such as 
measurement of HES and GATA3 transcription during stimulation with jagged2
-/-
 
SEA-DC, could help reveal whether it is Th2 initiation or maintenance that requires 
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jagged2 provision. Furthermore, examination of potential binding sites for 
transcription factors such as GATA3 or STAT6 (the downstream transcription factor 
from IL-4 signalling) within Notch ligand promoter regions would shed light on 
whether Notch ligands are receptive to Th1 or Th2 differentiation. STAT binding 
motifs can be quite variable, but typically utilise the 5’-TTC…GAA-3’ core 
palindrome (Kraus et al., 2003). The use of radioactive probes or RNAse protection 
assays could be used to confirm the activity of these transcription factors in Notch 
ligand promoter regions. 
Finally, given that Notch ligands and receptors are expressed on a wide 
variety of cell types (Yamaguchi et al., 2002), it is also possible that other cells could 
provide the Notch ligands necessary to induce CD4
+
 T cell differentiation. In our in 
vitro co-culture system, only DCs or other CD4
+
 T cells were available for Notch 
ligand provision. It would be interesting in future experiments to discern whether 
additional cell types, which are jagged2 sufficient and not involved in antigen 
presentation, are capable of restoring Th2 differentiation. It is also important to note 
that during in vitro co-culture, CD4
+
 T cells are jagged2 sufficient, and thus 
provision of jagged2 either through cis-interactions or via other T cells are not 
capable of inducing SEA-specific IL-4 production. In addition to investigating Notch 
ligands as a mechanism by which APCs induce CD4
+
 T cell polarisation, future work 
should also examine the extent to which Notch signalling is utilized by many other 
cell types within peripheral immunity. Recent work has suggested that Notch 
signalling may be important for NK cell activation (Kijima et al., 2008), NKT cells 
interaction (Wiethe et al., 2008) and T cell cytotoxicity (Maekawa et al., 2008). It is 
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important to remember that we have merely scratched the surface of the extent to 
which this dynamic signalling mechanism may be involved in the immune system. 
 
6.4 Is DC maturation impacted by infection related cytokines? 
Although Notch ligand expression by DCs may assist in the determination of 
a CD4
+
 T cell polarisation, ligand expression in vivo may be subject to influence by 
additional factors provided by the tissue microenvironment, such as TSLP, not 
present in vitro. To begin to address this possibility we exposed DCs to a panel of 
infection related cytokines, such as IL-4, IL-25, TSLP during their in vitro 
stimulation, or mimicked T cell interactions using an agnostic #CD40 antibody 
(Figures 5.1, 5.2 and 5.3). Overall, several tissue factors did have an impact on DC 
responses to stimuli, supporting the idea that the context of Ag exposure may be a 
key factor in subsequent activation. Addition of IL-4 was found to decrease IL-10 
production and increase IL-12p70 production by DCs. TSLP exposure showed a 
similar trend although these results were not significant. However, despite enhanced 
IL-12 production in vitro, transferred Pa-DCs stimulated in conjunction with IL-4, 
IL-25 or TSLP induced significantly less IFN-" than DCs stimulated by Pa alone 
(Figure 5.4). This fascinating outcome demonstrates that infection-related cytokines 
impact both the measurable activation status of DCs as well as their ability to 
polarise CD4
+
 T cell responses in vivo. The implications of these results impact all in 
vitro DC work, as it highlights the fact that cytokine micro-environment plays a 
substantial role in DC activation. Additionally, given the association of DC IL-12 
with Th1 induction (Gately et al., 1998), these results once again underline that 
conclusions drawn purely from in vitro assessment are not necessarily relevant in 
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vivo. More broadly, DC maturation and polarising behaviour may be profoundly 
altered within an infection context and all inferences from strictly in vitro analyses 
should take this into consideration. 
 
6.5 Are there any markers to distinguish SEA treated DC from 
unstimulated DC? 
The search for any measurable response by DCs to SEA treatment remains 
ongoing. Importantly, the work in this thesis has shown clearly that individual Notch 
ligands may not be useful as markers of Th2 stimulated DCs. We investigated other 
potential indicators of Th2 maturation by assessing DC expression of Ym1 and 
RELM#,  (Figure 5.9 and 5.10). However DCs exposed to SEA were no different 
from unstimulated DCs in the expression of these molecules. Doubtless, additional 
potential markers of Th2 activation will present themselves in the years to come and 
the discovery of such would perhaps be aided by a more broad screening approach to 
identifying new candidates. 
 
6.6 What defines the differences in antigen presenting capacity 
between DCs and M%s? 
 In the initial work of this thesis, DCs were compared to another major APC 
cell type, M%s. By contrasting their relative capacities to induce in vivo immune 
responses in relation to their production of cytokine and expression of co-stimulatory 
markers in vitro the intention was to discern which mechanisms might be essential 
for the “professionalism” of DCs in terms of T cell polarising ability. That DCs in 
general secreted or expressed greater levels of most conventional markers of 
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activation (Figures 3.2 and 3.3) was not unexpected (Mellman et al., 1998). 
However, given their reduced activation state in comparison to DCs, the similar 
ability of both DCs and M%s to induce an St-specific IFN-" response following 
transfer into naïve recipient mice was surprising (Figure 3.3). Interestingly, this APC 
ability equivalency was not seen when DCs or M%s were instead stimulated with the 
gram-positive bacterium P. acnes. Irrespective of this, several possibilities arise from 
these data. Either the threshold for cytokine secretion required by APCs for the 
establishment of an St-specific immune response is less than for P. acnes, or an 
exogenous factor encountered following M% transfer in vivo may heighten APC 
function by M%, or an additional mechanism stimulated by S. typhimurium (not 
measured in these studies) might be responsible for the unexpectedly effective M% 
induced inflammatory response. 
 
6.7 Concluding Remarks 
The work presented in this thesis illustrates an association of DC Notch 
ligand expression profiles with Th1 versus Th2 driving pathogens or pathogen 
products, and that the expression of specific Notch ligands by DCs may be critical in 
vitro but redundant in vivo. While this thesis supports the hypothesis that Notch 
ligands should be included in the array of signals considered to be involved in 
instruction of T cell polarisation, it is clear that other mechanisms for directing the 
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Wehaveaddressed thehypothesis thatNotch ligands playa decisive role in determining the
ability of antigen-presenting cells to influence T cell polarization. Dendritic cells displayed
distinct expression profiles of Delta and Jagged ligands for Notch when exposed to
biologically relevant pathogen preparations associated with Th1 or Th2 responses.
Expression of delta4 was increased, and jagged2 decreased, after dendritic cell exposure
to the Th1-promoting bacterium Propionibacterium acnes. In contrast, soluble egg antigen
(SEA) from the parasitic helminth Schistosoma mansoni, a potent Th2 inducer, failed to
significantly alter dendritic cell expression of any of the Notch ligands measured.
Irrespective of this, jagged2-deficient dendritic cells were severely impaired in their ability
to instruct Th2 polarization of naive T cells in vitro. However, the ability of SEA-pulsed
jagged2-deficient dendritic cells to induce a Th2 response in vivowas unimpaired relative to
jagged2-sufficient dendritic cells. Further, jagged2-deficient dendritic cells activated by
P. acnes exhibited no evidence of enhanced (or impaired) Th1 induction in vivo. These data
suggest that, although involved in Th2 direction in vitro, jagged2 is not fundamentally
required for Th2 induction by SEA-activated dendritic cells in vivo.
Key words: Cell differentiation ! Dendritic cells ! Infectious diseases ! Notch signalling !
T helper cells
Introduction
Conserved throughout the metazoan kingdom, the Notch signal-
ling pathway is remarkable for its extensive versatility, being
utilized for exchanging amplification signals, determining cell
lineages, and even inducing apoptosis [1, 2]. It has recently been
suggested that a possible role for Notch signalling may be to
provide a mechanism by which APC can influence T cell
polarization [3–7], a situation that is complicated by the existence
of four Notch receptors (Notch receptors 1–4) and five Notch
ligands (Delta-like1, Delta-like3 and Delta-like4, and Jagged1 and
Jagged2) in mammals [1].
Several lines of evidence suggest that signalling through Notch
receptors has an effect on both T cell proliferation and mature
T cell commitment [3, 4, 6, 8, 9]. In the context of CD4+ T cell
polarization, a recent in vivo study showed that blocking the
signalling ability of Notch receptors 1–4 resulted in impaired Th2,
but not Th1, responses [10]. In addition, studies in vitro have
suggested that both Delta and Jagged ligand families may be
associated with T cell differentiation but that Delta ligands
promote Th1 whereas Jagged ligands promote Th2 polarization
[4, 6, 11]. However, this contention remains controversial, with
other reports suggesting that no such association exists, that Delta
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can inhibit T cell cytokine production rather than promote Th1
differentiation [5,12], or that Jaggedmay induce Treg, rather than
Th2, differentiation [5, 8, 9, 13–15]. Thus, although evidence is
emerging that Notch has a function in immunity beyond its
developmental role, the exact nature of Notch signalling and the
relative contribution of the two ligand families in the adaptive
immune response is far from clear [6, 16–18].
Dendritic cells (DC) are the most proficient APC at activating
naive T cells. Their ability to dictate the tone of the developing
CD4+ T cell response is thought to be largely determined by the
nature of the stimulus they encounter. However, the molecular
mechanisms that are employed by DC to influence and instruct
T cell polarization are not completely understood, particularly in
the case of Th2 development [19].
In this study we first assessed whether the profile of expression
of Notch ligands by DC was altered in response to Th1- or Th2-
polarizing pathogens. We then used both in vitro and in vivo
approaches to examine the direct effect of a specific Notch ligand
deficiency in DC on polarization of transgenic and non-transgenic,
naturally occurring polyclonal populations of T cells. We found
that DC expression of the Notch ligand jagged2 was unchanged in
response to the Th2-associated pathogen Schistosomamansoni and
down-regulated in response to the Th1-associated pathogen
Propionibacterium acnes, and that jagged2–/– DC were severely
impaired in their ability to direct Th2 polarization of OVA-specific
TCR-transgenic T cells in vitro. However, the ability of jagged2–/–
DC to induce either Th2 or Th1 responses in vivo was unaffected.
Thus, our results support an association of defined patterns of
Notch ligand expression by DC responding to different T cell-
polarizing pathogens, but suggest a redundant role for jagged2 in
T cell polarization by DC in vivo.
Results and discussion
DC express a defined pattern of expression of Notch
ligands in response to diverse pathogens
Previous work has shown that stimulation with the Th1-associated
bacterial product LPS resulted in substantial up-regulation of Delta
by DC, while Th2-associated molecules such as prostaglandin E2
and cholera toxin promoted Jagged expression [6]. We used two
pathogen preparations that are well-characterized as being able to
drive either Th1 (heat-killed P. acnes, Pa) or Th2 (soluble egg
antigen from S. mansoni, SEA) induction via DC [20, 21] to
determine whether we could see any clear pattern of Notch ligand
expression associated with either type of stimulus. Over a 12-h
time course, DC were activated by these stimuli in a manner
consistent with previously published reports [20, 21]. Pa induced
DC maturation, provoking up-regulation of MHC class II and co-
stimulatory molecules (data not shown), as well as secretion of a
range of cytokines including IL-12, IL-6, TNF and IL-10 (Fig. 1A).
In contrast, and in keeping with previously published reports [22],
SEA-activated DC showed little evidence of phenotypic maturation
(data not shown) or cytokine secretion (Fig. 1A) when compared
to unstimulated cells.
The influence of the same stimuli on Notch ligand expression
by DC was determined using quantitative PCR to measure mRNA
levels 6 and 12 h after stimulation (Fig. 1B–D). delta4 expression
was significantly increased over unstimulated control levels in DC
activated with Pa (p<0.03; Fig. 1B), and this was evident from 6 h
post-stimulation. In contrast to this, although showing a trend for
elevated expression by 6 h that returned to control levels by 12 h
post-stimulation, delta1 was not significantly increased in
response to Pa. Although expression of jagged1 was unchanged
in DC responding to Pa, jagged2 expression showed a different
profile, being strikingly decreased by 6 h post-stimulation
(p<0.001; Fig.1B), and returning to a similar level to unstimulated
cells by 12 h.
Contrary to the dramatic up-regulation that was evident in
response to Pa, expression of delta4was not significantly altered in
DC exposed to SEA (Fig. 1B). Further, delta1, jagged1, and jagged2
were maintained at equivalent levels to unstimulated controls in
SEA-activated DC at both 6 and 12 h time points. delta3
expression in response to either Pa or SEA failed to show a
consistent pattern in any of the experiments carried out (data not
shown). Although SEA failed to have a marked impact on Notch
ligand expression, exposure to SEA resulted in DC that express
higher levels of jagged2 relative to delta4, whereas exposure to Pa
resulted in DC with the converse phenotype, expressing higher
levels of delta4 relative to jagged2 (Fig. 1B).
These data suggest that DC expression of a restricted cohort of
Notch ligands can be associated with pathogens that induce
distinct Th responses. However, they also reveal that the initial
description of Jagged and Delta ligands as being Th2- or Th1-
associated, respectively, is an oversimplification, and that expres-
sion of related members within the same ligand family does not
appear to be regulated identically.
Th2 and Th1 responses are capably induced in vivo by
jagged2–/– DC
jagged2 deficiency is embryonic lethal [23]. In order to address the
role of expression of jagged2 in BMDC development and Th
induction, jagged2–/– chimeras were generated by reconstituting
irradiated congenic Ly5.1+ C57BL/6 mice with fetal liver from
Ly5.2+ jagged2–/– (or jagged2+/+ control) embryos. DC were then
grown from BM isolated from jagged2–/– or control chimeras,
pulsed overnight with either Pa or SEA, and their activation status
compared. The absence of jagged2 did not significantly affect
growth, development or activation of the DC in vitro (Fig. 2).
Secretion of cytokines (Fig. 2A) and expression of co-stimulatory
molecules (Fig. 2B) was similar for both control and jagged2–/– DC
in response to SEA or Pa. Further, jagged2–/– DC did not
compensate for jagged2 deficiency by up-regulating expression
of jagged1, delta1, or delta4 in response to either stimulus
(Fig. 2C). Thus, jagged2–/– DC appeared similar to their wild-type
counterparts other than lacking jagged2 expression.
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We have previously shown that although DC activated with
SEA display a muted activation phenotype, they remain potent
inducers of a Th2 response both in vivo and in vitro [22]. While the
exact mechanism by which this occurs remains unclear, Th2
induction by in vivo transfer of SEA-stimulated DC is an active
process requiring DC expression of MHC class II, CD40, and
NF-jB1 [22]. We first assessed the ability of jagged2-deficient DC
to activate and polarize OVA-specific OTII TCR-transgenic Tcells in
vitro. Although equally proficient at stimulating Tcell proliferation
(Fig. 3A), jagged2–/– DC displayed a striking impairment in their
ability to provoke Th2 polarization in vitro, in comparison to their
jagged2+/+ counterparts (Fig. 3B).
We then asked whether expression of jagged2 was also
important for polarization of Th cells by DC in a more complex in
vivo setting. jagged2+/+ or jagged2–/– DC were activated with Pa or
SEA and then injected into the footpads of naive C57BL/6 mice.
Four days later draining LN were removed and examined for
cytokine secretion following restimulation with antigen in vitro
(Fig. 3C).
Pa-activated DC induced a marked Th1 response with high Pa-
specific IFN-c levels detected in culture supernatants irrespective
of whether transferred DC were jagged2+/+ or jagged2–/–
(Fig. 3C). Contrary to expectation, SEA-stimulated jagged2–/–
DC induced an equivalent or higher IL-4 response after transfer
into naive wild-type animals (Fig. 3C). This was irrespective of the
route of immunization as jagged2+/+ and jagged2–/– DC given i.p.
also showed equivalent ability to induce a Th2 response whether
measured by IL-4 (data not shown) or IL-5, IL-13, and IL-10
(Fig. 3D). Thus, despite the fact that DC maintain expression of
jagged2 after exposure to SEA in vitro (Fig. 1B), and jagged2–/– DC
are severely impaired in their ability to instruct Th2 polarization in
vitro (Fig. 3B), our data suggest that this Notch ligand is not
essential for the establishment of a Th2 response in vivo.
Figure 1. DC response to SEA or Pa. (A) DC were treated for up to 12 h with either medium alone (squares), 25 lg/mL SEA (circles), or 10 lg/mL Pa
(triangles) in 24-well plates. Cytokinesweremeasured in culture supernatants. Data shown indicate mean " SEM of cytokine measured by ELISA of
duplicatewells, and are representative of five separate experiments. (B) Notch ligand expression byDC in response to Pa or SEA as detailed in (A)was
measured by quantitative PCR. Expression of delta and jagged mRNAwas normalised to 18S RNA. Fold change of Notch ligand expression relative to
unstimulated cells (dotted lines) by DC exposed to SEA (black bars) or Pa (grey bars) is shown. Data are mean + SEM of three to six combined
experiments; *p<0.03, **p<0.001, comparing expression by SEA- or Pa-stimulated groups relative to medium controls.
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Concluding remarks
Studies examining the effect of wholesale inhibition of Notch
signalling to T cells [6, 10, 15] have demonstrated that signalling
through Notch receptors is required for the establishment of an
effective Tcell response. However, the mechanism by which Notch
signalling translates into polarized CD4+ T cell differentiation
remains unclear. Tu et al. [10] described how inhibition of Notch
signalling using dominant-negative MAML-transgenic mice during
live infections of either Leishmania major or Trichuris muris
resulted in a fully capable L. major Th1 response but an impaired
Th2 response and ineffective clearance of T. muris. This suggests
that in complete biological systems Notch signalling is required for
Th2 establishment, but does not reveal which ligands are required
to initiate this immunological response via Notch, or indeed
whether APC expression of Notch ligands is required.
As shown by our expression data, Delta and Jagged ligands are
expressed concurrently by DC in either Th1- or Th2-priming
conditions, but their relative expression changes dramatically
depending upon the stimulus encountered. Conceivably the ratio
of different Notch ligands expressed by APC may ultimately
determine the manner in which Notch signalling affects the
differentiation of a naive T cell. Our results clearly show that DC
expression of jagged2 alone can be critical for Th2 polarization of
naive CD4+ T cells in vitro (Fig. 3B). The presence of the other
Notch ligands (Fig. 2C) could not compensate for the absence of
jagged2 to enable Th2 polarization in vitro (Fig. 3B), indicating
that jagged1, delta1, and delta4 cannot fulfil the signalling
requirement by Notch receptors on CD4+ T cells to establish a
Th2 response in vitro.
In stark contrast to this, in the in vivo setting, DC expression of
jagged2 was dispensable for Th2 induction (Fig. 3C, D). Taken
together, our in vitro and in vivo results suggest that jagged2
signalling is important for Th2 polarization, yet Jagged2
expression need not be limited to the APC driving the response.
For example, the important interaction in vivomay not actually be
between a Notch ligand-bearing APC and a naive CD4+ T cell, but
rather between APC and NKT cells, or a subset of memory CD4+
T cells capable of producing IL-4 rapidly and independently of
STAT6 [24, 25]. It is therefore possible that in vivo the multi-
variant expression of Notch ligands by APC involves interactions
with multiple cell types since both Notch receptors and ligands can
be found in diverse cell types in addition toT cells and DC [6, 26].
Our in vivo experiments, in which all such cells are present,
reveal that DC expression of the Notch ligand jagged2 plays no
major role during SEA-specific Th2 response induction. jagged2
deficiency impaired neither DC generation nor activation, with
jagged2–/– DC producing equivalent levels of cytokine and
expressing the same levels of surface markers as similarly
stimulated jagged2+/+ controls. Furthermore, transfer of either
jagged2+/+ or jagged2–/– SEA-activated DC resulted in production
of similar quantities of SEA-specific IL-4, IL-5, IL-10, and IL-13 in
recipient mice. Whether this finding is indicative of the provision
of jagged2 by additional cell types, a redundant pathway, or
compensation via other Notch ligands remains to be determined.
Figure 2.Deficiency in jagged2 does not interfere with BMDC generation
or activation. BMDC were grown from BM derived from jagged2+/+ or
jagged2–/– chimeras and exposed to either medium alone (M),
SEA (S, 25 lg/mL) or Pa (P, 10 lg/mL) for 24 h. (A) Cytokine production
by jagged2+/+ (open bars) or jagged2–/– (black bars) DC. Data shown are
mean + SEM of cytokine measured by ELISA of duplicate wells and are
representative of two separate experiments. (B) Surface expression of
CD80 and CD86 on jagged2+/+ or jagged2–/– DC. Light grey filled
histograms indicate unstimulated DC, black unfilled histograms
indicate DC stimulated with SEA or Pa. Graphs are representative of
two separate experiments. (C) Expression of jagged1, jagged2, delta1, and
delta4 byDC exposed tomedium (open bars), Pa (grey bars), or SEA (black
bars) was assessed by quantitative PCR. Data shown aremean + SEM of
expression levels measured in duplicate relative to 18S, and are
representative of five separate experiments.
Alan G. F. Worsley et al. Eur. J. Immunol. 2008. 38: 1–74
f 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu
Even so, these results challenge themodel that selective expression
of Jagged ligands by DC is responsible for determining Th2
differentiation.
Animals and reagents
C57BL/6 mice were bred and maintained in the animal facilities at
the University of Edinburgh or at Cancer Research UK. A heat-
killed preparation of the Gram+ bacterium P. acnes (ATCC
No. 6919) was used as a Th1 stimulus, while SEA (prepared in-
house [20]) was used for its Th2-driving capacity. Animal work
was carried out under UK Home Office Project license, and was
approved locally by Ethical Review Committee.
Dendritic cell culture
Murine BMDC were generated in the presence of rGM-CSF
(Peprotech, London, UK) as previously described [20]. DC were
stimulated with 25 lg/mL SEA or 10 lg/mL Pa (measured by
Bradford assay) over a time course, supernatants assessed for
cytokine levels by ELISA, and cells harvested for RNA extraction.
Generation of chimeric bone marrow
Fetal livers from Ly5.2+ jagged2+/– # jagged2+/– matings were
removed from day-14.5 embryos, and jagged2–/– fetuses were
identified by PCR [23]. Irradiated Ly5.1+ recipients were
reconstituted with cells from jagged2–/– or jagged2+/+ womb
mates. DC were grown from BM 8–20 wk later. Donor origin of DC
was verified by flow cytometry (data not shown).
Figure 3. DC expression of jagged2 is dispensable for Th2 or Th1 induction in vivo. (A, B) CD4-purified OTII cells were co-cultured with jagged2+/+ or
jagged2–/–DC in the presence of OVA323–339 peptide (50 ng/mL) alone (medium) or in conjunctionwith SEA (50 lg/mL) or Pa (10 lg/mL). OTII cellswere
labelledwith CD4 and CFSE to assess proliferation (A) orwere examined for intracellular staining (B). Dotted lines in (A) represent CFSE levels on cells
cultured in the absence of peptide. Plots depicting intracellular staining in (B) are gated on live CD4 cells. Figures refer to percentage of dividing cells
(A) or cytokine-producing cells (B) and results are representative of three independent experiments. (C, D) jagged2+/+ or jagged2–/– DCwere exposed to
mediumalone (M), Pa (P, 10 lg/mL), or SEA (S, 25 lg/mL), then injected into the footpad (C) or i.p. (D) of naive C57BL/6 recipientmice. Popliteal LN cells
(C) or splenocytes (D) were removed 4 days (C) or 7 days (D) later and then stimulated in vitrowith medium (open bars), SEA (black bars), or Pa (grey
bars). Data shown aremean + SD of cytokinemeasured by ELISA of triplicate wells of combined LN cells (C) or mean + SEM of cytokinemeasured by
ELISA of three to five mice per group (D), and are representative of three (C) or two (D) separate experiments.
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Determination of DC activation status
Cytokine levels were measured in DC supernatants by ELISA using
commercial mAb (BD Pharmingen or R&D Systems). Phenotype
was assessed by flow cytometry using mAb for CD11c, CD80 and
CD86 (Pharmingen). Samples were acquired by FACSCalibur
using CellQuest software and analysed using FlowJo software
(TreeStar, Ashland, OR).
Assessment of DC priming ability in vitro
CD4+ Tcells were purified from the spleen and LN of OTII mice by
positive selection using magnetic sorting (Miltenyi). For studies
measuring proliferation, OTII CD4+ cells were stained with
carboxyfluoroscein succinimidyl ester (CFSE, 5 lM). CD4+ cells
(2 # 105) were co-cultured for 3 days with 2 # 104 jagged2+/+ or
jagged2–/– DC in the presence of OVA323–339 peptide (50 ng/mL)
alone or in conjunction with SEA (50 lg/mL) or Pa (10 lg/mL).
On day 3, CFSE-labelled CD4+ cells were washed, stained with
anti-CD4-allophycocyanin (Pharmingen), then assessed by flow
cytometry as described above. For measurement of intracellular
cytokine, non-CFSE-labelled CD4+ cells were stimulated for 4 h
with PMA (10 ng/mL), ionomycin (1 lg/mL), and Brefeldin A
(10 lg/mL). Cells were then washed and stained with anti-CD4-
allophycocyanin before being fixed using Cytofix/Cytoperm (BD
Pharmingen), according to manufacturer's protocol. Intracellular
cytokines were labelled with anti-IFN-c-FITC and anti-IL-4-PE
(both from Pharmingen).
Assessment of DC priming ability in vivo
DC activated overnight with either SEA or Pa were injected into
mice (2 # 105 per footpad or 3 # 105 i.p.). In some experiments,
DC were also pulsed with OVA peptide (data not shown). Cell
suspensions were prepared from spleens removed 7 days after i.p.
DC transfer, or popliteal LN cells 4 days after footpad injection. In
some experiments, mice received 4 # 106 OTII cells 1 day
previously. Spleen and LN cells were cultured in X-Vivo 15TM
serum free medium (Cambrex Bio Science, Wokingham, UK) with
2 mM L-glutamine (Gibco, Paisley, UK) and 50 lM 2-ME (Sigma,
Poole, UK) without or with SEA at a final concentration of 15 lg/
mL, Pa at 1 lg/mL, or OVA peptide at 1 lM. Supernatants were
harvested after 72 h (splenocytes) or 48 h (LN cells) for cytokine
analysis by ELISA. Results did not differ significantly when
transferred DC had been activated with SEA or Pa for 6 h rather
than overnight (data not shown). In OTII co-transfer experiments,
SEA was not found to consistently act as an adjuvant for OVA
peptide-specific IL-4 production (data not shown).
Determination of Notch ligand expression
Total RNAwas extracted from 1#106 DC using Trizol (Invitrogen)
and cDNA generated using Reverse Transcriptase System with
random hexamers (Promega, UK). Notch ligand expression was
assessed by quantitative PCR using SYBR green (Invitrogen), a
Chromo4 detector and Opticon Monitor software (MJ Research).
Relative expression values were calculated by dividing the
acquired expression quantity for the gene of interest using SYBR
by the expression quantity of 18S rRNA, and using a serially
diluted standard of pooled cDNA or using the 2–DDC(t) method.
Primers used were (50–30): murine jagged2 forward
GTCGTCATTCCCTTTCAGTTCG, reverse AGTTCTCATCACAGCG-
TACTCG; murine jagged1 forward GCAACGACCGTAATCGCATC,
reverse TGCCTGAGTGAGAAGCCTTTTC; murine delta4 forward
AGGTGCCACTTCGGTTACACAG, reverse CAATCACA-
CACTCGTTCCTCTCTTC; delta1 forward GCACTACTACGGA-
GAAGGTTGCTC, reverse TCACACCCTGGAGACAGATTG; 18S
forward GTAACCCGTTGAACCCCATT, reverse CCATCCAATCGG-
TAGTAGCG.
Statistical analysis
The one-sample t-test was used to determine whether means
significantly differed in comparison to a standardized control
value.
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